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Background
Mental health problems are common, 
with one in four adults experiencing 
a problem.1 They might suffer from 
formal mood or anxiety disorders 
but symptoms can also be at a sub 
threshold level, for instance depressed 
mood, anxiety, irritability, stress, 
sleeping problems or psychosocial 
problems. Prevalence rates in primary 
care, for instance in the Continuous 
Morbidity Registration (CMR)
Nijmegen database, vary from 12 to 
3 3 % .2-6 These rates are increasing 
in all sociodemographic layers of 
the population.7 The World Health 
Organization (WHO) Global Burden of 
Disease Survey estimates that by the 
year 2020 , major depression will be 
second only to ischemic heart disease 
in the amount of disability experienced 
by sufferers.8 Disability levels in terms 
of impaired functioning and number of 
work days lost are high.9 Quality of life 
is often influenced negatively and in 
many patients symptoms are recurrent 
or chronic,10 leading to frequent visits 
to their general practitioner (GP) ,11 
Therefore, mental health problems 
account for a substantial proportion of 
the GP's workload.
GPs are to provide and coordinate 
continuous and comprehensive care 
for the patient w ithin the context of 
the patient's physical, psychological, 
social, cultural and existential 
dimensions. Therefore, GPs use a 
person-centered and holistic approach 
within their patient contacts.12 An 
essential ingredient is the GP-patient 
partnership, because it offers the 
opportunity to empower patients 
to become active in managing their 
health. It has been advocated that 
patient empowerment should be
considered as one of the essential 
characteristics of family medicine.13 
Patient empowerment is a process 
of helping patients to assert control 
over factors that affect their health. 
This process begins w ith information 
and education and includes active 
participation of the patient in 
treatment decisions.14 When patients 
are more informed, involved, and 
empowered, they interact more 
effectively with healthcare providers 
and strive to take actions that 
will promote healthier outcomes. 
Contrary to the biomedical model, the 
empowerment model requires that 
patients are viewed as experts on 
their own lives who are responsible for 
their own health. This may in case of 
somatic illness, for instance diabetes, 
lead to the one patient deciding to stop 
smoking and the other patient deciding 
to lose weight. In the case of mental 
illness it is important to empower 
patients so that they learn how to deal 
better with their emotional symptoms. 
This fits  in w ith the wish of many 
patients with emotional symptoms to 
be treated non-pharmacologically.1517
Most patients w ith mental health 
problems are treated adequately 
by their GP and only a minority of 
patients is being referred.18 GPs 
often prescribe medication, usually 
benzodiazepines or antidepressants,18 
but medication is not always 
appropriate: it is not always indicated, 
has important side effects,19-20 patient 
adherence is low,21 the effectiveness 
of benzodiazepines is limited,22 and 
the effectiveness of antidepressants 
is being disputed.23 Pharmacological 
treatment mainly stems from the 
biomedical approach, whereas 
patients more frequently desire the
patient-empowering approach as 
they prefer non-pharmacological 
treatments.1517 Many GPs already 
incorporate non-pharmacological 
approaches in their mental health 
treatment, because counseling is 
nearly always part of the treatment by 
GPs.24 Nevertheless, both GPs and GP 
registrars have expressed the wish to 
learn a more structured way to manage 
patients w ith mental health problems 
in general practice.25 28 Although some 
educational interventions for GPs to 
manage mental health problems have 
been studied, patient outcomes have 
not significantly improved.29-30 
Problem-solving treatment (PST) could 
be an attractive non-pharmacological 
treatment option. It has a highly 
patient empowering character 
because the aim of PST is to teach 
patients how they can deal themselves 
w ith every-day problems. Patients are 
provided with tools to directly manage 
their actual behaviour on dealing with 
problems, rather than to manage their 
cognitions -  as is common in cognitive 
behavioural therapy. Furthermore, 
it is a brief and practical treatment 
w ith a treatment protocol specifically 
designed for use by primary care 
workers.
Problem-solving trea tm en t
Problem-solving treatment (PST) is 
a brief and practical psychological 
treatment, derived from cognitive 
behavioural therapy (CBT). In the 
seventies, the American psychologists 
D'Zurilla and Goldfried described 
problem-solving therapy  as a process 
w ith five stages31: problem orientation, 
problem definition, generation of 
alternative solutions, decision making, 
and solution implementation. This 
1 1 2 - 1 3  therapy was based on the principles
of CBT. In the nineties, the British 
psychiatrist Dr Mynors-Wallis 
developed an abbreviated form for 
usage in a primary care setting, and 
called it problem-solving treatment. 
This thesis is about the la tter form.
The aim of PST is to teach patients 
how to use their own skills to cope 
with everyday life problems in a 
systematic way. It is assumed that 
symptoms reduce when patient (re) 
gain control over their problems. 
Common emotional symptoms include 
depressed mood, feeling stressed, 
loss of enjoyment in life, worries, 
poor concentration, feeling hopeless, 
and irritability. Common physical 
symptoms include sleep problems, bad 
appetite, tiredness, headaches, and 
non-specific pains. Most frequently 
mentioned areas of problems in 
everyday life are relational problems 
with partner, children, family or 
friends; work; money; housing; health; 
few recreation activities.
As Mynors-Wallis set out in his 
manual,32 "the firs t goal of PST is to 
increase the patient's understanding 
of the link between their current 
symptoms and their current everyday 
problems, and that control over 
such problems will help to improve 
symptoms. The second goal is to 
increase the patient's ability to clearly 
define their current problems. Also, 
the importance of setting concrete 
and realistic goals is stressed and 
practised. The third goal is to teach the 
patient a problem-solving procedure 
how to solve their problems in a 
structured way. The fourth goal is to 
generate more positive experiences 
regarding the patient's ability to 
solve problems. In this way patient's 
confidence in their problem-solving
ability and their feelings of self-control 
during problematic situations increase. 
A fte r PST the patient should be 
able to cope w ith current and future 
problems and thus minimise emotional 
symptoms. It is a collaborative 
treatment w ith an active role for the 
patient who takes more control in 
subsequent sessions whereas the 
therapist's role gradually decreases." 
These treatment goals are aimed for 
via seven specific stages during each 
session. The seven stages are:
1. Explanation of the treatment and 
its rationale;
2. Definition and breaking down of 
the problem;
3. Establishing achievable goals;
4. Generating multiple possible 
solutions;
5. Evaluating and choosing the 
solution(s);
6. Implementing the preferred 
solution(s);
7. Evaluating the outcome after the 
solution has been implemented.
In stage 6, the therapist and 
patient formulate an action 
plan for implementation of the 
preferred solution w ith the actual 
implementation happening between 
two sessions. Stage 7, evaluation 
of the implemented solution, takes 
place in the subsequent session and is
Case v igne tte  
Intake
Frank is a 37-year old man. He is married and has two sons (6 and 8 years old). He visited my practice 
for a low mood, irritab ility and long lasting low back pain. Physical examination, an X-ray and a visit to 
the neurologist had not revealed any abnormalities of his back. He has been in sick leave for six weeks 
now and is not starting to feel any better. He works in a big car factory, where many colleagues have 
been fired due to the economic recession. Therefore, the atmosphere has changed negatively over 
the last few months. Furthermore, his manager is complaining about his sick leave and wants him to 
come back to work. At home he's feeling tired all the time, not doing any sports or social activities. He 
is feeling a bad father for his children and he's feeling an unpleasant husband for his wife.
F irs t PST session
In the firs t session I ask him which of these problems he wants to address first. He chooses the feeling 
of being a bad father. We work this out via the specific problem-solving stages and define them as 
following:
Problem: "I'm feeling a 'bad father' because I don't do any nice things with my children anymore.”
Goal: "To do at least two nice activities with my children within the next two weeks.”
Brainstorm: "To go to the play garden; to the cinema; cycling; swimming; painting; cooking pan cakes” 
Homework: "Taking them to the play garden, and preparing pan cakes with them.”
Follow-up session
They ate pan cakes together, and he went to the play garden w ith his two children. He was very 
satisfied about that and had enjoyed it a lot. When asking him how he had been feeling in the play 
garden, he looked surprised at me and said Actually I fe lt much better at that time'.
followed by addressing a new problem 
via the specific stages. The treatment 
consists of four to six sessions over a 
period of approximately 8-12 weeks 
w ith a duration of no more than 30  
minutes, except for the firs t session 
which may last 60 minutes. During 
each session the therapist uses a PST 
work sheet: see appendix A.
PST is effective in depression.33-36 
Also, there is some evidence that it 
has positive effects for anxiety,37-33 
unexplained physical symptoms,39 
deliberate self-harm,40 personality 
disorders,41 and palliative care.42 
Various self-management programmes 
that include problem-solving, for 
instance for diabetes, low back pain 
and osteoarthritis, showed improved 
self efficacy and patient outcomes.43- 
45 PST has been shown to be effective 
when delivered by different therapists, 
varying from psychiatrists and 
psychologists to nurses and research 
GPs, w ithout relevant differences 
in effectiveness. These therapists 
were, however, all unfamiliar to the 
patient. There is no evidence available 
for PST being provided by patients' 
own physicians. Furthermore, most 
studies included distinct groups of 
patients -  such as major and minor 
depression or dysthymia -  whereas 
GPs are mostly confronted with a 
typical mixture of emotional symptoms 
or with patients not meeting diagnostic 
(DSM-IV) criteria for depressive and/or 
anxiety disorders. For this category of 
patients there is only little  evidence for 
or against PST.37-46 There have been 
performed three systematic reviews 
on PST.47-49 However, these reviews 
did not specifically focus on studies 
performed in primary care nor did they
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of PST for the broad range of mental 
health problems seen in primary care.
The fact that PST is effective for 
many (mental) health problems 
implies that problem-solving skills 
can be used more widely as a tool 
for patient empowerment in general. 
Together with its brief character, this 
makes problem-solving an attractive 
technique for GPs. However, PST was 
not yet available in the Dutch primary 
care setting.
This s tudy
Worldwide, teaching of the 
management of mental health 
problems in residency programmes has 
largely focused on accurate diagnostic 
skills and appropriate prescribing,23 
whereas GP registrars would welcome 
learning more counseling skills and an 
effective tool for non-pharmacological 
treatment of emotional symptoms.50 
By introducing PST in the GP 
residency programme we expected 
two advantages: a. the registrars' 
need could be met in an early stage, 
and b. the residency programme 
would provide optimal training and 
supervision circumstances.
In the Netherlands, GP registrars 
follow a three-year residency 
programme. In the firs t and third 
year they are attached to a primary 
care practice in the community. In 
the second year they do a rotation 
between emergency room, nursing 
home and mental health care. 
Throughout the whole programme they 
come back to university one day every 
w eekfor supervision and training in 
groups. An American pilot study with
11 GP registrars being trained in PST 
showed that registrars can be trained 
successfully in PST but the authors
recommended further investigation 
with a larger sample of registrars and 
evaluation of patient outcomes.51 We 
aimed to include the broad range and/ 
or mixture of emotional symptoms 
which characterises general practice 
as GPs often see mixed symptoms 
rather than specific, full blown DSM-IV 
disorders.52
Therefore, in this thesis the following 
research questions are addressed:
I. What is the feasibility of PST 
training during GP residency?
II. What is the effectiveness of PST 
delivered by trained GP registrars 
for patients w ith recurrent or 
chronic emotional symptoms?
We planned to compare the 
effectiveness of PST versus usual care 
for patients w ith emotional symptoms 
in a pragmatic randomised controlled 
clinical trial. PST and usual care were 
provided by GP registrars who were in 
their last year before qualifying as a 
GP. As we aimed to include the broad 
range of emotional symptoms typically 
seen in the primary care setting, we 
defined emotional symptoms as sub 
threshold as well as formal disorders 
of depressed mood, anxiety, stress, 
irritability, sleep disturbance, and 
psychosocial problems. W ith the 
terms emotional symptoms, emotional 
problems and mental health problems 
we meant the same category of 
patients. Thus, in this thesis the 
terms emotional symptoms, emotional 
problems and mental health problems 
are interchangeable.
Outline o f th is  thes is
Part I. Feasib ility o f PST tra in ing
during GP residency
Chapter two  describes a feasibility 
study of GP registrars who were 
randomised to PST training. By 
observation and questionnaires, we 
measured registrars'participation in 
the training, the number of patients 
treated w ith PST, and registrars' 
opinions about the training and 
treatment.
Chapter three  shows the views of GP 
registrars on PST in general practice 
and on PST during GP residency.
For this objective we performed a 
qualitative focus group study.
Chapter four addresses the attitudes 
of GP registrars toward participation 
in research. One of the barriers we 
experienced during our study was the 
resistance of registrars to participate 
in the research project. We, therefore, 
were interested in their views on 
participation in research in general.
We assessed their participation and 
opinions through observation and a 
questionnaire.
Part II. E ffec tiveness o f PST fo r  
pa tien ts  w ith  emotional symptoms in 
prim ary care
Chapter five  shows the results 
of a systematic review according 
to the principles of the Cochrane 
Collaboration. We aimed to 
systematically review the evidence for 
and against the effectiveness of PST 
and to perform a meta-analysis, which 
generally provides a better overall 
estimate of a clinical effect than the 
results from individual studies. The 
review focused on the effectiveness 
of PST provided by specifically trained
GPs, nurses or other primary care 
health workers in primary care patients 
w ith all kinds of emotional problems.
Chapter six describes the results of an 
effectiveness study. We performed a 
controlled clinical trial to compare the 
effectiveness of PST and usual care in 
primary care patients with emotional 
symptoms. The main outcomes were 
symptom severity and quality of life.
Chapter seven contains a general 
discussion about the methods and 
findings of this thesis and ends with 
recommendations for general practice 
and GP residency programmes and for 
further research.
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Appendix A
Problem-solving worksheet
1. Problem
2. Goal(s)
cons: 
cons: 
cons: 
cons: 
cons:
4. Choice of solution(s)
5. Steps to achieve solution (homework)
a)
b)
c)
d)
Next appointment
3. Solutions
a) pros:
b) pros:
c) pros:
d) pros:
e) pros:
6. Evaluation
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In troduction
In primary care patients frequently 
present with emotional symptoms 
and/or psychosocial problems.1 
Most of these patients are treated 
w ithout specialist referral.2 Usual 
care by general practitioners (GPs) 
mostly consists of counseling and 
medication.2-3 However, medication 
is not always the best option4-5 nor 
does it meet patients' preferences,6 
and the effectiveness of counseling is 
unclear. Many GPs and GP registrars 
have expressed the need for more 
practical skills training in managing 
emotional symptoms.7-8 We therefore 
introduced training in problem­
solving treatment (PST) into the GP 
residency programme. PST is a brief, 
psychosocial intervention teaching the 
patient a systematic way of dealing 
with problems of everyday life. The 
treatment has shown effectiveness 
in depression and other emotional 
symptoms,911 and it also improved 
self-efficacy in patients with diabetes, 
low-back pain, and osteoarthritis.12“
14 This implies that problem solving 
skills can be used as a tool for 
patient empowerment in general. 
Together w ith its brief character, this 
makes problem solving an attractive 
technique for GPs. In this pilot study, 
we assessed the feasibility of PST 
training in GP residency.
Methods
We performed an observational study 
with GP registrars in the GP residency 
programme in the Netherlands. We 
randomly selected 21 third-year 
GP registrars, who were in their 
last year of training to qualify as a 
GP. A fte r training in PST, registrars 
selected and treated patients with 
emotional or psychosocial problems
with PST in their teaching practice. By 
observation and questionnaires, we 
measured: registrars'participation in 
the training; time spent on training, 
supervision, and treatment; number of 
patients treated w ith PST; registrars' 
performance in treating patients; and 
registrars' opinions about the training 
and treatment.
Problem-solving tre a tm en t and 
Training
PST is a brief psychological treatment, 
derived from cognitive behavioural 
therapy, specifically developed for 
primary care.15 Patients receive an 
explanation about the link between 
their emotional symptoms and current 
psychosocial problems. They learn 
how to use their own skills to resolve 
problems and improve their symptoms. 
PST comprises the following stages: 
clarification of the problems; 
establishing achievable goals; 
generating solutions; selecting and 
implementing preferred solution; and 
evaluation. The full treatment consists 
of four to six sessions of about 30  
minutes (first session 60 minutes).
The registrars received a two-day 
training by experienced PST trainers, 
followed byfive months'supervision on 
treatment of patients in the registrars' 
practice.
Results
Twenty registrars completed the two- 
day training and evaluated it as useful 
(see Table 1). They all practised PST 
and treated in total 52  patients under 
supervision (median 2.5 patients per 
registrar; range 1-5). The median 
number of sessions per patient 
was 3 (range 1-6). All 20 registrars 
received feedback on their treatment 
techniques. Average attendance
rate during the three group-feedback 
sessions (IV 2 hours each) was 70% . 
Sixteen registrars received individual 
feedback (5-30 minutes per contact). 
Overall, the supervisor reported good 
performance of PST in 18 registrars.
At the end of the supervised treatment 
period, 17 registrars completed a 
questionnaire (see Table 1). Aspects 
that registrars liked most included the 
clarifying character of the treatment 
(n=7), thinking in terms of practical 
solutions (n=7), the active role of the 
patient (n=4), and helping patients to 
increase insight in and control over
their own problems (n=4). Aspects that 
registrars liked less included the extra 
time they needed for treatment (n=10) 
and the d ifficu lty in defining their role 
as a GP whilst providing psychological 
treatment (n=3). Some registrars (n=4) 
liked the structure of the treatment; 
others (n=5) disliked it.
At the end of their third year, 15 
registrars completed the last 
questionnaire: 14 assessed education 
in PST as positive, and 14 assessed 
the amount of time necessary for 
treatment as negative.
Table 1 Registrars' opinions about the PST training programme
Item of questionnaire Average on 5-point 
scale8 (range)
Two-day training (20 participants): 
Usefulness overall 
Relevance of lectures 
Relevance of role-play 
Relevance of video feedback 
Feeling of being suffic iently trained
(20 respondents)
3.8 (3-5)
4.0(1-5)
4.2 (2-5)
3.9 (1-5)
3.8 (3-5)
Supervised treatment period (20 participants): 
Usefulness of group feedback 
Usefulness of individual feedback 
D ifficu lty with selecting appropriate patients 
D ifficu lty with patients willing to sta rt 
D ifficu lty with defining the problem clearly 
D ifficu lty with stating achievable goals 
D ifficu lty with finding solutions
(17 respondents)
3.6 (2-4)
3.9 (3-5)
3.8 (2-5)
2.6 (1-4)
3.7 (2-5)
3.6 (2-5)
2.8 (1-4)
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Discussion
This study demonstrated that 
training in PST is feasible during GP 
residency. Despite the compulsory 
character of the training and some 
critical comments, registrars stated 
that it brought them relevant, new 
skills. It met the need for practical 
skills training in the treatment of 
emotional symptoms in primary 
care. We therefore recommend PST 
training to be implemented as a core 
part in GP residency programmes. 
Experience from the US suggests that 
registrars will continue using PST, or 
parts of it, once qualified.16 This will 
be primarily for patients with mental 
health problems. However, the skills 
can be used more generically for a 
much larger part of the primary care 
population. It is most satisfying that 
our registrars themselves stressed the 
generic character of problem-solving 
skills: they appreciated having learnt
how to clarify patients' problems, 
to think of practical solutions, and 
to activate patients. These patient- 
empowering skills are useful in many 
other patient contacts and do not 
have to take much time. The fact that 
registrars themselves expressed this 
potential of problem-solving skills 
supports our reason of introducing 
PST during residency.
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Introduction
General practitioner (GP) registrars 
often express the need for more 
expertise of non-pharmacological 
treatments for patients with mental 
health problems. Problem-solving 
treatment (PST) could be an attractive 
option. We aimed to explore GP 
registrars'views on PST training 
during residency and on the actual use 
of PST in general practice.
Methods
We performed a qualitative study with 
four focus groups, interviewing 18 
Dutch registrars who had been trained 
in PST during residency. Data were 
analysed according to the principles of 
constant comparative analysis.
Results
Registrars thought that PST training 
during residency was feasible, 
interesting and helpful, but found 
that it took too much time in everyday 
practice and was not a GP's task.
All registrars, however, said they 
would use specific elements in a 
variety of consultations, for instance 
concretising problems, brainstorming 
about practical solutions, and 
activating patients.
Discussion
Registrars regarded PST training 
during residency feasible and helpful.
In daily practice they would apply 
specific elements of the treatment.
We recommend residency programmes 
to offer training in PST or another 
psychological treatment with 
comparable elements. Training should 
f it  in with the registrars' needs and 
level of training and experience.
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Many general practitioners (GPs) 
perceive educational needs with 
regard to the management of mental 
health problems. Mental health 
problems are common -  with one in 
four adults experiencing a problem1 - 
and further increasing in prevalence 
in primary care. The vast majority of 
these patients are treated by their 
own GPs,2 causing a considerable 
proportion of GPs'workload. In the 
teaching and training of (future) GPs 
the emphasis is on diagnostic skills 
and pharmacological treatment, at 
the expense of non-pharmacological 
treatment.3 Nevertheless, support 
and counseling are used in almost 
every case,3 7 but interventions 
for GPs to manage mental health 
problems did not improve patient 
outcomes significantly.8-9 GPs and 
GP registrars -  doctors in training 
to become a GP -  have expressed 
the need for more specific, practical 
(counseling) skills training in managing 
emotional symptoms.3-10-11 This fits  
in with the many patients who prefer 
non-pharmacological treatment within 
primary care for their mental health 
problems.1214 In this light, a different 
focus of mental health training in 
residency programmes has been 
proposed.15
Problem-solving treatment (PST) 
is a brief, practical psychological 
intervention, teaching the patient a 
systematic way to gain control over 
their own (mental health) problems of 
everyday life.16 (Re)gaining control will 
decrease symptoms. PST is effective 
in the treatment of depression and 
emotional symptoms.17-18 And there 
are indications that it is effective for
Introduction unexplained physical symptoms19, 
in palliative care,20 and in stroke 
patients.21 It has a maximum of six 
sessions, each limited to no more 
than 30  minutes. Furthermore,
PST incorporates skills such as 
patient empowerment that can 
be used in many patient contacts 
outside mental health problems. This 
makes it an attractive technique 
for GPs. PST training could meet 
the needs of registrars to learn a 
non-pharmacological intervention 
in an early stage of their career. An 
American pilot study showed that 
registrars are able to learn PST.22
We introduced training in PST into a 
Dutch GP residency programme. An 
earlier Dutch study confirmed that 
PST training was feasible during GP 
residency,23 but a number of registrars 
did not apply it to eligeable patients.24 
The aim of this study was to explore 
the registrars'views on PST and its 
use in general practice for patients 
with emotional symptoms.
Methods
We conducted focus group interviews 
with GP registrars in Nijmegen, the 
Netherlands, nested in a clinical tria l.24 
This trial had randomised 20 third- 
year registrars into PST treatment for 
emotional symptoms and provided PST 
training during their residency training. 
PST is a brief psychological treatment, 
derived from cognitive behavioural 
therapy, aiming to increase patients' 
awareness of a link between everyday 
life problems and symptoms, and 
to teach them to cope with these 
everyday problems in a systematic 
way.16 Each PST session comprises
seven stages in which problems are 
identified and clarified, goals are 
set, and solutions are worked out 
(Figure 1). This is a collaborative 
process between GP and patient, 
w ith the patient gradually taking over 
control. By learning better problem­
solving skills patients can deal better 
w ith current and future problems.
The treatment consists of four to 
six consultations over a period of 
approximately 8-12 weeks w ith a 
duration of no more than 30  minutes 
each, except for the firs t session which 
may last 60 minutes. The registrars 
were trained by experienced PST 
trainers in a two-day course and 
trainers supervised treatment during 
5 months through individual and 
group feedback sessions.23 This was 
followed by a six-month period of the 
clinical trial.
Focus group interviews took place 
at the end of the trial (February 
2004). We chose focus group 
interviews rather than individual 
interviews because of the benefit of 
group interaction which stimulates 
participants to explore and clarify 
their views into more depth.25 We 
grouped the registrars into four focus 
groups, taking into account their
gender and their attitude towards 
PST. We received information about 
their attitudes from one of the trainers 
who met the registrars regularly 
during group feedback sessions in 
the 5-month supervised treatment 
period. By putting registrars with 
negative attitudes in one and the same 
group, they got ample space for their 
(negative) comments. The minority of 
male registrars were spread over the 
groups. Two GP registrars were unable 
to attend the focus group interviews, 
leaving 18 participants (12 females) 
for two groups with four and two with 
five registrars. Their mean age was 32  
(range 27-41) and they had treated on 
average 4.3 patients with PST each 
(range 1-9).
The interviews lasted approximately 
60 to 90 minutes and were facilitated 
by two independent skilled moderators 
(one psychologist, one GP) and by 
using an interview guidebook. Through 
the guidebook (see Table 1) registrars' 
views were explored on: a. PST as a 
treatment for patients w ith emotional 
symptoms; b. PST in general practice; 
c. PST during GP residency. Both 
enabling and disabling factors for 
its use were discussed. In the fourth 
focus group interview saturation
Figure 1. Problem-solving tre a tm en t (PST)
A brief psychological treatment w ith 7 stages:
1.Explanation and rationale
2.Clarification and definition of the problems
3 .Establishing achievable goals
4 .Generating solutions through brainstorming 
5 .Selecting preferred solution
6 .Implementing solution
3 3 2 - 3 3  7. Evaluation of progress
was reached w ith no new major 
themes arising. The interviews were 
audio-recorded with the participants' 
consent and ethical approval for the 
project was provided by the University 
of Nijmegen.
Analysis
Data collection and analysis was 
conducted as an iterative process 
which means that the three 
researchers (LH, ToH, EvW) added 
relevant topics to the guidebook 
a fter a preliminary analysis of 
each interview. All interviews were 
transcribed verbatim. The firs t author 
checked the transcripts and entered all 
data into Atlas.ti, a software package 
to support the analysis of qualitative 
data. According to the principles of 
constant comparative analysis26 in 
which transcripts are subsequently 
thematically coded, transcripts were 
read and re-read by LH, ToH and 
EvW to identify recurring themes.
They independently made a firs t 
categorisation by coding meaningful 
sentences. Initial codes were 
discussed, seeking agreement on their 
content, and then grouped into themes 
to identify registrars'views on PST. 
Recurrent and important themes were 
frequently discussed and refined as 
part of an ongoing iterative process.27 
The emerging themes were then re­
read.
To enhance the validity of our 
findings we triangulated our data by 
comparing them with the results of a 
questionnaire survey among registrars 
of the subsequent year.28 The written 
answers to these open questions 
were qualitatively analysed by two 
researchers.
Results
Five major themes evolved from the 
focus groups: registrars' 1. views 
on GPs' role in mental health care;
2. positive experiences w ith PST; 3. 
negative experiences with PST; 4. 
views on PST in general practice; and
5. views on PST during residency. In 
general, those registrars who had 
treated more patients with PST were 
more positive about PST than those 
who had treated fewer patients. We 
did not find major differences between 
registrars who were grouped as having 
a more positive attitude and those with 
a more negative attitude.
Role o f GPs in mental health care
Registrars expressed that mental 
health care certainly is part of the 
GP's function. Firstly, GPs should 
be able to diagnose mental health 
problems. And secondly, they should 
be able to manage mental health 
problems up to a certain level. They 
saw their role more in support than 
in treatment of these problems, and 
in particular in case of relatively new 
and uncomplicated problems. They 
would refer patients who had more 
complicated or chronic problems, 
orwho needed more long-lasting 
counseling, or who did not improve. 
They emphasised the importance of 
the GP-patient relationship: in a good 
relationship they would tend to counsel 
longer, as this was often associated 
with better outcome. Applying a 
specific psychological treatment is 
not the task of a GP, according to the 
registrars, although it could be the 
interest of some GPs.
'7 would like to be able to map the 
problems out and diagnose them and 
then it's e ither done or I can re fer 
them or maybe I can help them - not 
in the sense o f developing a long-term  
trea tm en t plan but more in the sense 
of, uhm, offering support. I can't do 
much more than tha t."(14, male, FG4)
'7 do think I can play a role but tha t 
role would be small. That means short 
treatments. I would do tha t myself 
[...] If I th ink tha t it is going to take 
longer or tha t the problems are more 
complicated, then I would be more 
inclined to re fer patients to someone 
else." (01, male, FG1)
Positive experiences w ith  PST
Most registrars appreciated the 
structure of PST as this provided them 
with a model how to set the agenda of 
the consultation. They were happy with 
addressing 'here and now' problems 
because it made the treatment very 
practical. Also, they all liked that PST 
forced them to make the problems of 
the patients as concrete as possible. 
This enabled them to define problems, 
goals and homework more precisely. 
Furthermore, they explicitly stated 
they liked the activating character 
because the treatment has a patient- 
centred approach in which the goals 
and solutions are set and carried out 
by the patient. Specific parts of PST 
they had appreciated were linking 
symptoms to problems, the patients' 
insight in their problems, focusing at 
only one problem during each session, 
setting goals, and brainstorming about 
solutions.
'7 th ink tha t it is a good method for 
exploring things concretely and it gives 
people a tool by which they can s ta rt to 
work on things right away. It gets them  
started.” (05, female, FG2)
"You guide the patient but, really, it's 
the patient tha t does the work (sounds 
o f agreement); he or she comes up w ith  
the solutions." (07, female, FG2)
“What I think is really good is tha t you 
can help the pa tien t to explore his 
or her own problems and they learn 
something from that. I th ink it's good 
tha t they then can s ta rt dealing w ith  
those problems on the ir own. So it 
promotes independence." (06, female, 
FG2)
“I do make tha t link now between the 
complaints and the, the reasons behind 
them - the way all things [symptoms 
and problemsI are re lated to each 
other. That is defin ite ly a useful, uh, 
useful element." (13, female, FG3)
They had experienced PST sometimes 
as a diagnostic tool, because in some 
cases many more problems became 
clear during treatment. They also 
appreciated that patients came to the 
insight that symptoms decrease when 
they work on their problems. Most 
registrars found it advantageous to 
teach patients how they can look at 
and manage problems, as these skills 
can be used in future problems too.
“It is not ju s t the trea tm en t a t tha t 
point in time but also the method or 
the way o f thinking tha t you try  to give 
them so tha t they can la te r apply it 
themselves.” (01, male, FG1)
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The most important negative 
experiences were: l. th e  structure of 
PST; 2. registrars'competence; 3. 
doubt about the effectiveness; 4. time 
investment.
Some registrars described the 
structure of PST as rigid or artificial 
and not giving them enough space 
to listen to patients' new stories, 
symptoms or problems because 
the psychological treatment kept 
them focusing on the problem of 
today's session. They fe lt hindered 
to react empathically. Furthermore, 
it was emphasised that PST can only 
address some problems and only to 
some extent, whereas some patients 
brought up many more (complicated) 
problems.
Negative experiences with PST “If people have had complaints again, 
then, all o f the sudden, they end 
up s itting  down w ith the ir general 
practitioner who then doesn't want 
to ta lk about physical complaints 
but actually wants to work on other 
problems, and I found tha t d ifficu lt 
sometimes. It was d ifficu lt to keep 
those two things separate fo r me but 
it was particu larly d ifficu lt fo r the 
patients and it was hard to be clear 
about tha t [...] It was like you had to 
say, uh, 'If you want to deal w ith the 
physical complaints, then you need to 
come back fo r another appointment." 
(03, female, FG1)
'W hat I experienced every time, or 
at least almost every time, was tha t 
people come back w ith 'yeah, but'and  
then mention the ir fatigue again or 
whatever they came for, and, yeah, you
Table 1. Focus group in te rv iew  guidebook
l .  Non-pharmacological • How do you regard your role in the non-pharmacological
treatment of emotional treatment of emotional symptoms?
symptoms .  |s there a need for a tool to treat emotional symptoms?
How did you treat emotional symptoms before PST 
training?
What do you think of PST?
When or what patients suit PST? When not?
What do you think about the role of the doctor versus 
the role of the patient?
What do you think about the effectiveness of PST?
What is the place of PST in general practice?
Can GPs provide PST? Why (not)?
What are the most useful elements of PST?
What do you think of your competence of PST?
4. Feasibility of PST during • Do you think PST could and/or should be part of the 
GP residency residency programme? Why (not)?
• What elements of PST are especially helpful during 
residency?
2. Problem-solving 
treatment (PST)
3. Feasibility of PST in 
general practice
don't really have enough time to go into 
those things because you have to stick 
to the PST protocol and I have to admit 
tha t I find tha t kind o f restric tive." (06, 
female, FG2)
“It is tha t the method is so fixed, and 
I th ink that's what I struggle w ith [...]
It's like it's all or nothing." (03, female, 
FG1)
Most registrars judged their 
competence of PST as unsatisfactory. 
They said they had had too little 
education and experience in this field. 
The perceived lack of competence 
demotivated some registrars to s ta rt 
PST. Furthermore, they found it hard 
to leave it to the patient to do the work.
“I think tha t I've only had a small taste  
o f it, a t least that's how it feels. And  
it kind o f feels like that's a little  unfair 
to patients because you o ffe r the 
patients something tha t I am not sure I 
can give them in the way it is intended." 
(05, female, FG2)
“I think that, in general, we are 'do-ers' 
and so we want to determine how it 
can best be done." (16, female, FG4)
Registrars had doubts about the 
effectiveness of PST, because it did 
cost a lot of their energy and time but 
resulted in varying outcomes. Some 
believed the effect to be the result of 
time and attention. The likelihood that 
symptoms would improve over time 
w ithout doing a formal treatment like 
PST was a barrier to s ta rt PST. Once 
treatment results were less positive 
than expected, some registrars 
perceived this as a barrier to apply PST 
in further patients.
“Some patients have really been 
helped w ith it but there have also been 
a few patients whereby I really wasn't 
satisfied. I would like to see some more 
evidence." (03, female, FG1)
“I have consciously chosen not to 
suggest it but I've thought to myself 
W hat on earth am I subjecting this 
patien t to w ith P S T ? '(sounds o f 
agreement). I th ink tha t a lot o f issues 
resolve themselves in time and w ith  
a few consultations instead o f six, 
uh, ha lf hour consultations. And it 
demands a lo t from the patient, which 
doesn't always seem to be better." (02, 
female, FG1)
Registrars experienced time 
investment as the most important 
barrier. They thought that PST took 
too much time for an individual patient. 
They stated that the strong structure 
and repeating, long sessions did not 
f it  into the common structure of Dutch 
general practice w ith a 10-minute 
consultation system. Some of them 
had solved this problem by doing only
3 to 4 sessions w ith each patient or 
giving the patient homework.
“I th ink tha t the way in which the 
trea tm ent is conducted does not f it  
well w ith general practice. The number 
o f consultations and the length o f 
those consultations [..J I th ink it 
demands too much time from a fam ily  
doctor's practice [...] and it messes 
up your consultation hours. It is a lot 
o f hassle and it is very d iffe rent work 
than what we are used to." (02, female, 
FG1)
“I have to say tha t I indeed held three  
consultations and then I was p re tty
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much done w ith it. I dealt w ith two  
problems and when we got to the third,
I sent the patient home w ith homework 
and said, 'W rite up a list o f problems 
and do your homework.' I wouldn't want 
to do a six session PST." (09, female, 
FG3)
We identified two groups of registrars 
in terms of more flexible and more 
rigid. The firs t group regarded 
PST as a helpful tool they tried to 
use in a tailor-made way for many 
patients. They were satisfied with 
their competence. The other group 
regarded PST as an inflexible method 
w ithout any space for the patient. They 
saw only few indications for PST and 
did not feel very competent. The firs t 
group was more positive about PST 
than the la tter group.
“I noticed tha t the more, uh, you get 
used to it and develop the skills, the 
more you can let go and tha t you then 
kind o f make it your own thing." (07, 
female, FG2)
“You don't really consider who is s itting  
across from you. The procedure is 
p re tty  much the same fo r everyone." 
(01, male, FG1)
PST in general p rac tice
Most registrars thought that PST did 
not f it  into general practice because of 
the aforementioned time investment, 
structure and doubts about the 
effectiveness. There were some more 
barriers. Some registrars emphasised 
tha tthey  were not happy with their 
role during PST. They fe lt a 'double role' 
of being a psychologist and a GP at the 
same time. They thought it could be a
barrier for patients to come to them as 
a GP again a fter PST, because patients 
might see them as a psychologist.
“Perhaps that's why people haven't 
come back to see me. Perhaps they've 
gone to another GP fo r the ir other 
complaints because I treated the ir 
emotional symptoms. I can imagine 
tha t patients would find it more 
d ifficu lt to come back to me fo r ju s t a 
sore toe or something." (02, female, 
FG1)
Many registrars found it hard to decide 
on the proper indications for PST. They 
thought PST was applicable in only a 
small group of patients. They thought 
that the more longstanding the GP- 
patient relationship was, the easier it 
was to decide which patients would 
benefit from PST.
“I th ink tha t the training GPs are more 
suitable because they have already 
built a relationship w ith the patient 
and they are be tte r able to assess the 
patient." ( 18, female, FG4)
Nevertheless, most registrars were 
able to specify the indications for 
PST. They thought it was especially 
appropriate for patients w ith recently 
arisen, daily life problems -  such as 
problems w ith work, relationship, 
family, house, et cetera -  or patients 
who put forward their problems so 
that it became a chaos resulting in 
symptoms of mild depression, burn-out 
or varying physical symptoms. These 
patients don't see where to s ta rt 
managing their problems. According to 
the registrars, PST could give them the 
feeling of being in control of their lives 
again. Some registrars stated that
they did not think PST was appropriate 
for patients with many or complex 
problems because they thought they 
could reach too few effects, whereas 
others were happy to make at least a 
starting point.
“I th ink tha t it is particu la rly useful for 
giving people a sense tha t they can 
have control over the ir own lives and 
tha t they can deal w ith the ir problems 
again, and, yeah, it is not really tha t 
you can trea t someone's depression 
w ith it but it does give people 
something to hold onto and gives them  
the idea: 7 can do something about 
th is.1" (11, male, FG3)
“You try  to solve something and I find  
tha t tha t kind o f falls short. People 
have such huge problems and you can 
only deal w ith a tiny little  pa rt o f those 
problems in those few  sessions." (05, 
female, FG2)
“But even if  there are more problems, 
you have to s ta rt somewhere, righ t? " 
(03, female, FG1)
According to the registrars PST 
was less suitable for patients with 
moderate, severe or long-lasting 
depressive symptoms and contra­
indicated in suicidal patients. Also, 
patients w ith (alcohol) addiction, 
personality disorders or dependent 
personality traits, and patients who 
could not link symptoms to problems 
did not benefit from PST.
"A major depression or a m inor 
depression: I don't think I can [handle 
that]." 102, female, FG1)
“What is contraind icated?" (Moderator)
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“Alcohol abuse, addition." (02, female, 
FG1)
“I don't think it works tha t well w ith all 
patients because often they cannot 
make tha t link where, uhm, they move 
away from focusing on the complaints 
and towards dealing w ith the 
prob lems."(06, female, FG2)
Some registrars thought that it 
also depended on specific patient 
characteristics, for PST to be 
appropriate. They thought it was 
easier in patients w ith some 
intellectual capacities, whereas others 
thought that the patient's character 
and motivation was more important: 
patients must be willing to take the 
initiative to improve their situation.
“I don't think intelligence would be 
a barrie r a t all but it is more about 
whether or not it fits  w ith a particu la r 
personality. [...] I th ink it really fits  w ith  
someone who wants to take things 
into the ir own hands but w ith someone 
who is quite dependent on others 
and who, uhm, maybe is looking fo r a 
compliment, I don't th ink it fits  as well 
w ith those kinds o f people." (11, male, 
FG3)
“I would compare it to quitting smoking: 
I f someone isn't motivated, I can put all 
my energy into try ing to motivate him 
but I don't really want to do that, and I 
don't th ink it would have much effec t." 
(01, male, FG1)
Because of the above reasons, not 
all GPs should learn PST, according 
to the registrars. Nevertheless, they 
emphasised that GPs are able to 
master PST and that this would be
interesting for GPs w ith a particular 
interest in mental health care. Other 
GPs might in their view involve a 
(mental health) nurse or colleague-GP 
in their practice to actually perform 
the PST intervention. This would be 
interesting for patients, as registrars 
experienced that patients were happy 
to receive treatment for this type of 
problems in their own practice, rather 
than being referred.
“I th ink it is a good method and I 
th ink it would work ju s t fine w ith a 
psychologist or a nurse but, as a GP, I 
ju s t don't have enough time fo r it." (05, 
female, FG2)
"[S im ilarI to how we choose a certain  
drug, it's a method tha t needs to f it  
w ith somebody and if it does, then you 
choose tha t method." (05, female, FG2)
“I think tha t an advantage fo r the 
patient is the fac t tha t it's offered  
a t the GP's practice. It lowers the 
threshold significantly." (06, female, 
FG2)
Instead of using the entire treatment, 
registrars said that they would rather 
use elements of it, for instance 
concretising problems, setting goals, 
or brainstorming about solutions. Also, 
they preferred leaving more parts of 
PST as homework with the patient.
By doing so, they thought that PST 
sessions could f it  into regular double 
consultations of 20 minutes.
“I think tha t PST contains elements 
tha t I can use very well. For example, 
making things concrete and, uh, trying  
to work towards a goal and, uh, giving 
people homework." (03, female, FG1)
“Maybe a double consultation, twenty  
minutes. I think tha t would probably be 
enough, you could quickly go through 
all the steps and then I would probably 
give people more homework so they do 
more o f the work a t home." (07, female, 
FG2)
PST during residency
Before PST training, registrars fe lt that 
their diagnostic skills in mental health 
problems were satisfying but that this 
was not the case for their management 
skills. All registrars expressed the 
need for a more practical, structured 
tool to manage mental health problems 
and they thought that the current 
residency programme did not provide 
enough tools.
“Despite the fac t tha t we have known, 
fo r a long time, tha t many o f the 
complaints tha t present to the GP have 
a psychological aspect, I th ink tha t 
the GP residency programme pays too 
little  a tten tion to tha t." (10, male, FG3)
“I have always been frustra ted  tha t
I didn't have any tools to deal w ith  
that. It has always been lim ited  
to ju s t talking through things and 
those conversations are re latively  
unstructured, [...] sure, people can 
get things o ff the ir chests but there 
was nothing concrete you could do for 
them." (09, female, FG3)
“I have never really been tra ined in 
how to conduct a, uhm, therapeutic  
treatment, no t even during my 
psychiatry ro tation where I had really  
hoped to have been taught something  
like this." (06, female, FG2)
“It seems to be useful to have some 
kind o f s truc ture that, let's say, 
outlines how you should approach 
tha t." (18, female, FG4)
Registrars were positive about 
the PST training, because they 
found PST a useful and practical 
technique. Registrars thought that 
PST training during residency was 
feasible. However, in the opinion of 
the registrars the training should have 
been spread throughout the whole
3-year residency programme rather 
than being put solely in the 'over­
filled' third year. Also, registrars had 
experienced the limitation of being in 
training: they fe lt that many patients 
w ith mental health problems consulted 
their own GP rather than a registrar. 
Whether PST should be a standard 
part of the residency programme was 
being discussed: some thought it 
would be useful, especially the two- 
day training. All registrars thought, 
however, it could well be an optional 
part for interested registrars.
“I found the [two day[ course to be 
very useful." (06, female, FG2)
“I th ink tha t i f  it were to be 
incorporated in the residency 
programme, tha t it should not be 
crammed into the th ird year [...] but 
tha t maybe it should be spread out 
over the entire programme." (12, 
female, FG3)
'When I hear from fou r people who 
have done it tha t they will no t use it in 
the future, then I wonder i f  it should 
be incorporated in the residency 
programme where reg istrars already 
have too little  time to learn what they
need to learn [...] Perhaps it should be 
an elective." (03, female, FG1)
Discussion and Conclusion  
Discussion
This study aimed to explore the views 
of GP registrars on training of PST 
during residency and the use of PST 
in general practice for patients with 
emotional symptoms. It showed that 
registrars perceived a shortcoming in 
the residency programme with regard 
to providing them with skills to manage 
mental health problems. They stated 
that PST training during residency was 
feasible, interesting and helpful. They, 
however, thought that the training 
had been intensive within one year, 
and therefore suggested to spread 
the training over the full three years 
of their residency training. All said 
they would use particular elements of 
PST in general practice, rather than 
applying the entire treatment which 
they did not regard as part of the GP's 
tasks. They especially appreciated 
concretising problems, brainstorming 
about practical solutions, and 
activating patients. They thought that 
implementing specific elements could 
f it  into relatively regular 20-minute 
consultations. This corresponds with 
Hegel's study in which registrars 
mostly used abbreviated versions of 
PST, when evaluated at 3-year follow- 
up after training.22 Furthermore, 
the mentioned elements f it  in with 
the point of view on mental health 
care in general practice, published 
by the Dutch College of General 
Practitioners, stressing the 
importance of defining problems 
and helping patients to use their own
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resources to solve problems.29
Our findings f it  in w ith research 
among experienced GPs. For instance, 
our registrars mentioned the same 
barriers and enablers of using PST 
as GPs did in an earlier Australian 
study about PST.30 Both mentioned 
the useful, practical character of 
the treatment, which fits  into the 
pragmatic nature of many GPs' 
approach. Both regarded time as a 
precondition. Also, both registrars 
and GPs experienced the change from 
giving advice to facilitating the patient 
finding a solution that the patient 
owns. Although our registrars thought 
this was sometimes d ifficult to do, they 
valued this treatment characteristic 
highly. In a Danish study, GPs 
considered non-specific factors such 
as attentive listening very important.31 
Our registrars too thought that good 
listening is important but they thought 
that PST did not always give them 
enough space to do so, because they 
fe lt pressured by the structure of the 
treatment. They often experienced 
the structure as a handicap, which 
is striking since we know that most 
young physicians are positive about 
using highly structured guidelines for 
somatic illnesses.32 Perhaps they need 
some more confidence both in the 
contact with patient with emotional 
problems and in 'playing'with the 
treatment structure.
In some aspects, the registrars 
expressed different experiences 
than experienced GPs. Because it 
takes time to build a good doctor- 
patient relationship and because 
this relationship is needed in treating 
patients w ith emotional symptoms,
they experienced a disadvantage of 
working in the same training practice 
for just one year. Obviously, they 
were aware of the importance of 
the GP-patient relationship, which is 
known to correlate highly w ith patient 
outcomes.33 Due to the short-standing 
relationships they had difficulties 
deciding on 'the adequate patients' for 
PST. On the other hand they were able 
to mention many indications for PST, 
which reflects the relatively general 
character of PST.
The registrars stated that applying a 
full psychological treatment did not 
belong to the GP's tasks. In the light 
of the registrars' experience that 
mental and physical health problems 
are interwoven frequently, combined 
with the strong wish of patients to be 
treated by their GP,34 this attitude can 
be seen as somewhat unsatisfactory, 
as this interplay of mental and physical 
health problems was reason to 
propagate the integration of mental 
health into primary health care.35 An 
important factor that might play a 
role is that some registrars are not 
intensively enough exposed to mental 
health problems, because these 
patients prefer to contact their own 
GP rather than the resident as patients 
value longstanding relationships. It 
stresses the need -  for residency 
programmes -  to secure that registrars 
see the whole range of primary care 
patients, including those with mental 
health problems. This may strengthen 
their perception of their role in 
mental health care. Furthermore, 
registrars might still be predominantly 
biomedically oriented in order not 
to miss any illness. Considering 
these arguments, PST training could
probably be optimised by offering 
them generic elements of PST in an 
early stage of residency and repeat 
these in more detail in a later stage 
when they perceive a greater need.
In our view, the registrars 
expressed an ambiguity towards 
their involvement in mental health. 
They complained of a lack of tools 
provided in the residency programme
- a complaint that has been aired 
before.11-36 But at the same time, 
they objected to the compulsory 
nature of the PST training module, 
and expressed a restricted task for 
themselves and for GPs in general 
in mental health. In order to solve 
this ambiguity, as there is currently 
a strong advocacy to in tens ify  GPs' 
and primary care's role in mental 
health,35 we propose to insistently 
discuss this antinomy within residency 
programmes.
There were some limitations in our 
study. We evaluated in this focus group 
study the experiences w ith the very 
firs t Dutch PST training in residency. It 
is likely that this training suffered from 
its newness, influencing registrars' 
experiences negatively. On the other 
hand, the availability of a supervisor 
may have facilitated the use of PST. 
Also, registrars had been obliged to 
participate in the PST study, which 
caused a lot of resistance amongst 
them and made them experience 
PST training as'something extra' 
in an already full programme. This 
influenced their opinions negatively.
It was a strength of our study that we 
involved a relatively large number of 
registrars who had all participated in
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the full training programme. By doing 
a qualitative study we explored and 
clarified what they thought about 
PST during residency and about PST 
in daily practice. We succeeded to 
collect both positive and negative 
experiences. Triangulation of our 
data showed that the positive and 
negative experiences identified in 
this focus group study were more or 
less identical to those expressed in 
a questionnaire of another group of 
registrars.
This qualitative study examined 
registars' perceptions about PST 
and not their actual behaviour. By 
studying these perceptions we 
identified the experienced needs, 
barriers and enablers which can help 
in the implementation of PST or other 
psychological treatments in residency 
and everyday practice. Tape-recording 
the discussions, multiple coding during 
analysis and our triangulation strategy 
added to the rigour of the study.
Conclusion
Registrars thought that PST training 
is feasible and helpful during GP 
residency, especially because they 
had perceived a lack during residency 
in the tools being provided for the 
management of emotional symptoms. 
All registrars liked to use specific 
elements of the treatment in a variety 
of consultations within general 
practice. They especially appreciated 
concretising problems, brainstorming 
about solutions, and activating 
patients. However, they thought that 
the entire treatment costs too much 
time in everyday practice and is not 
part of the GP's tasks.
We recommend residency programmes 
to offer training in PST or another 
psychological treatment with 
comparable useful elements. It should 
be part of the standard programme, 
rather than being part of a research 
project in order to avoid 'study 
resistance'. Based on the experiences 
with the registrars of these focus 
groups, we have implemented an 
adapted PST training programme in 
the firs t year of residency in Nijmegen 
since 2008 . This programme focuses 
specifically on the generic elements 
of concretising, brainstorming and 
activating patients. We encourage our 
registrars to find multiple uses for their 
skills to increase the learning process 
and to transfer these skills into their 
practice patterns. Evaluation results 
of this new programme were good. 
Subsequently, we offer an optional 
programme with training in the fu ll 
psychological treatment in the second 
and third year. This will be evaluated 
in a later stage. Offering a training 
programme with generic skills at the 
s ta rt of residency and more specific 
skills in a later stage seems to f it  in 
with the registrars' needs and their 
level of training and experience.
In general, we highly recommend 
residency programmes to address 
the ambiguity of registrars' need for 
practical skills training against their 
restricted view on GPs' task in mental 
health.
Based on our results and those 
of an Australian study with GPs 
experiencing PST as useful,30 PST 
training might also be useful for GPs 
as a support in their management
Practice implications of mental health problems. In the 
Netherlands, the Dutch College of 
General Practitioners is offering a PST 
training since 2007. We recommend 
ongoing follow-up with booster 
sessions to consolidate the new skills, 
because training then is most likely to 
be effective.37
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A bs tra c t
Introduction
Early exposure of general practitioners 
to research is recommended to 
increase family medicine research 
capacity. However, vocational training 
programmes encounter difficulties in 
engaging general practice registrars 
in research projects. We investigated 
registrars' opinions of research and 
their participation in research in daily 
practice.
Methods
Sixty- seven Dutch general 
practice registrars participated 
in a trial concerning patients with 
emotional symptoms. We assessed 
the registrars' participation and 
opinions through observation and a 
questionnaire.
Results
Response rate was 82% . Registrars 
recruited 208  patients. The 
participants liked learning a new 
skill and participating in research. 
Obligatory participation, lack of 
time and difficulties with patient 
recruitment were important barriers to 
participation.
Discussion
Registrars report that participation 
in research during vocational training 
is interesting but that it should not be 
compulsory, and that they prefer to 
choose their own research subjects. 
We recommend implementing an 
attractive research program during 
vocational training.
In troduction
Primary care research is im portant1 
but there is general concern about 
the d ifficu lty of linking research to 
patient care.2-3 Research development 
is even more problematic in primary 
care than in other disciplines.4 
Policies to enhance general practice 
research include the creation of 
research networks,5 collaborations 
w ith research institutes,6 and 
early exposure to research during 
undergraduate teaching and specialty 
training.7 Early exposure prompts 
students to consider research as 
part of their future career, and better 
equips future practitioners to deliver 
evidence based patient care.8 
The importance of early exposure 
to research is generally accepted 
by both general practice registrars 
and directors of vocational training 
programmes.7-9 Most programmes 
include research curricula or related 
activities, including training in 
knowledge and skills, conducting 
research projects, or participation in 
research in daily practice.8-10 Although 
research curricula create more positive 
attitudes toward research,11 there are 
no indications that more registrars are 
participating in research,12 and we still 
know little  about the long term effects 
of such curricula.8-12 Furthermore, 
most studies have assessed changes 
in registrars' attitudes toward 
performing a research project or 
undertaking education in research 
skills during vocational training, rather 
than assessing registrars' participation 
in research during daily practice.9-11 
This study analyses registrars' 
participation in research tasks during 
their daily work with patients. The aim 
was to assess patient recruitment,
4 5 0 - 5 1  factors influencing recruitment, and
registrars'views and suggestions with 
regard to participation.
Methods  
Setting  & design
Dutch general practice registrars 
undertake a 3 year specialty training 
program. They spend the firs t and 
third year in a training practice in the 
community, and in the second year 
they rotate between hospital posts. In
2003  and 2 0 0 4  our training program 
included participation of all third year 
registrars (70) in a controlled clinical 
trial as part of their core program.
The tr ia l
A controlled clinical trial of the 
effectiveness of registrars using 
problem solving treatment (PST) -  a 
brief psychological treatment to teach 
patients how to use their own skills to 
cope w ith problems -  for patients with 
emotional symptoms. It is theoretically 
assumed that symptoms are reduced if 
problems can be resolved.13 
Registrars were randomly allocated 
to either the intervention group or the 
control group. Both groups recruited 
patients with emotional symptoms 
during their regular clinical work.
We asked each registrar to recruit
4 -6  patients who had presented for 
three or more consultations in the 
past 6 months, had a score of four or 
more on the 12 item general health 
questionnaire (GHQ-12), and who 
experienced emotional symptoms. 
Exclusion criteria were severe 
medical illness, current contact with 
psychiatric services (or contact in 
the past year), current psychological 
treatment or past cognitive behavioral 
therapy, severe mental disorder, 
organic psychiatric disorder or
substance misuse, active suicidal 
ideas, and lack of suffic ient Dutch 
language to participate.
Registrars in the intervention group 
received a 2 day training course in 
PST14 and provided the psychological 
treatment to the patients they had 
recruited within 8 months. Registrars 
in the control group provided 'care as 
usual' and were asked to complete 
their patient recruitment within 4 
months. The trial design was approved 
by the Medical Ethics Committee of 
the Radboud University Nijmegen 
Medical Centre, The Netherlands.
Outcomes and analysis
We administered a self developed 
questionnaire to explore registrars' 
opinions about their participation in 
the trial, barriers they experienced 
in patient recruitment, and their 
opinions and suggestions with regard 
to enhancing research participation. 
Recruitment data were obtained from 
the trial records.
Recruitment data and scaled answers 
from the questionnaire were analysed 
with descriptive statistics and 
independent sample t-tests using
SPSS statistical analysis software.
The answers to open ended questions 
were independently ordered into 
categories.
Results
Sixty-seven of the 70 registrars 
participated in the trial (37 in 
intervention group [27 women] and 30 
as controls [18 women]).
Registrars randomly allocated to 
the intervention or control group 
in 2003  expressed resistance to 
obligatory participation. We modified 
the process for the 2004  cohort, 
offering registrars an individual 
choice to participate in the training. 
Registrars who participated in PST 
training comprised the intervention 
group (17); the others, providing usual 
care, were regarded as the control 
group. The registrars were also offered 
more research assistance, and both 
groups were given 8 months to recruit 
patients.
Patien t rec ru itm en t
The registrars in the 2003  intervention 
group recruited 83 patients; the 
registrars in the control group
Table 1 Recruitment of patients
2003 2004 p-value
Mean number 
o f pa tien ts  
per reg is tra r
Range Mean number 
o f pa tien ts  
per reg is tra r
Range
Intervention group 4.2 
Control group* 1.0
Total 3.0
1-9
0-3
3.9
2.5
3.2
2-6
0-5
0.653
0.007
0.781
* Control group recruitment in 2003  took 4 months; in 2004  8 months 
(intervention group recruitment in both years 8 months).
recruited 11 patients. The registrars in 
the 2 0 0 4  intervention group recruited 
66 patients; the control group 48 
(Table 1). We explicitly asked registrars 
in 2 0 0 4  to describe the difficulties 
they had experienced recruiting 
patients (Table 2).
Reg is tra rs 'op in ions and suggestions
The questionnaire had a response rate 
of 84%  (30 of 37  registrars in the 
intervention group, 26 of 30  registrars 
in the control group [p=0.54]).
Positive points reported by the 
registrars included the interesting 
and relevant nature of the topic, 
the opportunity to learn a new skill, 
becoming acquainted with and 
contributing to research and evidence 
based medicine, good research 
support, becoming more attentive 
to diagnosing and treating emotional
problems, and developing a critical 
view.
Negative points included the time 
investment required (this was 
especially mentioned by intervention 
group registrars). All registrars 
in 2003  criticised obligatory 
participation; only control group 
registrars were negative about 
obligatory participation in the 2004  
cohort.
To improve participation, registrars 
suggested they be allowed to choose 
between several research projects to 
better match the research topic with 
their personal interests. They fe lt 
they needed to spend enough time 
in clinical practice training, early and 
good information about a research 
project, and involvement of their 
general practitioner tutors in patient 
recruitment.
Table 2 I mportant factors in the recruitment of patients (2004, 31 respondents)
Response to  question 'D id the  fo llow ing reason play Numbers o f reg is tra rs  (%) 
a role in the  inclusion o f pa tien ts? 'in  questionnaire Yes No Missing
Lack of patients who met inclusion criteria 18(58) 12 (39) 1(3)
Lack of time 16 (52) 14 (45) 1(3)
Patients refusing to s ta rt the intervention* 10 (67) 4 (27) 1(7)
Patients refusing to participate in research 12(39) 18(58) 1(3)
Too many administrative actions 12(39) 17 (55) 2(6)
Difficulties in explaining the research 8 (26) 23 (74)
Difficulties leaving the role as a GP and asking 8 (26) 22(71) 1(3)
patients for research participation 
Lack of patients with emotional symptoms 3 (10) 28(90)
* Intervention group (15 respondents)
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In 2003 , all respondents said that 
they wanted to be involved in research 
in the future; in 2 0 0 4  this was the 
case for 14 of 15 intervention group 
respondents and nine of 13 control 
group respondents (Table 3).
Discussion
Sixty-seven registrars recruited 
208  patients in total. Registrars 
expressed an interest in participation 
and appreciated contributing to 
research. They enjoyed learning a new 
skill and being more attentive to a 
particular disease and/or symptoms. 
Nevertheless, their patient recruitment 
rate was below our expectations. 
Initially the obligatory nature of 
participation was considered to be an 
important barrier. Engaging registrars 
by offering the choice to voluntarily 
take part in the training did not
however, result in major improvements 
in recruitment: the doubled patient 
recruitment rate in the control group 
can be attributed to the doubled 
recruitment period.
Registrars suggested that the option 
to choose an interesting and relevant 
research topic, the opportunity 
to learn new skills and a report of 
the research results would make 
participation in research projects more 
attractive.
The recruitment rate in this trial 
does not d iffer from the moderate 
recruitment rates recorded by GPs: 
Peto et al,15 for instance, found an 
average rate of 3.7 patients recruited 
per GP per annum. Registrars' barriers 
and wishes are also comparable 
with those of GPs: moderate 
patient recruitment because of time 
pressures, the need for interesting,
Table 3 Requirements that make research projects attractive for
participation during vocational training (2004, 31  respondents)
Requirements o f research p ro jec t Mean score on 
5 -po in t scale*
Most im portan t The topic should be interesting 4.7
The topic should be relevant to general practice 4.7
There should be a report of the research results 4.6
Less im po rtan t 1 should have enough time 4.4
1 should learn something, e.g. a skill 4.2
The project should be well adapted to the practice 4.0
There should be feedback on my own performances 4.0
Least im portan t Participation should contribute to my own career 3.2
1 should have a say in the project 2.8
There should be a financial reward 2.4
* 1= very unimportant, 5=very important
practice oriented and relevant 
projects, personal support, good 
information, and good feedback about 
the research results.3-15~17
S treng ths  and lim ita tions
As far as we are aware, this is the 
firs t study exploring general practice 
registrars'actual performance 
in research. The study explored 
the attitudes of registrars toward 
research rather than opinions of GPs 
or directors of vocational training 
programmes. Furthermore, it studies 
registrars' opinions about participation 
in a trial within their routine practice 
rather than requiring them to conduct 
a research project themselves.
The study is limited however, by the 
modest sample of registrars, all of 
whom belonged to the same training 
program and who participated in a 
single trial alone. However, the findings 
are similar to those of other studies 
concerning registrars' appreciation of 
research experience.7-11 The study was 
compromised by the change made in 
2 0 0 4  to select registrars on the basis 
of their motivation. In 2003 , however, 
we observed variation in the registrars' 
selection and recruitment of patients, 
which was related to their individual 
motivation as expressed during 
supervision sessions. For this reason 
we believe the actual effects of the 
change were limited.
Im plica tions fo r  general p rac tice
Research experience during medical 
school is associated w ith postgraduate 
research involvement.18 Assuming 
that this applies to registrars too -  and 
assuming a desire for research to be 
part of the culture of family medicine
-  we suggest that researchers and
4 5 4 - 5 5  training programmes should offer
research in such a way that registrars 
will find it an attractive activity in 
which to participate.
This requires attention to the wishes 
of registrars and availability of 
resources,11 and the development of 
a culture that motivates registrars 
to prioritise research rather than 
a culture that views research as 
'unnecessary'.19 
The way in which the training 
environment values research is an 
important factor in how registrars 
respond to participation. This 
environment includes both the training 
program, training practice and the 
profession at large. Faculty play an 
important role in this.7 W ith their 
expertise and experience, enthusiastic 
faculty could successfully integrate 
research into vocational training.20 
Finally, registrars might be motivated 
by colleague peers, namely registrars 
actively involved in research such 
as those w ith an academic registrar 
position.21
Creating attractive research 
programmes should motivate 
registrars to voluntarily participate 
in research. Research networks, 
departments of family medicine, and 
residency training programmes must 
collaborate to develop programmes 
that o ffer registrars the opportunity 
to participate in distinct research 
projects. Whether this increases 
registrars'participation in research 
activities is a question for further 
study.
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WAYS Ways of Coping Questionnaire
Abstra c t
Background
Many patients present to their general 
practitioner with 'emotional problems! 
Emotional problems may include true 
mental disorders but may also include 
psychosocial problems or psychological 
symptoms not severe enough to reach 
thresholds for a formal diagnosis. 
Current evidence-based care consists 
of medication and/or some form of 
psychological treatment. Evidence 
for psychological treatment, however, 
comes largely from studies in the 
secondary care setting, yet there is 
considerable demand for psychological 
treatments within primary care. 
Problem-solving treatment (PST) is a 
brief psychological treatment which has 
shown effectiveness in primary care 
patients with depression.
Objectives
To assess the effectiveness of PST 
versus usual care, medication, or other 
psychological treatments in adult 
patients with emotional problems in 
primary care.
Search methods 
We searched The Cochrane 
Collaboration Depression Anxiety 
and Neurosis group Controlled Trials 
Register (CCDAN-CTR), Medline, 
EMBASE, CINAHL, LILACS, Psyclnfo, 
databases of ongoing trials, and 
reference lists. Date of search was 
January 2008.
Selection criteria
Randomised controlled trials comparing 
PST in a primary care setting with any 
other intervention for adult patients 
with emotional problems.
Data collection and analysis 
Two reviewers read all abstracts, 
assessed quality and extracted data 
independently. The standard mean 
difference was used to pool continuous 
data, and odds ratios were used to 
pool dichotomous data, using a random 
effects model.
Results
We included twelve trials (2261 
participants). Control conditions 
consisted of usual care (8 studies), 
antidepressant medication (3 studies), 
placebo medication (2 studies), or 
another psychological treatment (5 
studies). Four studies were of good 
quality, five studies of moderate quality 
and three studies of low quality. Overall, 
PST was not different from usual care, 
antidepressants, placebo or other 
psychological treatments. For patients 
with major depression, however, two 
good quality trials showed that PST was 
more effective than usual care, placebo 
medication and group psychoeducation. 
For patients with other emotional 
problems we found evidence in one 
moderate quality trial favouring PST 
above usual care whereas six other 
trials did not show differences between 
PST and control treatments. Costs and 
health care use did not show major 
differences.
Authors' conclusions 
We consider PST more effective than 
control treatments for major depression 
in primary care. For emotional problems 
other than major depression however, 
there was insufficient evidence 
to show statistically significant 
differences between PST and usual 
care, medication, placebo, or other 
psychological treatments.
Background 
Description o f the condition
Mental health disorders and other 
psychological problems are highly 
prevalent in primary care. The WHO 
Collaborative Study on Psychological 
Problems in General Health Care 
reported a pooled 21%  point 
prevalence of disorders such as 
major depression, anxiety disorders, 
somatoform disorders and substance 
dependence in consecutive attenders 
of primary care facilities across 
14 countries (Ormel 1994). These 
disorders are the cause of considerable 
disability. Moreover, these disorders 
frequently occur as comorbid 
conditions in primary care (Wittchen 
1999). Additionally, psychological 
symptoms that do not reach thresholds 
for formal diagnoses are generally 
excluded from such prevalence 
estimates despite their prevalence, the 
accompanying burden to patients, and 
the resultant increased use of health 
services (Gureje 2002). Finally, many 
patients present psychosocial problems 
to the general practitioner that are 
not classified into strictly mental 
categories but are labelled as: problems 
with work, problems with parents or 
children and so on. For the purposes of 
this study, we refer to all of the above 
disorders and psychological symptoms 
or psychosocial problems as 'emotional 
problems!
Current evidence-based care for 
patients with emotional problems 
consists of medication (mainly 
antidepressants and/or sedatives) 
and/or some form of psychological 
treatment. Antidepressant medication, 
cognitive behaviour therapy and 
interpersonal psychotherapy have 
5 60 - 61 bee n proven effective in depressive
disorders; both antidepressants 
and cognitive-behaviour therapy are 
effective in panic disorder; cognitive 
therapy and some antidepressants are 
effective in generalized anxiety disorder 
(Kumar 2002; Geddes 2002; Gale
2002). However, the evidence for the 
use of psychological treatments comes 
largely from studies in secondary 
care. Additionally, psychological 
interventions are often relatively 
lengthy (12-16 sessions), scarce, 
and delivered only by specialists 
with a specific interest in a particular 
intervention. Despite the lack of 
evidence and potential barriers to more 
wide-spread use, there is considerable 
patient and physician demand for 
psychological treatments in primary 
care (Fritzsche 2002; Oopik 2006). 
Consequently, there is a need to both 
identify psychological interventions 
applicable to the treatment of 
emotional problems in primary care, 
as well as to assess the potential 
effectiveness of their use.
Description o f the in tervention
Problem-solving treatment (PST) is a 
psychological intervention 'focusing on 
the here and now' (Mynors-Wallis 2000) 
and may be a suitable treatment to 
deal with the broadness of emotional 
problems seen in primary care. PST 
teaches patients to use their own skills 
and resources to improve functioning 
(Gath 1997). A link is established 
between emotional symptoms and 
current everyday problems and it is 
explained that if patients succeed in 
solving and gaining control over (part 
of) their problems, symptoms might 
improve. The treatment is relatively 
brief, with the firs t introductory session 
usually lasting one hour, and remaining 
sessions lasting maximum half an hour.
In primary care, PST has a maximum 
of 6 treatment sessions (Gath 1997) 
and can be administered by general 
practitioners, practice nurses, or other 
primary care workers. PST is thus 
considered a 'generic treatment' aiming 
to improve the individual's skills to solve 
problems encountered in everyday life.
It is this generic character that makes 
PST uniquely applicable to the wide 
range of problems seen in the primary 
care setting.
Why it  is im portan t to  do th is  review
Three recently published systematic 
reviews have focused specifically 
on PST. Bell and D'Zurilla conducted 
a meta-analysis of controlled 
outcome studies on the efficacy 
of PST in reducing depressive 
symptomatology. PST was found to 
be as effective as other psychosocial 
therapies and medication, and more 
effective than support groups or 
no treatment (Bell 2009). Similarly, 
Cuijpers et al in 2007  conducted a 
meta-analysis of the effectiveness of 
problem solving therapies for treating 
depression. Their results showed a 
mean standardized effect size for 
PST of 0.83 in the random effects 
model, with very high heterogeneity 
(Cuijpers 2007). Because of the 
high heterogeneity, the authors 
recommended more research to 
ascertain the conditions and subjects 
in which these positive effects may 
be realized. A third review by Malouff 
aimed to assess the efficacy of 
PST across all types of mental or 
physical health problems (Malouff).
This meta-analysis showed that PST 
is significantly more effective than 
no treatment (d=1.37), treatment as 
usual (d=0.54), and attention placebo 
(d=0.54), but not significantly more
effective than other evidence-based 
treatments offered as part of a study 
(d=0.22). While not statistically 
significant, there was a trend in favour 
of PST over other treatments in this 
meta-analysis. Ultimately, none of 
these three reviews specifically focused 
on studies performed in primary care 
and all of them recommended further 
research.
Three additional Cochrane reviews have 
addressed the treatment of emotional 
problems in primary care. Den Boer 
et al (Den Boer 2005) focused on 
the effectiveness of any kind of 
psychological treatment delivered 
by'paraprofessionals' in community, 
primary and secondary care settings 
for the treatment of anxiety and 
depressive disorders. They reported 
positive outcomes for treatments 
delivered by paraprofessionals 
as compared to no treatment. In 
another review, Bower and colleagues 
(Bower 2001) aimed to assess the 
effectiveness and cost effectiveness 
of counseling interventions for patients 
with psychological and psychosocial 
problems considered suitable for 
counseling in primary care. The review 
showed a modest effectiveness of 
counseling in short term outcomes 
(standardised mean difference 
-0.28, 95%  Cl -0.43 to -0.13, n =
772). A third review (Huibers 2003) 
assessed the effectiveness of a 
variety of psychosocial interventions 
delivered by general practitioners 
and concluded that there is little 
evidence for the use of psychosocial 
interventions by general practitioners. 
Of the interventions reviewed, PST 
for depression seemed the most 
promising tool for general practitioners, 
although the reviewers emphasised 
that stronger evidence is necessary
and effectiveness in routine practice 
has yet to be demonstrated (Huibers
2003). None of the above three 
reviews specifically addressed the 
effectiveness of PST for the broad 
range of emotional problems seen in 
primary care.
Responding to the requirement for 
a stronger evidence-base for PST in 
primary care, our review focuses on 
the effectiveness of PST provided 
by specifically trained general 
practitioners, nurses or other primary 
care health workers in patients with 
the broad range of emotional problems 
typically seen in the primary care 
setting.
Objectives
We aim to assess the effectiveness of 
PST (delivered by general practitioners, 
practice nurses or other primary care 
workers) versus any other treatment in 
adult patients with emotional problems 
in primary care.
Methods 
Criteria fo r considering studies fo r  
th is  review  
Types o f studies
We included randomised controlled 
trials on PST versus any other 
treatment. Non-randomised studies 
were excluded as they tend to be 
biased in unpredictable directions (Kunz 
1998). Studies with both PST delivered 
to individuals and PST delivered in a 
group format were included. Studies on 
group treatment were included only if 
they used cluster randomization in their 
design.
Types o f partic ipants
5 6 2 - 6 3  The review was intended to be broad
with respect to the diversity of 
problems and was not confined to 
patients with DSM-IV diagnoses such 
as major depression or anxiety disorder. 
We also aimed to include patients 
with 'below threshold disorders', 
minor depression, dysthymia and 
psychosocial problems. Therefore, 
all studies including adult patients 
with'emotional problems'treated in 
a primary care setting were eligible 
for the review. We defined 'emotional 
problems' as 1) major depression 
according to DSM-IIIR/DSM-IV 
or ICD-9/ICD-10 classification,
2) anxiety disorders according to 
DSM-II IR/DSM-IV or ICD-9/ICD-10 
classification, 3) minor depression 
according to the DSM-IV classification,
4) dysthymia according to the DSM- 
IV classification, 5) psychological 
symptoms not reaching thresholds for 
classification systems, 6) psychosocial 
problems: problems with work, 
problems with relations, problems 
with (the acceptance of) disease, or 7) 
somatoform symptoms.
Types o f in terventions
This review included studies using 
individualized or group-based PST 
as the experimental condition. PST 
consists of a maximum of 6 sessions 
with 7 stages (Mynors-Wallis 2005). 
The stages are: explaining the 
rationale; clarification of the problems; 
establishing achievable goals; 
generating solutions; selecting and 
implementing preferred solution; and 
evaluation. There was no restriction 
concerning the nature of control 
conditions. To be included in the 
review the article had to state that 
the therapists (general practitioner, 
psychologist, nurse or social worker) 
were trained in problem solving
techniques. Patients were required 
to have had at least three treatment 
sessions.
Types o f outcome measures
Primary outcomes
Given the broad range of problems and 
diversity of study designs, numerous 
outcome measures were used. We 
considered symptom severity (as 
measured with symptom scales) and 
recovery rates as primary outcome 
measures.
Secondary outcomes
As secondary outcomes we included 
quality of life measures and cost 
effectiveness. With respect to cost- 
effectiveness, we measured days off 
work and financial costs. Adverse 
effects such as deterioration of 
symptom scores, increased use of 
psychotropic medication, or more days 
off work were analysed separately.
Search methods fo r iden tifica tion  o f 
studies  
Electronic searches
In order to identify studies for review, 
we searched the following databases 
(search date August 2009  - no 
language restriction):
1) The Cochrane Collaboration 
Depression Anxiety and Neurosis group 
Controlled Trials Register (CCDAN- 
CTR). This database contains records 
on trials comparing treatments within 
the scope of the CCDAN, including 
mood disorders, anxiety disorders, 
somatoform disorders, dissociative 
disorders, and eating disorders.
The CCDAN-CTR also includes
clinically significant problems, such 
as deliberate self-harm and suicide 
attempt, which are often associated 
with these disorders. The register is 
updated quarterly and includes results 
from searches of CINAHL, EMBASE, 
LILACS, MEDLINE, NRR, PSYCLIT, 
PSYCINFO, PSYNDEX and SIGLE. 
Additional quarterly screening of 
conference proceedings as well as hand 
searching of relevant journals are also 
conducted by the CCDAN.
We also separately searched 2) 
MEDLINE, 3) EMBASE, 4) CINAHL,
5) PsyclNFO, 6) NRR, 7) Lilacs, and 7) 
Psyndex.
Search strategy:
We used the search strategy as 
modified by CCDAN (www.iop.kcl.ac.uk/ 
iop/ccdan.index.htm). The syntaxes 
for the other databases were modified 
according to the properties of those 
databases.
The syntaxes for CCDAN-CTR, 
MEDLINE, EMBASE, CINAHL 
and PsyclNFO can be found in the 
Appendices.
Searching o ther resources
Additionally searches were conducted 
by checking reference lists of retrieved 
publications as well as other reviews on 
PST. Finally we identified unpublished 
studies by personal communication 
with experts in the field and 
researchers currently performing trials 
on PST.
Data collection and analysis 
Selection o f studies
Abstracts of records retrieved by the 
electronic searching process were 
assessed for inclusion in the review 
independently by two reviewers (LH and
JC) (Edwards 2002). If necessary the 
full article was read. Disagreements 
were resolved by discussion, or via 
mediation by a third reviewer (PL) when 
necessary
Data ex trac tion  and management
Data extraction of selected trials 
was performed by two reviewers 
independently on pre-coded electronic 
forms. Disagreements were resolved 
by discussion. The following data were 
extracted:
1. General information: published/ 
unpublished, title, authors, source, 
country, contact address, language 
of publication, year of publication, 
duplicate publication, sponsoring,
2. Trial characteristics: design, 
duration, randomisation method, 
allocation concealment, blinding of 
outcome assessors.
3. Interventions: integrity of PST 
(patient attended three or more 
sessions), number of PST sessions, 
qualification of providers (general 
practitioner, nurse, social worker), 
adequacy of provider training 
(provider received practical skills 
training in PST), number of providers, 
type of control intervention
4. Participants: sampling (convenience, 
random), inclusion and exclusion 
criteria, number of participants
in intervention and control group 
at baseline, gender, age, baseline 
characteristics, duration of the 
emotional problem, definition of the 
emotional problem, withdrawals/ 
losses to follow up, subgroups,
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5. Outcomes, adverse effects. The 
primary outcomes were changes in 
symptom scores as measured with 
any validated scale and recovery 
rates. Secondary outcomes were 
quality of life measures, resolution 
of psychosocial outcomes such as 
work related or relational problems 
and cost effectiveness. Finally, we 
recorded adverse events such as 
deterioration of symptom scores and 
adverse effects of medication.
We attempted to include any necessary 
missing data by directly contacting 
investigators.
Assessment o f r is k  o f  bias in included 
studies
Methodological quality
In order to determine study quality 
we used the validated 5-item Jadad 
scale (Jadad 1996) and the 23-item 
CCDAN Quality Rating Scale as a field- 
specific quality rating scale (QRS, see 
Table 1) (Moncrieff 2001). The Jadad 
scale contains items on randomization 
method, allocation concealment, 
blinding and completeness of follow- 
up. There is empirical evidence that 
allocation concealment, generation 
of allocation sequences, blinding and 
completeness of data is associated 
with trial results (Juni 2001).The scale 
has a range from 0 to 5, with higher 
scores indicating good quality. The 
QRS includes 23 items on sample size, 
allocation, use of diagnostic criteria, 
compliance, attrition and statistical 
analysis. Each item at the QRS is 
scored 0, 1 or 2, which gives a total 
score range of 0 to 46.
Methodological quality was scored 
independently by two reviewers.
Disagreements were resolved by 
discussion or by consulting a third 
reviewer when discussion did not result 
in consensus.
We considered generation of allocation 
sequences adequate if the resulting 
sequences are unpredictable. 
Unpredictability can be achieved by 
one of the following methods: computer 
generated random numbers, table 
of random numbers, drawing lots or 
envelopes, coin tossing, shuffling cards 
or throwing dice. Inadequate methods 
are: sequences resulting from case 
record numbers, date of birth, date of 
admission or alternation (Juni 2001).
We considered concealment of 
allocation sequences adequate 'if 
patients and enrolling investigators 
cannot foresee assignment': central 
randomisation (performed at a 
site remote from trial location) or 
sequentially numbered, sealed, opaque 
envelopes (Juni 2001). We included 
trials with inadequate allocation 
concealment in the meta-analysis, but 
planned to perform sensitivity analyses 
to study the influence of inadequate 
allocation concealment on outcomes. 
Blinding of patients and care 
providers is not possible in studies on 
psychological treatments. The only 
possible form of blinding in trials on 
PST is blinding of outcome assessors, 
which was recorded.
Patients lost to follow-up after 
allocation to treatment groups may lead 
to attrition bias. Adequate handling of 
attrition bias presupposes analyses 
according to the intention to treat 
principle. Correct handling of losses 
to follow-up requires the application 
of the last observation carried forward 
principle (LOCF). Trials with > 20%  
lost to follow-up were considered 
inadequate. Trials with > 10%
difference in dropout rate between 
experimental and control group were 
considered inadequate as well.
We planned to further examine the 
influence of quality on the results of the 
meta-analysis with sensitivity analyses 
(see Statistical analysis).
Measures o f trea tm en t e ffec t
Continuous data were analysed if (i) 
means and standard deviations were 
available and (ii) there was no clear 
evidence of a skewed distribution i.e. 
if the data were normally distributed 
according to the original publication.
As a measure of treatment effect for 
continuous data we used weighted 
mean differences (WMD). If data was 
skewed, measures were dichotomised 
according to the median value. Where 
different instruments or scales 
were used to measure the same 
clinical outcome, standardised mean 
differences (SMD) were calculated and 
combined across studies.
We used the differences from baseline 
to endpoint as the actual measure 
of effect of all continuous variables.
The standard deviations of these 
differences are essential for the data 
to be included in the meta-analysis.
If the standard deviation (SD) of the 
difference was not reported, we 
calculated the SD of the difference with 
the following formula: SD ...„pairedditterence
V[(SD1)2 + (SD2)2 - 2 x r x S D lx  SD2], 
SDpaireddifference = standard deviation of 
the difference (pre- / post-treatment), 
SD1 = Standard deviation of the pre­
treatment value, SD2 = Standard 
deviation of the post-treatment value, r 
= correlation coefficient between pre/ 
post treatment. We used a conservative 
correlation coefficient of 0.4. 
Dichotomous data were analysed by 
calculation of the relative risk with the
95%  confidence interval. If applicable 
we used NNT with 95%  confidence 
intervals.
For the dichotomous and the 
continuous outcomes, a random 
effects model was used to allow for the 
expected heterogeneity. In pooling the 
data, we weighted the effect estimates 
by the inverse of their variance. Thus, 
the larger the trial the greater the 
weight the study received in the meta­
analysis. We considered pooling not 
appropriate when the data were too 
heterogeneous as indicated by the I2 
test and by inspection of the clinical 
characteristics.
Unit o f analysis issues
There were no unit of analysis 
issues because all trials randomised 
participants individually.
Dealing w ith  missing data
If outcome data had remained missing 
despite our attempts to obtain 
complete outcome data from authors, 
we performed an available-case 
analysis, based on the numbers of 
patients for whom outcome data were 
known.
Assessment o f heterogeneity
Consistency of results was assessed 
visually and by examining I2, a quantity 
which describes approximately 
the proportion of variation in point 
estimates that is due to heterogeneity 
rather than sampling error (Higgins 
2002 ).
Assessment o f reporting biases
As an indication for publication bias 
we examined funnel plots of effect size 
against study precision. (Egger 1997).
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Data synthesis
If possible, and where appropriate, 
overall effects were calculated, using 
Cochrane Collaboration software 
(current version: RevMan 5).
Subgroup analysis and investigation  
o f heterogeneity
We intended to separately analyse the 
effects of the intervention in the various 
emotional problems. We considered 
the following subgroups particularly 
relevant: major depression, anxiety 
disorders, dysthymia, somatoform 
symptoms and psychological 
problems not reaching thresholds 
for classification systems. Also, we 
intended to separately analyse the 
effects of the intervention by type of 
therapists, for instance nurses versus 
GPs.
Sens itiv ity  analysis
Sensitivity analyses were conducted to 
determine the impact of study quality 
on outcome. The sensitivity of the 
results for good versus low quality was 
determined by subgroup analyses to 
explore the influence of the quality of 
the studies.
In te rpre ta tion o f Results
We based our conclusions about 
effectiveness on the differences 
in psychological outcomes and 
quality of life outcomes. For this 
purpose we considered primarily the 
statistically significant results. For 
further refinement we discussed the 
clinical importance of the effects. 
Statistical significance was based on 
the 95%  confidence intervals. Clinical 
importance was based on the 'minimal 
clinically important difference' (MCID) 
which we defined as a change of 15%  
or more on dimensional scales of
primary outcomes (symptom severity, 
quality of life) or as rate of recovery 
for specific syndromes. We therefore 
regarded numbers of recoveries as 
clinically relevant when the difference 
between PST and control group 
was 15%  or more. For continuous 
outcomes, we looked at the extent of 
clinical importance by considering the 
relationship of the MCID with the point 
estimate and the 95%  confidence 
interval (Cl) surrounding it (Man-Son- 
Hing 2002):
1. definite, when the MCID is smaller 
than the lower limit of the 95%  Cl;
2. probable, when the MCID is greater 
than the lower limit of the 95%  Cl, 
but smaller than the point estimate 
of the efficacy of the intervention;
3. possible, when the MCID is less than 
the upper limit of the 95%  Cl, but 
greater than the point estimate of 
the efficacy of the intervention;
4. definitely not, when the MCID is 
greater than the upper limit of the 
95%  Cl.
With regard to SMDs, we considered 
0.5 and higher as the value for the 
MCID.
Results 
Description o f studies  
Results o f  the search
The searches of the databases yielded 
a total of 2403  abstracts: 170 in 
the CCDAN-controlled trial register, 
536  references in MEDLINE, 773  
in CINAHL, 621  in EMBASE, 161 in
PsyclNFO, 4 in Lilacs, 127 in Psyndex 
and 11 in the National Research 
Register. Of these 2304  abstracts, 
we studied, after removing duplicates, 
the fu ll-text version of 130 articles 
for definite judgment on inclusion. We 
contacted 13 authors for additional 
information.
Included studies
Finally, 12 studies met eligibility 
criteria and were included in the review 
(Barrett 2000; Catalan 1991; Dowrick 
2000; Kendrick 2005; Liu 2007;
Lynch 1997; Lynch 2004; Mynors- 
Wallis 1995; Mynors-Wallis 1997; 
Mynors-Wallis 2000; Schreuders 
2007; Tezel 2006). The studies by 
Williams and Barrett both belonged to 
the Treatment Effectiveness Project 
and were therefore described as one 
study.
Patients, the rap is ts  and control 
trea tm ents
The twelve studies included 2261  
subjects with 803 in the PST condition 
and 1458  in the control conditions. 
Participants were recruited from the 
community or in general practice during 
the consultation or in the waiting room. 
Most patients were between 18 and 
65 years old; a minority were elderly 
people. Two studies included patients 
with major depression (Mynors- 
Wallis 1995; Mynors-Wallis 2000); 
three studies included patients with 
dysthymia, mild or minor depression 
(Barrett 2000  ; Lynch 1997; Lynch
2004); six studies included patients 
with a range of mental health problems, 
including depressed mood, anxiety, 
tension, or reaction to life difficulties 
(Catalan 1991; Dowrick 2000; 
Kendrick 2005; Liu 2007; Mynors- 
Wallis 1997; Schreuders 2007); and
one study included only women who 
were postpartum (Tezel 2006). Most 
studies used 'care as usual' as the 
control condition. Other studies used 
antidepressant medication, placebo 
medication or other psychological 
treatments. All control treatments 
were applied individually except the 
group psychoeducation in one study 
(Dowrick 2000). PST was generally 
applied as an individual treatment 
consisting of a maximum of 6 sessions 
with 7 stages. In 2 studies PST was 
applied by telephone (Lynch 1997; 
Lynch 2004). PST was mostly 
delivered by nurses; some studies 
used research GPs, psychiatrists, or 
psychologists. In all but two studies 
(Catalan 1991; Tezel 2006) it was 
clear that therapists were trained in 
PST. In three studies the adherence to 
the treatment protocol was checked 
by audio/videotaping (Dowrick 2000; 
Kendrick 2005; Schreuders 2007).
In six studies there was supervision 
in order to optimize treatment quality. 
The number of sessions in PST and 
control interventions varied between
2 and 8. Three studies did not report 
the attendance rates (Lynch 1997; 
Lynch 2004 ; Tezel 2006). In the other 
studies, more than 2/3 of the patients 
had had 4 or more sessions. The only 
study with less than 3 sessions, which 
is considered as the minimum number 
needed for treatment, was the study 
by Liu with 2.3 sessions on average. 
Follow-up varied from 6 to 52  weeks. 
For the meta-analyses, we categorised 
four trials with a duration of 6-16 
weeks for practical reasons in the 
3-month follow-up category (Liu 2007; 
Lynch 1997; Lynch 2004 ; Tezel 2006) 
and one trial of 9-months follow-up in 
the 12-month follow-up (Schreuders
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Excluded studies
Other studies were excluded from 
the review (see excluded studies 
table), mainly because they were not 
performed in primary care or did not 
investigate PST. We excluded studies 
in which PST was part of a (stepped) 
care programme, e.g. the IMPACT 
study and the PEARLS study (Unutzer 
2001; Ciechanowski 2004) because 
we could not calculate PST effects 
separately. The included studies table 
describes the characteristics of the 
trials, including the characteristics 
of participants, the interventions, 
outcome measures, and methodological 
quality. We did not find additional 
references via reference checking.
Risk o f bias in included studies
Overall methodological qua lity
All data related to quality assessment 
and outcome was extracted by two 
review authors, who then reached 
consensus on final ratings. Two studies 
scored 1 point on the 5-point Jadad 
scale, three studies 2 points, and seven 
studies 3 points (mean 2.4, SD 0.8).
All studies scored zero points at the 
items 'described as double blind' and 
'blindness adequately described! The 
overall QRS mean score for included 
studies was 29.8  (SD 7.9), ranging 
from 17 (Lynch 1997; Tezel 2006) to 
38 (Mynors-Wallis 2000), see Table 2 
and Table 3. Four trials were of high 
quality (highest quartile of the QRS), 
five were of moderate quality and three 
of low quality. Most trials scored low 
on blinding of subjects and assessors, 
sample size, duration of follow-up, and 
intention-to-treat analysis.
Allocation Incomplete outcome data
Randomisation and allocation  
concealment
Although all studies described the 
allocation of participants to groups as 
'randomised', Lynch 1997, Lynch 2004  
and Tezel did not specify their methods 
for generating the random sequence. 
Eight studies adequately concealed 
allocation of patients and three 
studies did not describe the method of 
allocation (Lynch 1997; Lynch 2004; 
Tezel 2006). Catalan used drawing 
cards from a random pack to assign 
participants to groups but it was not 
clear whether allocation was concealed 
from the investigators and therefore 
considered inadequate.
Blinding 
Blinding o f trea tm en t
All studies scored zero points 
at 'blinding of subjects' because 
in psychological treatments it is 
not possible to keep patients and 
therapists blinded. Trials investigating 
PST versus antidepressant medication 
and placebo medication could keep 
medication blinded; PST, however, not. 
Therefore, we scored all trials zero 
points.
Blinding o f outcome measurement
The assessor was blinded in six studies 
(Barrett 2000; Catalan 1991; Liu 
2007; Lynch 1997; Mynors-Wallis 
1995; Mynors-Wallis 2000). Blinding 
was, however, not tested. Lynch 2004  
did not report any blinding at all. In five 
studies this item was not applicable 
because of self rating outcome 
measures; these were rated as zero 
points.
Losses to  fo llow  up
We separated the attrition rate in 
'non-compliance of patients with 
treatment'(non-completers, i.e. 
those who withdrew before the end 
of treatment) and 'lost to follow-up 
from study assessments' (those with 
incomplete follow-up data, i.e. until 
the very last follow-up of the regarding 
study). Non-compliance ranged from 
0% to 33%  (average 20%). Lost to 
follow-up numbers ranged from 0%  
to 45%  (mean 27% , median 28%), 
with Lynch 1997  and Lynch 2004  
being exceptionally high with 43%  
respectively 45% . Tezel did not report 
data on non-compliance; Barrett and 
Catalan did not report data on lost to 
follow-up. Reasons of non-completion 
were only given in four studies (Barrett 
2000; Catalan 1991; Mynors-Wallis 
1995; Mynors-Wallis 2000).
E ffec ts o f in terventions  
Overview o f results
We calculated effect sizes for 158 
comparisons in ten studies. The studies 
of Lynch 1997  and Lynch 2004  did 
not provide sufficient data to do so.
The statistically significant results 
concerned comparisons on main 
outcome (24), cost-effectiveness (9) 
and patient satisfaction (1). All other 
comparisons (124) yielded effect sizes 
that were not statistically significant. 
Twenty-four comparisons on main 
outcomes showed statistically 
significant differences in outcome 
between PST and control treatment. Of 
these, nine were in favour of the control 
treatment and fifteen in favour of PST. 
The majority (13) of the statistically 
significant differences in favour of PST
resulted from two studies (Mynors- 
Wallis 1995; Dowrick 2000). In these 
studies PST was effective compared 
with placebo medication at 3-month 
follow-up, compared with usual care 
at 6- and 12-month follow-up and 
compared with group psychoeducation 
at 12-month follow-up. The nine 
statistically significant differences 
not in favour of PST resulted from 3 
studies: antidepressants were more 
effective than PST for dysthymic or 
minor depressed patients, postnatal 
care was more effective than PST 
in women at risk for postpartum 
depression, and at one outcome 
generic mental health nurse care was 
more effective than PST for emotional 
symptoms.
The seven statistically significant 
effects of PST resulting from cost 
analyses demonstrated less days off, 
less consultations, less consultation 
costs and less medication costs but 
higher total treatment costs in the 
PST group (Kendrick 2005; Liu 2007; 
Mynors-Wallis 1997).
The significant difference resulting 
from measurement of patient 
satisfaction  was in favour of PST as 
compared with usual care.
We performed 49 meta-analyses on 
effect sizes of 10 studies. Forty-six 
meta-analyses did notyield significant 
differences between PST and control 
condition. The three meta-analyses 
that did yield a significant difference 
favoured PST above usual care in 
quality of life outcomes at 6-month 
follow-up and favoured antidepressant 
medication above PST in psychological 
and quality of life outcomes at 3-month 
follow-up. Heterogeneity between 
studies was large (I2 varying from 0%  
to 91%).
5 7 0 - 7 1
Detailed description o f results  
PST versus usual care
3-month follow-up
Seven trials compared PST and usual 
care at 3-month follow-up (694 
patients: 65 with minor depression/ 
dysthymia; 629 with emotional 
symptoms). In individual studies 
we found statistically significant 
differences in 1 of 22 comparisons 
(with 13 different outcome measures 
in total). This difference was in favour 
of PST with a magnitude of 3 points on 
a scale ranging from 0-240  (Catalan 
1991).
Trial data of Lynch 1997  and Lynch
2004  of patients with minor depression 
were not detailed enough to use 
the meta-analysis. In the firs t trial,
BDI scores after treatment were 
significantly better in the PST group 
than in the usual care group. The 
second trial did not find any statistically 
significant difference in outcomes 
between PST and usual care.
We performed 10 meta-analyses: 6 
with psychological symptom scores and
4 with quality of life scores. None of 
these yielded a statistically significant 
difference between PST and usual care. 
So, there is no evidence that PST was 
significantly more effective than usual 
care at 3-month follow-up.
6-month follow-up
Four trials compared PST and usual 
care at 6-month follow-up (602 
patients: 317  with major depression; 
285 with emotional symptoms).
In individual studies we found 6 
statistically significant differences 
in 17 comparisons (with 12 different 
outcome measures in total). These 
differences came from two studies and
were all in favour of PST. Catalan found 
a statistica lly significant WMD at the 
PSE of -4 .70  (95%  Cl -8 .35  to -1 .05, 
n=47) in favour of PST. Dowrick's 
study, w ith mostly major depressed 
patients, found tha t PST patients had 
sta tistica lly significant better BDI 
scores (63-point scale) and SF-36 
scores (mental role, social function, and 
mental health; 100-po in t scales). More 
PST patients than usual care patients 
recovered at the BDI (RR 2 .54, 95%  Cl 
1.85 to 3 .50 , n=270).
We performed 8 meta-analyses.
The meta-analyses of psychological 
symptom scores did not show 
sta tistica lly significant differences.
The meta-analysis of 3 trials measuring 
quality of life showed a statistica lly 
significant advantage fo r PST patients 
(SMD 0.33, 95%  Cl 0 .15  to 0.51, 
n=497).
So, at 6-month follow-up, quality of life 
was significantly better fo r patients 
who received PST than for those who 
received usual care. Overall, there was 
no difference in e ffect on psychological 
symptoms.
12-month follow-up
Two trials compared PST and usual care 
at 12-month follow-up (492 patients: 
3 1 7  w ith major depression; 175  with 
emotional symptoms). In individual 
studies we found 1 statistica lly 
significant difference in 9 comparisons 
(with 7 different outcome measures 
in total). Depressed patients had 
sta tistica lly significant better scores 
at the 100-po in t SF-36 social function 
scale after PST than after usual care 
(WMD 14.01 , 95%  Cl 5 .51  to 22 .51 , 
n=218).
We performed 3 meta-analyses. SF- 
36  mental health scores did not d iffer 
significantly between groups. Also,
psychological outcomes and quality of 
life outcomes did not d iffer significantly 
between PST and usual care (SMD 
-0 .11 , 95%  Cl -0 .36  to 0 .14 , n=345 
respectively 0 .15, 95%  Cl -0 .06  to
0.36, n=345).
So, after 12  months, there were no 
differences between PST and usual 
care.
In conclusion
At 3-month follow-up there were no 
statistica lly significant differences 
between PST and usual care. A t 
6-month follow-up, PST patients' 
quality of life was significantly better 
than usual care patients' quality of life 
and patients w ith major depression 
had higher chances of recovery 
after PST than after usual care. At 
12-month follow-up, however, we 
did not find sta tistica lly significant 
overall differences in quality of life nor 
psychological outcomes.
PST versus antidepressant 
medication 
3-month follow-up
Three trials compared PST and 
antidepressant medication at 
3-month follow-up (571 patients:
136  w ith major depression; 4 3 5  
w ith minor depression/dysthymia). 
Medication consisted of an SSRI in 
two studies and amitriptyline in one 
study. In individual studies we found
4 statistica lly significant differences 
in 26  comparisons (with 8 different 
outcome measures in total). For 18 -59  
year-old patients w ith dysthymia or 
minor depression symptom resolution in 
the firs t 2 weeks was more rapid in the 
SSRI group than in the PST group but in 
week 2 -11  this difference disappeared. 
HSCL-D scores improved significantly
more in the SSRI group. For dysthymic 
patients of 60  years and older HSCL-D 
scores improved significantly more too 
in the SSRI group. For minor depressed 
or dysthymic patients of 60  years 
and older HDRS scores improved 
significantly more in the SSRI group 
than in the PST group. The trial with 
major depressed patients did not show 
factors predictive fo r which patients 
might benefit from either PST or 
amitriptyline (Mynors-Wallis 1995).
We performed 11 meta-analyses.
Two showed significant differences in 
favour of antidepressant medication: 
psychological symptom scores (SMD
0.23, 95%  Cl 0 .01  to 0 .44  n=461) 
and the change in SF-36 Mental health 
score (WMD -2 .70 , 95%  Cl -5 .20  to 
-0 .19 , n=329). Recovery rates did not 
d iffer significantly between groups:
RR 0 .98, 95%  Cl 0 .83  to 1.17, 
n=564. The other 8 meta-analyses 
were not significantly different neither. 
Sensitivity analyses on tricyclic 
antidepressants and SSRI's did not 
alter these findings.
6-month follow-up
At 6-month follow-up, one trial 
compared PST w ith an SSRI fo r 286  
patients w ith minor depression or 
dysthymia and found no statistica lly 
significant difference in the numbers 
of recovered patients at the HDRS (RR
0.90, 95%  Cl 0 .65  to 1 .26, n=286).
12-month follow-up
One trial compared PST versus an 
SSRI fo r 75  patients w ith major 
depression at 12-month follow-up (5 
comparisons, 4 outcomes). PST did not 
lead to statistica lly significant more 
recovered cases than medication (RR
1.11, 95%  Cl 0 .76  to 1 .63, n=75).
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not significantly different. Quality of 
life outcomes were not reported. Meta­
analyses were not possible.
In conclusion
There is some evidence that 
antidepressant medication is more 
effective for dysthymic or minor 
depressed patients than PST at the 
short-term. A t the long-term there 
are no differences between PST and 
antidepressant medication fo r patients 
w ith dysthymia or major or minor 
depression.
PST versus placebo medication 
3-month follow-up
Two trials reported outcomes at 
3-month follow-up (499 patients: 60 
w ith major depression; 4 3 9  w ith minor 
depression/dysthymia). In individual 
studies we found 7 statistica lly 
significant differences in 21 
comparisons (with 7 different outcome 
measures in total). Major depressed 
patients in the PST group had better 
scores at the PSE, SAS, BDI and HDRS 
and they had higher recovery rates 
than patients in the placebo group (RR 
2 .25, 95%  Cl 1 .16  to 4 .36 , n=60). 
Dysthymic patients of 60  years and 
older had better SF-36 Mental health 
scores after placebo medication than 
after PST. Also, symptom resolution for 
patients aged 18 -59  was quicker from 
week 0 to 2 at placebo medication. This 
difference disappeared from week 2 to
11 .
We performed 6 meta-analyses. The 
proportion of recovered patients nor 
the psychological symptom scores 
and quality of life scores differed 
significantly between treatm ent groups 
(RR 1.06, 95%  Cl 0 .77  to 1.46, 
n=505). Sensitivity analyses on age
nor diagnosis showed statistically 
significant differences.
6-month follow-up
One trial reported recovery rates 
at 6-month follow-up (290 patients 
w ith dysthymia or minor depression). 
There were no statistica lly significant 
differences between PST and placebo 
fo r dysthymia nor minor depression (RR 
1.02, 95%  Cl 0 .75  to 1 .39, n=290).
In conclusion
Overall, there were no statistica lly 
significant differences in outcome 
between PST and placebo medication. 
In the study investigating patients 
w ith major depression, PST was more 
effective than placebo medication.
PST versus other psychological 
treatm ent 
3-month follow-up
Four trials reported outcomes at 
3-month follow-up (436 patients: 98 
w ith minor depression/dysthymia; 3 3 8  
w ith emotional symptoms). In 3 trials, 
we found 2 statistica lly significant 
differences in 12 comparisons (with 10 
d ifferent outcome measures in total). 
Both differences came from one trial, 
investigating PST versus postnatal 
care in women at risk fo r postpartum 
depression. The trial showed 
sta tistica lly significant more recoveries 
and a significant better improvement 
at the BDI in the postnatal care group 
than in the PST group (RR 0.49, 95%
Cl 0 .31  to 0 .76, n=62; WMD 6.30, 
95%  Cl 2 .84  to 9 .76 , n=62).
We performed 3 meta-analyses. 
Psychological symptom scores did 
not show statistica lly significant 
differences fo r emotional symptoms 
nor overall (overall SMD 0.22, 95%  Cl
-0 .31  to 0 .74, n=335). Quality of life 
outcomes neither differed significantly 
(SMD 0.12, 95%  Cl -0 .11  to 0.36, 
n=273).
So, there is no evidence fo r statistically 
significant differences between PST 
and other psychological treatments.
In the single study investigating PST 
in women at risk for postpartum 
depression, there was evidence that 
PST gave less improvement than 
postnatal care. In the other 3 trials, 
there were no differences in outcomes 
between PST or any other psychological 
treatment.
6-month follow-up
Two trials reported outcomes at 
6-month follow-up. One regarded 
depressed patients (n=236, mainly 
major depression) and compared 
PST w ith group psychoeducation 
for depression. The other study 
regarded emotional symptoms 
(n=169) and compared PST with 
generic mental health nurse care.
In the individual studies we found 1 
statistica lly significant difference in 
11 comparisons (with 10 different 
outcome measures in total): in the study 
with patients w ith emotional symptoms, 
Kendrickfound statistica lly significant 
more improvement of 4 points on 
the 57-point CIS fo r generic mental 
health nurse care than fo r patients 
who received PST (WMD 4 .00 , 95%  Cl
0 .12  to 7 .88 , n=133).
We performed 2 meta-analyses. 
Psychological outcomes did not d iffer 
significantly between PST and control 
groups (SMD 0.04, 95%  Cl -0 .53  
to 0 .62, n=305). Neither existed 
statistica lly significant differences in 
quality of life scores (SMD 0.11, 95%  
Cl -0 .11  to 0 .34 , n=305).
So, at 6-month follow-up there were
no statistica lly significant differences 
between PST and general mental health 
nurse care or group psychoeducation.
12-month follow-up
One study reported 12-month follow- 
up and included 2 3 6  depressed 
patients mainly suffering from major 
depression. It compared PST w ith group 
psychoeducation for depression. Three 
of 5 comparisons (with 4 different 
outcome measures in total) were 
significantly in favour of PST : 4 points 
on the 63-po in t BDI (WMD -4.15,
9 5%  Cl -7 .01  to -1 .29, n=172); 8 
points on the 100-poin t SF-36 mental 
health score (WMD 7.69, 95%  Cl 
1 .25  to 14 .13 , n=172) and 14 points 
on the 100-po in t SF-36 mental role 
(WMD 13 .61 , 95%  Cl 0 .97  to 26 .25 , 
n=172). The proportion of recoveries 
did not d iffer significantly between the 
PST group and the psychoeducation 
group (RR 1.17, 95%  Cl 0 .90  to 1.51, 
n=172).
So, at 12-month follow-up PST 
fo r patients w ith major depression 
was more effective than group 
psychoeducation for depression, mainly 
in terms of quality of life.
In conclusion
Overall, short-term outcomes after 
PST do not significantly d iffer from 
outcomes after other psychological 
treatments. PST might be less effective 
than postnatal care for women at risk 
fo r postpartum depression. The single 
trial w ith long-term outcomes, for 
patients w ith major depression, favours 
PST above group psychoeducation.
Costs and Health care use
Of the twelve studies in this review, 
five reported data on costs or health
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(Kendrick 2005 ; Mynors-Wallis 1997; 
Schreuders 2007) performed a formal 
cost analysis in terms of health care 
use, costs of disability days and 
costs of treatment, one study (Liu 
2007) reported the number of GP 
consultations at 3-months follow-up 
and one study (Catalan 1991) briefly 
described health care use regarding 
GP consultations, prescription of 
psychotropic medication and referral to 
specialist psychiatric treatment.
We found 9 statistica lly significant 
differences between PST and control 
treatment in 28 comparisons (with 7 
different outcome measures in total). 
We performed 5 meta-analyses.
Disability days
In the three trials reporting numbers 
of disability days and costs there was
1 statistica lly significant difference. 
Mynors-Wallis found a statistica lly 
significant lower number of 12 
disability days at 6-month follow-up in 
the PST group than in the usual care 
group (WMD -11 .88 , 95%  Cl -20 .99  
to -2 .77, n=70). The meta-analysis on 
total number of days o ff did not d iffer 
significantly between PST and usual 
care.
Health care use and costs
Four trials compared numbers of GP- 
consultations during PST and during 
usual care. Kendrickfound significantly 
less GP-consultations and hence lower 
consultation costs in PST than usual 
care patients. Mynors-Wallis found 
significantly lower medication costs 
for PST than fo r usual care patients. 
Mynors-Wallis and Kendrick, however, 
found higher total costs for PST 
than fo r usual care. Costs of hospital 
admissions did not d iffer significantly. 
The four meta-analyses did not show
significant differences.
Two trials compared numbers of GP- 
consultations during PST and during 
other psychological treatments. Both 
found significantly lower consultations 
rates, and hence costs, in the PST 
than the control treatment group. 
However, including the numbers of 
treatm ent sessions - additional to the 
GP-consultations - total costs between 
PST and other psychological treatment 
did not differ. Costs of medication 
and hospital admissions were not 
significantly different between groups 
either.
In conclusion
There are no clinically or socially 
relevant differences between PST and 
control treatments w ith regard to the 
numbers and costs of disability days, 
nor total health care use and costs.
Satisfaction outcomes
Four trials reported outcomes on 
patient satisfaction about treatment 
(Catalan 1991 ; Kendrick 2005 ; 
Mynors-Wallis 1997 ; Mynors-Wallis 
2000). The 3 trials comparing PST with 
usual care all reported that patients 
experienced PST as more helpful 
(Kendrick 2005 ; Mynors-Wallis 1997), 
or tha t patients perceived PST as more 
positive (Catalan 1991) or that patients 
were more likely to recommend PST to 
a friend (Kendrick 2005 ; Mynors-Wallis 
1997). In the trial comparing PST with 
antidepressant medication, PST did not 
result in higher patient satisfaction nor 
in a quicker or greater resolution of the 
patient's perception of the severity of 
their problems. Neither did PST result 
in a quicker or greater sense of mastery 
and self-control as rated by patients 
(Mynors-Wallis 2000).
In conclusion
Patients were more satisfied 
after PST than after usual care or 
after antidepressant medication. 
Satisfaction levels of patients who 
received generic mental health nurse 
care were comparable w ith those of 
PST patients.
Clinical importance o f the outcome 
effects
For the continuous psychological 
outcomes and quality of life outcomes, 
we also looked at the clinical 
importance besides the statistical 
significance according to the method 
of Man-Son-Hing. We found 21 
statistica lly significant differences 
in 111  comparisons. Of the 21 
statistica lly significant differences
13 were in favour of PST : 1 was 
definitely clinically important, 11 
were probably important and one was 
possibly important. Definitely clinically 
important was the SF-36 social 
function score compared to usual care 
at 6-month follow-up (Dowrick 2000). 
With regard to the numbers of 
recoveries, we found 3 statistically 
significant differences in 21 
comparisons. Two were clinically 
relevant in favour of PST compared 
to usual care at 6-month follow-up 
(Dowrick 2000) and compared to 
placebo medication at 3-month follow- 
up (Mynors-Wallis 1995). The third was 
relevantly in favour of postpartum nurse 
care (Tezel 2006).
Of the 90  non-statistically significant 
differences 51 were in favour of PST : 5 
were probably important and 46  were 
possibly important. Twenty differences 
were definitely not clinically important.
Heterogeneity
Heterogeneity was high. Firstly,
there were several types of patients 
included, varying from women at 
risk fo r postpartum depression 
to patients w ith anxiety, sleeping 
problems, psychosocial problems, 
dysthymia, minor or major depression. 
Secondly, types of comparison 
group varied from usual care to 
antidepressants, placebo, and various 
other psychological treatments. Thirdly, 
the length of follow-up varied from
6 weeks to 52  weeks w ith different 
follow-up moments between baseline 
and endpoint and many different 
outcome measures. Finally, the types 
of therapists varied from nurses to 
GPs, psychiatrists, psychologists and 
students. I2 ranged from 0%  to 91% . 
Because of this high heterogeneity we 
described studies individually too.
Subgroup analyses
We intended to conduct subgroup 
analyses of the effects of the 
intervention on the various emotional 
problems, however, all subgroup data 
were derived from post-hoc analyses, 
and we therefore chose not to carry out 
these analyses. Data lim itations also 
prevented us from performing subgroup 
analyses by type of therapists. 
According to the 'eye-ball tes t'w e  did 
not discover relevant differences in 
outcome between PST by nurses (7 
studies), GPs (2 studies), psychiatrists 
(2 studies), psychologists (1 study), 
and (medical/psychology) students (1 
study).
Sensitivity analyses
We performed sensitivity analyses 
on the following items: study quality, 
allocation concealment and integrity 
of treatment. With regard to the firs t 
we repeated our analyses but omitted
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1997 ; Lynch 2004 ; Tezel 2006).
These studies scored worst at losses 
to follow-up. With regard to allocation 
concealment we repeated our analyses 
w ithout these three studies and the 
study of Catalan because the adequacy 
of allocation concealment in these four 
studies was not clear. With regard to 
integrity of treatment, we repeated the 
analyses w ithout Liu's study because 
the average delivered number of 
sessions in this study was less than 3. 
None of the sensitivity analyses altered 
our conclusions.
Publication bias
We had too few studies to create 
reliable funnel plots fo r examining 
publication bias.
Discussion 
Summary of main results
In our review we included 12 studies 
w ith 2 2 6 1  patients. Two studies did 
not provide suffic ient data to calculate 
differences between treatm ent groups. 
Three studies showed statistically 
significant differences favouring PST, 
three showed significant differences 
favouring control treatm ent and six 
did not show significant differences 
between PST and control treatments. 
For patients w ith major depression we 
found positive effects favouring PST 
over placebo medication (Mynors-Wallis 
1995). For patients w ith emotional 
symptoms PST was favourable over 
usual care or group psychoeducation 
(Catalan 1991 ; Dowrick 2000). In 
Dowricks study, 7 1 %  of participants 
w ith emotional symptoms had major 
depression. The positive evidence came 
from two trials of high quality (Dowrick 
2000 ; Mynors-Wallis 1995) and one 
trial of moderate quality (Catalan
1991). PST affected quality of life more 
than psychological outcomes, which is 
consistent w ith the premise tha t PST 
affects quality of life improvements 
through addressing daily problems.
The type of therapist does not seem to 
determine the outcome in these trials 
as Dowrick had nurses and Catalan and 
Mynors-Wallis had GPs or a psychiatrist 
as PST therapists. Two trials favoured 
control treatment, one of high quality 
(Barrett 2000) and one of low quality 
(Tezel 2006): we found positive effects 
favouring (placebo) medication above 
PST in dysthymic or minor depressed 
patients (Barrett 2000); and for women 
at risk for postpartum depression 
postnatal care was favourable above 
PST (Tezel 2006). One high quality trial 
showed only one significant favourable 
e ffect fo r mental health nurse care 
above PST fo r patients w ith emotional 
symptoms (Kendrick 2005). Overall, 
we found few statistica lly significant 
differences between PST and usual 
care, (placebo) medication or other 
psychological treatments fo r patients 
w ith emotional symptoms. However, 
when looking at the clinical relevance 
of the non-significant differences, 
we cannot rule out the existence of 
positive effects in favour of PST.
Overall completeness and 
applicability of evidence
Although we included only twelve 
studies (2261 participants in total), 
a broad range of patients were 
represented, varying from emotional 
symptoms, to at risk fo r post partum 
depression, to minor and major 
depression. We included trials using 
several types of control interventions 
varying from usual care, (placebo) 
medication and other psychological 
treatments. Also, all studies used valid
and reliable outcome measures that are 
relevant fo r primary care. Ultimately, 
we consider the external validity of the 
evidence to be good.
Quality of the evidence
The mean score on the Jadad scale 
was 2.4 (range 1-3) and on the QRS 
29.8  (range 17-38). According to the 
QRS, four studies were of high quality, 
five of moderate quality and three of 
low quality. There was no clear relation 
between quality and outcome because 
both low and good quality trials pointed 
both in positive and neutral directions 
for PST, which was confirmed by our 
sensitivity analyses on high/moderate 
versus low quality. The evidence in our 
review had some limitations. Firstly, 
most sample sizes were small. This 
led to many wide confidence intervals 
in the differences between outcomes 
which made interpretation of clinical 
relevance often inconclusive because 
many significant and non-significant 
differences in outcomes were 'possibly' 
or'probably' clinically important. 
Secondly, there was only one study 
w ith 'time and attention' as control 
condition (Mynors-Wallis 1995). The 
lack o f'tim e and attention' control 
groups in the other studies might 
have caused an overestimation of the 
e ffect of PST. From the five studies 
w ith a psychological treatm ent as 
control group (Dowrick 2000 ; Kendrick 
2005 ; Liu 2007;Lynch 2004 ; Tezel 
2006), in which time and we presume 
attention was provided too, only 
Dowrick showed relevant differences 
in favour of PST. We, therefore, cannot 
exclude the possibility that structural 
time and attention is more important 
than the specific type of intervention 
provided. Thirdly, there was no blinding 
of participants in the trials but this is
inherent to studies of psychological 
treatments. If applicable, however, 
outcome assessors were blinded. 
Fourthly, there was not any study in 
which the patient's own GP applied PST. 
As a good doctor-patient relationship 
contributes to the effectiveness of 
treatments in non-specific ways, this 
lack of patient-doctor relationship 
might have given an underestimation 
of the e ffect of PST and this might 
explain the good outcome of usual 
care. Fifthly, in three studies the same 
therapists delivered both PST and a 
control intervention (Mynors-Wallis 
2000 ; Lynch 2004 ; Tezel 2006) which 
might have led to contamination i.e. 
the application of PST principles in 
the control intervention, leading to 
an underestimation of the treatment 
e ffect of PST. Sixthly, six studies had 
a very short follow-up, ranging from
6 to 16 weeks. In medication studies, 
e.g. Barrett 2 000 , an 11-week follow- 
up is too short to make sure you have 
reached the optimal effect, even more 
as in some cases the dose was raised 
in week 6-8 to the final dosage. For 
PST we would suggest a follow-up of 
at least 6 months as optimal e ffect is 
likely seen between 3 and 6 months 
after baseline. Finally, eight studies 
had more than 20%  of patients lost to 
follow-up. This, however, is common in 
trials w ith psychological interventions 
(Huibers 2003).
Potential biases in the review process
We feel confident we were able to 
capture the existing body of evidence 
regarding PST in primary care for 
several reasons. Compared w ith the 
reviews of Cuijpers and Malouff we 
did not miss any relevant study and 
our review differed primarily only in 
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adults in primary care. Further, no 
additional studies were identified via 
reference checking after electronic 
searches suggesting our search 
strategy was suffic iently broad. Lastly, 
as one of our authors (LMW) is a 
pioneer in the field of PST and a leading 
authority regarding the application of 
PST to primary care, he is likely to be 
fam ilia rw ith  available literature on the 
subject.
There were, however, potential biases 
to the review process. Unfortunately 
we were unable to obtain additional 
data from two authors in spite of our 
request (Lynch 1997 ; Lynch 2004 ; 
Tezel 2006). These were, however, low 
quality trials and the results therefore 
likely less relevant. Similarly, we were 
unable able to carry out comprehensive 
meta-analyses because studies were 
very heterogeneous in terms of types 
of participants, types of control 
treatments, outcome measures, and 
moments of follow-up. We therefore 
assigned more weight to the findings 
of individual studies rather than the 
limited number of meta-analyses we 
were able to carry out.
Agreements and disagreements with 
other studies or reviews
To our knowledge three other 
systematic reviews on PST have been 
performed (Cuijpers 2007 ; Malouff 
2007 ; Bell 2009). Bell included 21 
studies (1264  participants) looking 
at the efficacy of PST in decreasing 
depressive symptomatology. They 
showed PST to be equally effective 
as other psychosocial therapies 
and medication treatments, and 
significantly more effective than no 
treatment and support control groups. 
Cuijpers included 13 studies (1133 
participants) investigating PST in
depression and found favourable 
results for PST in most studies. 
Contrary to our findings, they found 
that PST had smaller effects in major 
depression. This may be due to the fact 
that they included minor depression 
studies w ith positive effects that we 
did not include in our review because 
they did not take place in primary care. 
Heterogeneity in their study was very 
high. The authors therefore concluded 
that PST has varying effects on 
depression but that more research is 
needed to determine whether PST has 
larger or smaller effects.
Malouff included 31  studies (2895 
participants) investigating PST in 
mental and physical health problems. 
The review showed tha t PST was 
significantly more effective than 
placebo treatm ent and treatment 
as usual, but not significantly more 
effective than other bona fide 
treatments such as antidepressant 
medication or other psychological 
therapies. These findings correspond 
w ith our own results.
Authors' conclusions 
Implications for practice
We suggest that care providers 
involved in the treatm ent of patients 
w ith emotional problems in primary 
care consider PST, along w ith other 
therapies of proven effectiveness 
(cognitive behaviour therapy, 
interpersonal therapy, antidepressant 
medication), fo r the treatment of 
major depression. It is preferable to 
be able to offer the patient several 
equally effective alternatives, 
because different patients prefer 
d ifferent treatments. Some patients 
prefer antidepressant medication, 
notwithstanding recent debate about
their effectiveness (Kirsch 2008) 
or adverse effects (Williams 2000). 
Most patients seem to prefer non- 
pharmacological treatments (Fritzsche 
2002) however. Ultimately, the 
treatment choice should be the result 
of a shared decision process in which 
the patient's preference is considered 
after being appropriately informed by 
the primary care provider. If PST is the 
treatment of choice, it can be delivered 
by any appropriately trained therapist 
as we did not find relevant differences 
between types of therapists. We 
encourage interested general 
practitioners to learn PST as it is one of 
the briefest psychological treatments 
available and therefore fits  well into the 
setting of daily practice. Further, a good 
patient-doctor relationship, as fostered 
by PST delivered by the patient's 
own physician, is likely to positively 
influence the treatment e ffect of PST 
(Kaptchuk 2008 ; Van Os 2005).
For emotional problems other than 
major depression, only one moderate 
quality trial favoured PST above usual 
care (Catalan 1991). In six other trials 
we did not find evidence fo r statistica lly 
significant differences between PST 
and usual care, placebo, medication 
or other psychological treatments. 
Unfortunately, not knowing the exact 
content of'usual care' in most trials, it 
is d ifficu lt to determine what specific or 
non-specific elements were effective. 
An alternative explanation is that other 
emotional problems may have relatively 
favourable outcomes w ith symptoms 
simply improving over time. This seems 
plausible as patients in this review did 
indeed improve after placebo and 'usual 
care! Similarly, the same reasoning 
may explain why we found significant 
differences only fo r major depressed 
patients and not other milder forms
of depression or mood disorders. 
However, based on the results of 
clinical importance we could not 
exclude positive effects of PST above 
control treatments
Implications for research
The effectiveness of PST in patients 
w ith emotional problems should be 
studied further considering both 
the high prevalence and associated 
disability burden (Wittchen 1999; 
Lecrubier 2001) as well as our finding 
tha t clinical relevant outcomes 
are probable and possible. Future 
researchers should endeavour to 
provide larger and more homogeneous 
samples. In addition, as our findings 
showed improvement of quality of life 
in PST-treated patients, we recommend 
further research in homogenous groups 
stratified by disability levels in order 
to quantify outcomes and facilita te 
subgroup analysis. Future studies 
should also include a control group in 
which an equal amount o f'tim e and 
attention' is provided to participants in 
an e ffo rt to provide a more comparative 
control fo r PST. Researchers should 
also consider studying the effects 
of PST as delivered by the patient's 
own GP in order to better assess
the effects of the patient-doctor 
relationship. Study outcomes should 
include costs, including both disability 
days and health care use, particularly 
for patients w ith major depression, as 
this information is currently lacking. 
Similarly, as long-term outcomes are 
limited in the current body of evidence 
on PST in primary care, and given that 
the optimal e ffect of PST is likely seen 
between 3 and 6 months after baseline, 
we recommend follow-up moments at
3, 6 and 12 months. Lastly, any future 
comparison w ith other treatments 
of proven effectiveness should 
be designed as equivalence trials 
(Hermens 2003).
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Characteristics of studies
Characteristics of included studies 
B arrett 2 0 0 0
Methods Treatment Effectiveness Project.
USA: Multicentre RCT to compare 3 conditions.
Blocked and stratified randomisation (by site and diagnosis). 
Recruitment by referrals from GPs.
Assessments on 3  occasions: baseline, 6 and 11 weeks.
Participants 656 Patients (aged >18) with dysthymia or minor depression (HDRS>9, 3  of 
9 DSM-iil-R symptoms of major depression >4 weeks) recruited from GPs in 4 
cities.
Mean age: 61; males: 53%
Interventions T1 (n=218): Problem-solving treatment.
T2 (n=217): Paroxetine (initiated at 10 mg/day and increased at week 2 to the 
target dose of 20 mg/day. A t week 4 or 6, the dose could be increased to 30 
mg/day and at week 6 or 8 to 40  mg/day for patients who showed partial or no 
improvement) and general support.
C (n=221): Placebo (titrated as paroxetine) and general support.
T l :  6 sessions over 11 weeks, firs t session 1 hour, subsequent visits 30 
minutes each. Antidepressant medication use was prohibited; T2 and C: 6 
sessions over 11 weeks, 10-15 minutes each.
T l,  T2, C: individual treatment.
Therapists: PST-providers: 7 PhD psychologists and 5 masters prepared 
therapists. Medication therapists: psychiatrists (fellows), PC-physicians 
(residents), or general internists.
Therapists received training in PST. Supervision o f therapists during treatment 
unknown.
Outcomes 11-week tollow-up: HDRS, HSCL-D, SF-36.
In the 18-59 year-old group: Paroxetine and to a lesser degree PST improved 
remission of dysthymia more than the use of placebo plus nonspecific clinical 
management. For minor depression, the 3  interventions were equally effective. 
In the 60 years and older group: PST did not show significantly greater 
improvement but did show more rapid late-course resolution o f symptoms than 
placebo plus clinical management. PST led to functional improvement for fewer 
patients than paroxetine.
Notes Less females than males. Antidepressant prescription forbidden in PST group. 
PST fidelity check: no.
Non-compliance (<4 sessions): T1 :18% ; T2: 22% ; C: 15%; overall 18%. Lost 
to follow-up: not reported.
Compliance/attendance: 82%  attended at least 4  treatment sessions and 
79%  completed all scheduled treatment sessions (T1: 84%  completed all 6 
sessions; T2 and C: 94%  achieved target dose). T2, C: at each visit, patients 
self-reported medication adherence.
ITT/PP analysis: ITT and PP.
Quality Rating: Jadad scale = 3; CCDAN-QRS = 37.
Allocation concealment? Adequate
Catalan 1 9 9 1
Methods USA: Singlecentre RCT to compare 2 conditions.
Recruitment by referrals from GPs.
Assessments on 4 occasions: baseline, 4 ,1 1  and 28 weeks.
Participants 113 Patients (aged 18-65) with recent onset complaints (anxiety, tension, 
depressed mood, irritability, sleep disturbance, or somatic symptoms) recruited 
from 26 GPs in 16 practices. During the next 4  weeks the GPs were free 
to give any treatment o f their choice. A t the end of week 4 patients were 
assessed at interview; those suitable were randomly allocated to PST or 
control treatment for the next 6 weeks. A t week 4, 66 (58%) were low risk and 
47  (42%) high risk. All high risk pts entered the trial.
Mean age: 33.5; males: 32%
Interventions T1 (n=21): Problem-solving treatment.
C (n=26): Usual GP care (any treatment of the GP's choice, whether 
psychological, social, pharmacological or no treatment.)
T l:  4  sessions over 6 weeks; T2: not specified.
T l,  T2: individual treatment.
Therapists: 1 research psychiatrist.
Therapists received PST training; PST supervision not reported.
Outcomes 28-week follow-up: PSE, GHQ-28, checklist o f helpful components.
The PST group showed significant greater reductions in syptoms, both at the 
end of treatment and at follow-up.
Notes Small sample size, only one psychiatrist delivering intervention.
PST fidelity check: no.
Non-compliance: T l:  0%; C: 0%; overall: 0%. Lost to follow-up: not reported. 
Attendance: median number of PST sessions 4.
ITT/PP analysis: unclear.
Quality Rating: Jadad scale = 3; CCDAN-QRS = 29.
Allocation concealment? Unclear
Dowrick 2 0 0 0
Methods Outcomes of Depression International Network.
Europe (Ireland, UK, Norway, Finland, Spain): Multicentre RCT to compare 3 
conditions.
Recruitment in community.
Assessments on 3 occasions: baseline, 6 and 12 months.
Participants 425 Patients (aged 18-65) with a depressive episode (according to ICD-10, 
dysthymia or adjustment disorder; depressive disorders according to DSM-IV, 
dysthymia adjustment disorder, bereavement, or other depressive disorders): 
52%  single major depressive disorders; 19%  recurrent major depressive 
disorders; 16%  dysthymia; 4%  adjustment disorders; 9%  others.
Age: 5%  18-25 year-old, 46%  26-45 year-old, 50%  46 -65  year-old; males: 
35%
Interventions T1 (n=128): Problem-solving treatment.
T2 (n=108): Group psychoeducation for depression (promoting relaxation, 
positive thinking, pleasant activities and social skills).
C (n=189): no intervention from the research team.
T l:  6 30 -60  minute sessions over 3 months; T2: 8 2,5 hour sessions; C: usual 
care o f G P.
T1, C: individual treatment; T2: group treatment.
Therapists: Mental health facilitators with qualifications in psychology, nursing, 
or allied health professionals (unknown number).
Therapists were trained and received supervision during treatment.
5 8 2 - 8 3
Outcomes 12-month follow-up: BDI, SF-36.
Compared with the control treatment, PST and group psychoeducation 
participants were less likely to remain cases of depression and more likely 
to report improved subjective mental and social functioning. Participants 
assigned to PST were less likely to report depressive symptoms.
Notes Concurrent antidepressant use was not an exclusion criterion.
PST fidelity check: yes.
Non-compliance: T1: 37% ; T2: 56%; C: 0%; overall 29%. Lost to follow-up: 
T l:  30% ; T2: 23% ; C: 32% ; overall 39%.
Attendance: completed treatment T l :  63%; T2: 44%.
ITT/PP analysis: ITT.
Quality Rating: Jadad scale = 2; CCDAN-QRS = 34.
Allocation concealment? Adequate
Kendrick 2 0 0 5
Methods UK: Singlecentre RCT to compare 3 conditions. 
Stratified randomisation (by referring GP).
Recruitment by referrals from GPs.
Assessments on 3 occasions: baseline, 8 and 26 weeks.
Participants 247 Patients (aged 18-65) with a new episode of anxiety, depression or 
reaction to life difficulties (duration of symptoms 4 weeks to 6 months; GHQ- 
12 score 3  or more): around 42%  mixed anxiety and depressive disorder, 
around 34%  a diagnosis o f moderate/severe depressive episode, 19%  
primarily anxiety disorder. Referred by 98 GPs in 62 practices.
Mean age: 35; males: 30%
Interventions T1 (n=90): Care from nurses trained in problem-solving treatment.
T2 (n=79): Generic mental health nurse care (Nurses were asked to use 
whatever treatments they thought appropriate for the patient's problems).
C (n=78): Usual GP care (GPs were asked not to refer patients for psychological 
treatments during the firs t 8 weeks).
T1&T2: firs t session 1 hour, sessions 2-6 30 -45 minutes each.
T l,  T2, C: individual treatment.
Therapists: 53 community mental health nurses (29 T2; 24 T l).
Therapists were trained and received supervision during treatment.
All patients remained free to consult their GPs throughout the study, and to be 
prescribed psychotropic drug treatments as the GP thought fit.
Outcomes 26-week follow-up: CIS, GHQ-12, HADS, SAS, EQ-5D, Patient satisfaction. 
No significant differences between groups in effectiveness at either point. 
Satisfaction was significantly higher in both nurse-related groups, so were 
costs.
Notes PST fidelity check: yes.
Non-compliance (less than 4 sessions): T l:  38% ; T2: 27%; C: 0%; overall: 
22%. Lost to follow-up: T l :  20%; T 2 :19%; C: 31% ; overall 23%. 
Attendance: T1: 62%  received 4 or more sessions; T2: 73%  received 4  or 
more sessions.
ITT/PP analysis: ITT analysis.
Quality Rating: Jadad scale = 3; CCDAN-QRS = 37.
Allocation concealment? Adequate
Liu 2 0 0 7
Methods Taiwan: Singlecentre RCT to compare 3  conditions. 
Blocked randomisation.
Recruitment by referrals from nonpsychiatric physicians. 
Assessments on 2 occasions: baseline and 16 weeks.
Participants 254 Patients (aged 18-70) with common mental disorders (CIS-R score 12 
or more): major depressive disorder (53.1%), mixed anxiety and depressive 
disorder (26.8%; defined as a mixture o f anxiety, depression, and various 
somatic symptoms with the sum of scores for each CIS-R section 12 or more, 
but not meeting criteria for other specific anxiety or depressive disorder), and 
anxiety disorders (20.1%). Recruited in general medical clinics in a general 
hospital (19 family physicians, 12 internists).
Mean age: 43.7; males: 19%
Interventions T1 (n=84): Problem-solving treatment plus usual care.
T2 (n=85): Psychiatric consultation plus usual care.
C (n=85): Usual care.
T1: up to six sessions over 16 weeks, duration o f sessions not reported; T2: 
consultation of a psychiatrist with follow-up visits to the psychiatrist at his/her 
discretion; C: patients continued seeing their treating physician as usual, and 
they were permitted to see mental health professionals.
T l,  T2, C: individual treatment.
Therapists T l:  4  psychologists, 2 psychiatric social workers, psychiatric 
nurse. Therapists were trained; PST supervision not reported. Therapists T2:
6 psychiatrists. All patients remained free to consult their usual physicians 
throughout the study, and these physicians could prescribe psychotropic drugs.
Outcomes 16-week follow-up: CIS-R, HDRS, SF-36.
No statistically significant differences between at 16 weeks on any o f the 
measures.
Notes Low mean number of PST sessions (2.27)
PST fidelity check: unknown.
Non-compliance (all droptout before start o f treatment):T1: 41% ; T 2 :19%; C: 
20%, overall: 27% . Lost to follow-up: T l:  25% ; T2: 9%; C: 22% ; overall 19%. 
Attendance: on average 2.3 sessions.
ITT/PP analysis: ITT.
Quality Rating: Jadad scale = 2; CCDAN-QRS = 34.
Allocation concealment? Adequate
Lynch 1 9 9 7
Methods USA: Singlecentre RCT to compare 2 conditions. 
Stratified randomisation (by sex).
Recruitment in waiting room of general practice. 
Assessments on 2 occasions: baseline and 7 weeks.
Participants 29 Patients (aged 18 or older) with a subthreshold or minor depression (as 
screened by the MOS-Depression Screening Inventory) recruited in the waiting 
room of a family practice.
Mean age: 48; males: 14%
Interventions T1 (n=15): Telephone-based problem-solving treatment 
C (n=14): Usual GP care
T l :  6 sessions, administered by telephone, once a week, 20 minutes.
T l ,  C: individual treatment.
Therapists: 2 student therapists (one a second-year medical student, one 
graduate nursing student). Therapists were trained and received supervision by 
psychiatrist.
Outcomes 7-week follow-up: HDRS, BDI, Duke Health Profile, PSI.
The PST group had significantly lower post-intervention scores on the HDRS 
compared with their pre-intervention scores; scores did not differ significantly 
over time in the control group.
5 8 4 - 8 5
Notes Small sample, brief follow-up, comparison group treatment not described.
PST fidelity check: no.
Non-compliance: T l:  27% ; C: 0%; overall 14%. Lost to follow-up (complete 
data): T1: 53% ; C: 36% ; overall: 45% . Lost to follow-up, just HDRS: T1: 27%; 
C: 7%; overall: 17%.
Attendance: not reported.
ITT/PP analysis: unclear.
Quality Rating: Jadad scale = 2; CCDAN-QRS = 17.
Allocation concealment? Unclear
Lynch 2 0 0 4
Methods USA: Singlecentre RCT to compare 3 conditions.
Stratified randomisation (by Hamilton scores (11-17 ,18-26) and 
antidepressant use (use, nonuse).
Recruitment in waiting room of general practice.
Assessments on 2 occasions: baseline and 6 weeks.
Participants 54 Patients (aged 18 or older) with minor or moderate depression (HDRS score 
11-26), recruited in the waiting room o f 3 family medicine practices.
Mean age: 38.5; males: 17%
Interventions T l  (n=18): Telephone-based problem-solving treatment 
T2 (n=18): Stress-management intervention (as attention-control group; 
identifying sources of stress in one's life, discussing importance o f diet and 
exercise in coping with stress. )
C (n=18): Usual GP care (whatever the PC-physician deemed appropriate) 
T l,  T2: 6 sessions, administered by telephone, once a week, 20 minutes. 
T l,  T2, C: individual treatment.
Therapists: nurses (unknown number). Therapists were trained and received 
supervision by psychiatrist.
Outcomes 6-week follow-up: HDRS, BDI, Duke Health Profile.
No significant differences in the amount of decrease between groups on any 
scores.
Notes Small sample, high dropout rate. The same therapists for both psychological 
treatments. PST was not clearly described.
PST fidelity check: no.
Non-compliance: T1: 50%  (all dropt out before start o f treatment); T2: 50%  
(all dropt out before start of treatment); C: 0%; overall 33% . Lost to follow-up: 
T l:  50% ; T2: 50% ; C: 28% ; overall: 43% .
Attendance: not reported.
ITT/PP analysis: unclear.
Quality Rating: Jadad scale = 1; CCDAN-QRS = 20.
Allocation concealment? Unclear
Mynors-Wallis 1 9 9 5
Methods UK: Singlecentre RCT to compare 3 conditions. 
Stratified randomisation (by severity of depression). 
Recruitment by referrals from GPs.
Assessments on 3  occasions: baseline, 6 and 12 weeks.
Participants 91 Patients (aged 18-65) with major depression (low mood, 4  key depression 
symptoms, > 2 weeks, HDRS 13 or more): mean HDRS-scores in all groups 
around 18-19 = major depression. Referred by 26 GPs in 15 local practices. 
Mean age: 37.1; males: 23%
Interventions T1 (n=30): Problem-solving treatment
T2 (n=31): Amitriptyline (50 mg was prescribed for two nights, followed by an 
increase of 25 mg every third night until 150 mg was being taken)
C (n=30): Placebo (same dosage scheme asT2)
T l ,  T2, C: 6 sessions over 3 months (weeks 1, 2, 3, 5, 7, and 11). One 
additional therapy session could be offered at the therapist's discretion; first 
session about 60 minutes, session 2-6 about 70 minutes.
T2, C: Amitriptyline and placebo were prescribed as if  amitriptyline was 
being given, and both patient and therapist were blind to the contents of 
capsules. Specific psychological interventions were avoided, but non-specific 
interventions such as listening, encouraging, and sympathising were included. 
T l ,  T2, C: individual treatment.
Therapists: 3  therapists (a psychiatrist experienced in PST and 2 GPs who had 
received training in PST and in a standardised method of drug administration). 
Therapists received training; supervision during treatment not reported.
Outcomes 12-weektollow-up: HDRS, BDI, PSE, SAS.
PST was significantly superior to placebo at both six weeks and 12 weeks 
on all outcome measures. No significant difference between PST and 
amitriptyline.
Notes PST fidelity check: no.
Non-compliance: T1: 3%  (less than 4 sessions); T 2 :13%; C: 13%; overall 
10%. Lost to follow-up: not reported per group; overall 29%.
Attendance: 4 sessions 90%  (T1: 97%; T2: 87% ; C: 87%), 6 sessions 
71.4%  (T l: 93%; T2: 81% ; C: 40%).
ITT/PP analysis: PP, only data of patients with 4 or more sessions were 
analysed.
Quality Rating: Jadad scale = 3; CCDAN-QRS = 35.
Allocation concealment? Adequate
Mynors-Wallis 1 9 9 7
Methods UK: Singlecentre RCT to compare 2 conditions. 
Recruitment by referrals from GPs.
Assessments on 3  occasions: baseline, 8 and 26 weeks.
Participants 70 Patients (aged 18-65), of 4 primary health care centres, with emotional 
disorders o f at least a month's duration, identified by their GP. Complaints: 
anxiety, tension, depressed mood, irritability and sleep disturbance, somatic 
symptoms not apparently due to a physical disorder. The GP reassessed the 
patients 4 weeks after the initial consultation and only referred those with 
persistent symptoms: mild depression (17%); moderate depression (40%); 
severe depression (9% ); generalised anxiety disorder (3%); mixed anxiety 
depression (11%); no psychiatric diagnosis (20%). Patients did not have to 
meet additional severity criteria.
Mean age: 38; males: 23%
Interventions T1 (n=40): Problem-solving treatment 
C (n=30): Usual GP care
T l :  4  or 5 sessions over 8 weeks, unknown duration.
T l ,  C: individual treatment.
Therapists: 6 nurses (4 practice nurses, 1 district nurse, 1 health visitor). 
After treatment (week 8-26) all patients received usual GP care.
Therapists received training and video-taped supervision during treatment.
5 8 6 - 8 7
Outcomes 26-week follow-up: CIS, GHQ-28, SAS, Self-report measure of patient 
satisfaction, number o f disability days, number o f days o ff work.
No significant differences at clinical outcomes between groups at either 
follow-up assessment. The cost analysis showed that PST was more costly 
in terms of direct healthcare costs but there were significantly less disability 
days in the PST group.
Notes No demographic characteristics per group.
PST fidelity check: no.
Non-compliance: T1: 28% ; C: 0%; overall: 16%. Lost to follow-up: T1: 45%; 
C: 13%; overall: 31% .
Attendance: T1: 73%  4 or more sessions.
ITT/PP analysis: ITT.
Quality Rating: Jadad scale = 3; CCDAN-QRS = 26.
Allocation concealment? Adequate
Mynors-Wallis 2 0 0 0
Methods UK: Singlecentre RCT to compare 4 conditions.
Stratified randomisation (by severity and chronicity of depression). 
Recruitment by referrals from GPs.
Assessments on 4  occasions: baseline, 6 ,1 2  and 52 weeks.
Participants 151 Patients (aged 18-65) with major depression (HDRS 13 or more, 
symptoms > 4 weeks): mean HDRS-scores in all groups around 19-20 = major 
depression. Referred by 24 GPs.
Mean age: 35; males: 23%
Interventions T l  (n=39): Problem-solving treatment by GP 
T2 (n=41): Problem-solving treatment by nurse
T3 (n=36): SSRI by GP (20 mg paroxetine or 100 mg fluvoxamine once daily. 
Aim was to encourage patients' compliance with medication in a supportive 
and encouraging framework but with avoidance of specific psychological 
interventions).
T4 (n=35): SSRI by GP and Problem-solving treatment by nurse 
T l,  T2: 6 sessions over 12 weeks; firs t 1 hour, session 2-6 30  minutes; T3: 
6 sessions over 12 weeks; T4: 6 PST sessions and 6 drug sessions over 
12 weeks. In all groups one extra treatment session could be offered i f  the 
therapist thought it clinically necessary.
T1-T4: individual treatment.
Therapists: 3 research GPs and 2 research practice nurses for all 4  groups. 
Therapists received training and supervision during treatment.
Outcomes 52-weekfollow-up: HDRS, BDI, CIS, SAS, credibility of treatment.
All four groups improved during treatment. There were no significant 
differences between the four treatment g ro u p sa t6 ,1 2 ,o r5 2  weeks.
Notes In our review we only used data of T l  (PST by GP) andT3 (SSRI by GP).
The same research GPs delivered both PST and drug sessions.
PST fidelity check: no.
Non-compliance: T l:  36% ; T2: 22%; T 3 :17%; T 4 :17%; overall 23%. Lost to 
follow-up: T l :  36% ; T2: 32% ; T 3 :17%; T 4 :14%; overall: 25%.
Attendance: completed treatm entT l: 82%; T2: 61% ; T3: 83%; T4: 83%. 
ITT/PP analysis: ITT.
Quality Rating: Jadad scale = 3; CCDAN-QRS = 38.
Allocation concealment? Adequate
Schreuders 2 0 0 7
Methods The Netherlands: Singlecentre RCT to compare 2 conditions. 
Blocked randomisation with random permuted blocks o f 4. 
Recruitment in waiting room of general practice. 
Assessments on 3  occasions: baseline, 3 and 9 months.
Participants 175 Patients (aged 18 or older) with mental health problems (GHQ-12 score 4 
or more, 3 or more GP consultations in past six months): the 3 most frequently 
occurring diagnoses were major depressive disorder, panic disorder, and 
somatic disorder which was not further specified. Recruited in waiting rooms 
of 12 general practices.
Mean age: 52.8; males: 29%
Interventions T1 (n=88): Problem-solving treatment by nurse 
C (n=87): Usual GP care
T l :  up to 6 sessions over 3  months; first 1 hour, session 2-6 3 0  minutes. 
T l-C : individual treatment.
Therapists: 12 nurses with experience in mental health care.
Therapists received training and supervision during treatment.
Outcomes 9-months follow-up: HADS, PHQ, SPSI-R, SF-36, PSYCHLOPS, EQ-5D, costs 
and health care utilization.
No significant differences between groups.
Notes PST fidelity check: yes.
Non-compliance: T1: 31% ; C: 21% ; overall 26%. Lost to follow-up: T1: 33% ; 
C: 22% ; overall: 27%.
Attendance: T l:  on average 4 sessions.
ITT/PP analysis: ITT and PP.
Quality Rating: Jadad scale = 3; CCDAN-QRS = 33.
Allocation concealment? Adequate
Tezel 2 0 0 6
Methods Turkey: Single centre RCT to compare 2 conditions.
Random assignment, matched regarding mean scores on the BDI, parity and 
education level.
Recruitment through screening (EPDS) in 10 primary health care units (BDI 10 
or more).
Assessments on 2 occasions: baseline and 6 weeks.
Participants 62 Women (postpartum one week) with a risk of postpartum depression (EPDS 
> 11) but without exhibiting major depression symptoms (as resulted from BDI 
and SCID).
Mean age: 25; males: 0%
Interventions T1 (n=32): Problem-solving training
T2 (n=30): Care Group Intervention (Postnatal care was tailored flexibly to 
individual needs, using activities from the Nursing Interventions Classification). 
T1: one visit weekly for 6 weeks, 3 0 -5 0  minutes.
T l ,  T2: individual treatment.
Therapist: one nurse researcher for both interventions.
The therapist was trained in PST according to the principles o f D'Zurilla. 
Supervision of therapist unknown.
Outcomes 6-week follow-up: BDI.
T2 was effective women for with depressive symptoms and PST was also 
effective. Utilizing the BDI, it was found out that the nursing care was more 
effective than education alone.
Notes No placebo group; very small groups, short follow-up. The same researcher 
delivered both interventions and interviewed all patients.
PST fidelity check: no.
Non-compliance: not reported. Lost to follow-up: T l :  0%; T2: 0%; overall: 0%. 
Attendance: not reported.
ITT/PP analysis: ITT.
Quality Rating: Jadad scale = 1; CCDAN-QRS = 17.
5 8 8 - 8 9 Allocation concealment? Unclear
Characteristics of excluded studies
Reason for exclusion
Alexopoulos 2003  
Allen 20 02
not performed in primary care
not performed in primary care (hospital & oncology clinicsT 
not performed in primary care (senior centres)Arean_1993_ 
Atha 1992 no PST investigated ______
not performed in primary care, no PST investigated 
Predictors ot compliance with psychological interventions 
tecRr
Audrain 1999~uso-M ateos 20 0 7
Ball 2002
Bamblina 2 0 0 6
no PST investiga d (memory training, reasoning training, speed-of-processing- 
trainina)
PST in control arouo too (supervised vs unsuoervised PST)
No RCT (description of Barrett 2 001 that is included) 
No RCT (description of 2 psychological approaches) 
No PST investigated
Barrett 1999
Bennun 1985__________
Beralund 1997  
Blumbera Lgpidus 2001 No PST as experimental condition investigated
Brouwers2 0 0 7 No PST
Bumalda 2006 Not solely performed in primary care
£is<_____
Collin s 1 9 9 7  
Del Pino 20 04
20 04_____ PEARLS Study: stepped care model without randomisation at the start
No RCT no PST investigated no emotional symptoms investigated 
No PST investigated
No PST not performed in primary c a r~  
No PST investigated
Den Boer 20 0 7  Doorenbos 2006~  
Elliott 20 08 Not solely performed in primary care 
No PST investigated (a combined treatment) 
Not performed in primary care
Elliott 2009  Elliott 2 0 0 9 -b 
Fitzpatrick 2005  F ried fil 99 8  
Gallo 20 00
No PST investigated (one session only)'
NoRCT,
No RCT (Editorial)G eH is2007 Patients not recruited in primary care
jellis Patients not recruited in primary carejensfchen 2006  
jlasoow 2005
No RCT
No RCT__________
No PST investigated ________
Not performed in primary care
3ran t 1 9 99
3ran t2002
Hussain 1981  Not performed in primary care (nursing home)
U ff2 0 0 7  Not solely PST investigated (a combined treatmentT"
IMPACT Study 20 01  Stepped care model without randomisation at the start 
Inernev2004 Not performed in primary care
Jacobson 1984 No PST investigated
Jacobson 1985 No PST investigated
J announ 1980 No PST investigated (a combined treatment)
Kenneav20 05 No RCT
Kina 1995 No RCT
Laoidus 2001 No PST investigated
McDonaah 2005 No PST investigated (present-centered therapy)
Mitchell 2009 Not oerformec in primary care
Mvnors-Wallis 2001 No RCT
Nezu 1986 Not oerformec in primary care
Nezu 2003 — NoLDfiriomifiC in primary care_________________________________________Pathw ays Study 2003  Stepped care programme v : randomisation at the start
Patsiokas 1985 Not performed in primary care
Pavne 1997 No PST investigated (a counseling model)
Porste/'nsson 2003 NoRC"
Rivera 2003 NoRC''
Roberts 1995 Not performed in primary care
Robinson 2008 Prevention rat 1er than treatment of emotional svmotoms
Rovner 2 0 0 7 Not oerformec in primary care (outpatient clinic)
Rovner 2008 Prevention rather than treatment of emotional svmotoms
Rudd Rajab 1996 Not performed in primary care, no PST investigated (combined treatment with 
PST as 1 of 3 components)
Sahler2002 Not performed in primary care
Sahler 2005 Not performed in primary care (hospital sites)
Salkovskis 1990 Not performed in primary care, no PST investigated
Schwartz 1998 Not performed in primary care, no PST investigated (one session only)
ihiplev 19 73 No RCT no PST investigated
immer 2003 No RCT
jpp 1978 Not performed in primary care
Tarrier 1993 No emotional symptoms investigated^Teri 1 9 9 7 No PST investigated
Toseland 1989 No PST investigated (combined treatment)
2000 No RCTVan den Hout 1998  
Van der Klink 2003
No RCT__________  __________ ____________
No PST investigated (stress inoculation traininöT"Van S tra ten  2008~  Van Vliet20Ö6~ No PST investigated (combined treatment)
Warmerdam 2008  
Wood 19 97
No RCT__________ _ _ _ _ _ ___________________
No PST investigated (combined treatment)
Not performed in primary care (palliative care setting)
Characteristics of studies awaiting classification
Oxman 2 0 0 8
Methods USA: RCT to compare 2 conditions
Assessments on 4  occasions: baseline. 4. 9 and 35  weeks.
Participants 141 Patients with minor depression
Interventions T l  (n=72): PST
T2 (n=69): usual care
T l.  T2: individual treatment.
Outcomes 35-week follow-up: HRDS, MADRS, HSCL-d-20, Brief COPE, SF-36.
PST patients improved more quickly than usual care patients did. Patients 
with an avoidant coping style showed greater improvement with PST than with 
usual care.
Notes The data as currently presented in the paper are not appropriate for usage in 
meta-analyses. We asked the authors for more detailed outcome data.
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Characteristics of ongoing studies
Hewitt 2 0 0 4
Study name Problem-solving treatment for Primary Care Depression
Methods RCT
Participants 300  adults (aged 18 or older). Inclusion criteria: primary care patient; HDRS 
Score >= 10 and minor depression a t time of entry and after 4 weeks of 
observation. Exclusion criteria: psychosis, Obsessive Compulsive Disorder 
(OCD), or Post Traumatic Stress Disorder (PTSD); active substance abuse; 
receiving treatment for depression.
Interventions In the firs t phase, participants are observed for 4  weeks to identify those 
most in need of depression-specific treatment. Participants are then exposed 
to the PST. After 4 weeks, patients who do not respond adequately to the 
treatment are randomly assigned to either continued PST or to usual care for 
9 weeks. Participants are followed for 6 months after the study.
Outcomes Not reported
Starting date December 2002
Contact information Not reported (see: http://clinicaltrials.gov/ct/show/NCT00055328)
Notes
Walsh 2 0 0 4
Studv name PST in Geriatric Deoression With Executive Dysfunction
Methods
Participants 240 elderly people (aged 60 or older). Inclusion criteria: nonpsychotic, unipolar 
major depression; cognitive impairment; English speaking.
Exclusion criteria: high suicide risk; dementia; acute or severe medical illness; 
current osvchotheraov.
Interventions Problem-solving therapy versus brief supportive therapy. Patients are 
randomly assigned to receive 12 sessions (1 session/week for 12 weeks) of 
either PST or BST.
Outcomes Following treatment, patients are followed for 6 months to determine 
functional and clinical outcomes. Depression scales, disability scales, and 
scales that measure oroblem solvina skills are used to assess oatients.
S tartinadate Seotember 2002
Contact information Jennifer Walsh: 914-997-5914
Notes
CCDAN Quality Rating Scale
1. Objectives
2. Sample size
3. Duration of trial and follow-up
4. Power
5. Method of allocation
6. Concealment
7. Description of treatment
0 = objectives unclear
1 = objectives clear but main outcome not a priori
2 = objectives clear and main outcome a priori
0 = < 50 per Group
1 = 5 1 - l0 0  per Group
2 = > 100 per Group
0 = < 3 months
1 = > 3 months and < 6 months
2 = > 6 months
0 = not reported
1 = mentioned without details
2 = details of calculation provided 
ely0 = unrandomised and lik  to be biased
1 = partial or quasi-randomised with bias possible
2 = randomised allocation
8. Blinding of subjects
9. Source of subjects, representativeness of sample
0 = not done or not reported
1 = partial concealment reported
2 = done adequately ..........................
0 = main treatments not clearly described
1 = inadequate details of main or adjunctive 
treatments
2 = full details of main or adjunctive treatments
10. Diagnostic/inclusion criteria
0 = not done
1 = done, but no test of blind
2 = done and integrity of blind tested
0 = source of subjects not described
1 = source of subjects but unrepresentative
2 = source of subjects plus representative sample
11. Record of exclusion criteria, exclusions, refusals
0 = none
1 = diagnostic criteria or clear inclusion criteria
2 = diagnostic criteria and specification of severity
0 = criteria and number not reported
1 = criteria or number not reported
2 = criteria and number reported
12. Description of sample demographics
13. Blinding of assessor
14. Compliance /attendance for therapy
0 = little/no info (only age/sex)
1 = basic details (marital status/ethnicity)
2 = full description (socio-economic status/clinical history)
15. Details on side effects
16. Record of number/reasons for withdrawal by group
17. Outcome measures/use of validated instruments
18. Group comparability and adjustment in analysis
0 = not done
1 = done but no test of blind
2 = done and integrity of blind tested
0 = not assessed
1 = assessed for some experimental treatments
2 = assessed for all experimental treatments
0 = inadequate details
1 = recorded by group but details inadequate
2 = full side effect profiles by group___________
0 = no information on withdrawals by group
1 = withdrawals by group without reason
2 = withdrawals and reason by group__________
19. Inclusion of withdrawals in analysis (ITT)
20. Results presented with data for re-analysis
0 = outcomes not described clearly
1 = some outcomes not clearly described
2 = outcomes described and valid/reliable
0 = no information on comparability
1 = some information with adjustment
2 = sufficient information with adjustment
0 = not included or reported
1 = withdrawals included by estimation of outcome 
- 2 = ................... ........................................................= withdrawals followed up and included in analysis 
= inadequate presentation
21. Appropriate statistical analysis
22. Conclusions justified
0 
1 = adequate
2 = comprehensive
0 = inappropriate
1 = mainly appropriate
2 = appropriate and comprehensive
23. Declaration of interests
0 = no
1 = partially
2 = yes
0 = No 
2 = Yes
Quality Rating Scores per study
Objectives and specification of main outcomes a priori
Barrett
2001
2
Catalan
1991
2
Dowrick
20 0 0
2
Kendrick
2006
2
Liu
2 0 0 7
2
Lynch
1997
2
Lynch
2 0 0 4
2
Mynors-
Wallis
19 9 5
2
Mynors-
Wallis
1997
1
Mynors-
Wallis
2 0 0 0
2
Screuders
2 0 0 7
2
Tezel
2 0 0 6
1
Sample size (number per group] 2 0 2 1 1 0 0 0 0 0 1 0
Planned duration of trial including follow up 0 2 2 2 1 0 0 1 2 2 2 0
Power calculation 2 0 2 2 0 0 2 2 0 2 2 0
Method of allocation/randomization 2 2 2 2 2 1 1 2 2 2 2 1
Concealment of allocation 2 0 2 2 2 0 0 2 2 2 2 0
Clear description of treatment (including doses of drugs) & adjunctive treatment 2 1 1 2 1 0 1 2 1 2 1 1
Blinding of subjects 0 0 0 0 0 0 0 0 0 0 0 0
Source of subjects described and representative sample recruitment 1 1 1 1 1 1 1 1 1 1 1 1
Use of diagnostic criteria (or clear specification of inclusion criteria) 2 2 1 2 2 1 2 2 2 2 2 1
Record of exclusion criteria and number of exclusions and refusals reported 2 0 2 2 2 1 2 2 0 2 2 0
Description of sample demographics 2 0 1 2 2 1 1 2 1 2 1 2
Blinding of assessor 1 1 0 0 1 1 0 1 0 1 0 0
Assessment of compliance with experimental treatments (including attendance for therapy) 2 2 1 2 2 0 0 2 2 2 2 0
Details on side-effects 1 0 0 0 0 0 0 0 0 0 0 0
Record of number and reasons for withdrawal by group (i.e. completing treatment or not) 2 2 1 1 1 1 1 2 1 2 1 0
Outcome measures described clearly or use of validated instruments 2 2 2 2 2 2 2 2 2 2 2 2
Information on comparability and adjustment for differences in analysis 2 2 2 2 2 2 1 2 1 2 2 2
Inclusion of withdrawals in analysis (ITT or endpoint) 1 2 2 2 2 0 0 2 1 2 0 2
Presentation of results with inclusion of data for re-analysis of main outcomes (eg SDs) 1 2 2 2 2 0 1 2 2 2 2 2
Appropriate statistical analysis (including correction for multiple tests where applicable) 2 2 2 2 2 2 1 2 2 2 2 1
Conclusions justified 2 2 2 2 2 0 0 2 1 2 2 1
Declaration of interests (eg source of funding) 2 2 2 2 2 2 2 0 2 2 2 0
5 92 - 93 Total CCDAN-QRS score (max 46) 37 29 34 37 34 17 20 35 26 38 33 17
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Data and analyses
1 PST versus Usual Care at 3-month follow-up
Outcome or Subgroup
1.1 Change in GHQ-28 score
Studies
2
Participants
110
1.2 Change in HADS depression score 2 252
1.3 Change in HADS anxiety score 2 252
1.4 Change in HADS total score 1 130
1.5 Change in CIS score 3 314
1.6 Change in SAS score 2 185
1.7 Change in HDRS score 1 129
1.8 Change in PSE score 1 47
1.9 Change in GHQ-12 score 1 122
1.10 Change in SPSI score 1 130
1.11 Change in SF-36 Mental Health score 2 259
1.12 Change in SF-36 Physical Health score 2 259
1.13 Change in Euroqol-5D score 2 185
1.14 All depression scales, changes 5 491
1.15 All quality of life scales, changes 4 444
2 PST versus Usual Care at 6-month follow-up
Outcome or Subgroup
2.1 Change in GHQ-28 score
Studies
2
Participants
105
2.2 Change in SAS score 2 180
2.3 Change in CIS score 2 180
2.4 Change in HADS depression score 1 122
2.5 Change in HADS anxiety score 1 122
2.6 Change in BDI score 1 218
2.7 Recoveries at BDI 1 270
2.8 Change in GHQ-12 score 1 122
2.9 Change in PSE score 1 47
2.10 Change in SF-36 Mental Health score 1 218
2.11 Change in SF-36 Mental Role score 1 218
2.12 Change in SF-36 Social Function score 1 218
2.13 Change in Euroqol-5D score 2 180
2.14 All depression scales, changes 4 445
2.14.1 Emotional symptoms 3 227
2.14.2 Depressive disorders 1 218
2.15 All quality of life scales, changes 3 497
2.15.1 Emotional symptoms 2 180
2.15.2 Depressive disorders 1 317
5 1 0 4 - 1 0 5
Statistical Method
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl)
Statistical Method
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Risk Ratio (M-H, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl)
Effect Estimate
-1.20 [-4.23,1.83]
-0 .53 [-1.66, 0.59] 
0.40 [-0.66,1.45] 
-0 .70 [-3.37,1.97] 
0.14 [-2.25, 2.53] 
-0 .05 [-0.22, 0.12] 
0.50 [-1.44, 2.44] 
-3 .00 [-5.64,-0.36] 
-0 .70 [-2.10, 0.70] 
3 .45 [-1.15, 8.05] 
0.49 [-3.22, 4.21] 
0.30 [-3.44, 4.05] 
0.07 [-0.01, 0.14] 
-0 .09 [-0.28, 0.09] 
0.12 [-0.09, 0.32]
Effect Estimate
-0 .47 [-5.66, 4.72]
0.05 [-0.09, 0.18] 
0.97 [-2.36, 4.31] 
-0 .73 [-2.38, 0.92]
I .5 9  [0.00,3 .18] 
-3 .09 [-5.78,-0.40]
2.54 [1.85,3 .50] 
-0 .50 [-1.77, 0.77] 
-4 .70 [-8.35,-1.05] 
8.91 [2.82,15.00]
I I . 8 9  [-0.02, 23.80] 
17.47 [8.85, 26.09] 
0 .06 [-0.02, 0.13] 
-0 .19 [-0.52, 0.13] 
-0 .15 [-0.63, 0.33] 
-0 .31 [-0.58,-0.04] 
0.33 [0.15, 0.51] 
0.22 [-0.08, 0.52] 
0.39 [0.16, 0.62]
3  PST versus Usual Care at 12-month follow-up
3.1 Change in HADS total score 1 127
3.2 Change in BDI score 1 218
3.3 Recoveries at BDI 1 171
3.4 Change in SPSI score 1 127
3.5 Change in SF-36 Mental Health score 2 345
3.6 Change in SF-36 Physical Health score 1 127
3.7 Change in SF-36 Mental Role score 1 218
3.8 Change in SF-36 Social Function score 1 218
3.9 All depression scales, changes 2 345
3.9.1 Emotional symptoms 1 127
3.9.2 Depressive disorders 1 218
3.10 All quality of life scales, changes 2 345
3.10.1 Emotional symptoms 1 127
3.10.2 Depressive disorders 1 218
Statistical Method
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Risk Ratio (M-H, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl)
4  PST versus Medication at 3-month follow-up
Outcome or Subgroup
4.1 Change in HDRS score
Studies Participants
4.1.1 Minor Depression & Dysthymia, 18-59 1 
year-old
4.1.2 Minor depression & Dysthymia, 60- 
years and older
4.1.3 Major depression
4.2 Recovered cases (HDRS<8)
4.2.1 Major depression
4.2.2 Dysthymia, 18-59 year-old
4.2.3 Minor Depression, 18-59 year-old
4.2.4 Dysthymia, 60-year and older
4.2.5 Minor Depression, 60-year and older
4.3 Change in BDI score
4.4 HSCL-D symptom resolution, 18-59 
year-old
4.4.1 week 0-2
4.4.2 week 2-11
4.5 Change in HSCL-D score
4.5.1 Minor Depression & Dysthymia, 18-59 1 
year-old
4.5.2 Dysthymia, 60-year and older
4.5.3 Minor Depression, 60-year and older
4.6 Change in HSCL-D score
4.6.1 Minor depression [Frank]
4.7 Change in PSE score
4.8 Change in SAS score
465
126
215
124
564
129
85
75
141
134
124
320
160
160
330
123 
109 
98 
156 
156 
56
124
IV,
IV,
IV,
Statistical Method
Mean Difference (IV, 
Random, 95%  C[ 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Risk Ratio (M-H 
Random, 95%  Cl 
Risk Ratio (M-H 
Random, 95%  Cl 
Risk Ratio (M-H 
Random, 95%  Cl 
Risk Ratio (M-H 
Random, 95%  Cl 
Risk Ratio (M-H 
Random, 95%  Cl 
Risk Ratio (M-H 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl)
IV,
IV,
IV,
IV,
IV,
IV,
Effect Estimate
0.38 [-2.45, 3.21]
-2.05 [-4.61,0.51]
1.01 [0.80,1 .29]
4 .51 [-0.63, 9.65]
2 .07 [-1.92, 6.07] 
-2.43 [-6.70,1.84]
6 .60 [-4.83,18.03]
14.01 [5.51, 22.51] 
-0.11 [-0.36,0.14] 
0 .05 [-0.30, 0.40] 
-0.21 [-0.49, 0.06] 
0 .15 [-0.06, 0.36] 
0 .05 [-0.30, 0.40] 
0 .21 [-0.06, 0.48]
Effect Estimate
0.93 [-0.21, 2.07]
0 .30 [-1.28,1.88]
1.70 [0.32,3 .08] 
0 .36 [-2.87, 3.60] 
0 .98 [0.83,1 .17] 
0 .96 [0.69,1 .32] 
0 .92 [0.54,1 .57] 
0 .97 [0.60,1 .57]
1.17 [0.80,1 .72] 
0 .91 [0.58,1 .43] 
-0.75 [-5.26,3.76] 
0 .05 [-0.34, 0.43] 
0 .24 [0.07, 0.41] 
-0.15 [-0.33, 0.03] 
0 .16 [-0.01, 0.33] 
0 .25 [0.05, 0.45] 
0 .25 [0.01, 0.49] 
-0.01 [-0.23,0.21] 
-0.10 [-0.32,0.12] 
-0.10 [-0.32,0.12] 
0 .30 [-4.08, 4.68] 
-0.03 [-0.46, 0.41]
4.9 Change in CIS score
4 .10 Change in SF-36 Mental Health score
4.10.1 Minor Depression & Dysthymia, 18- 
59 year-old
4.10.2 Dysthymia, 60 years and older
4.10.3 Minor Depression, 60 years and 
older
4 .11 Change in SF-36 Physical Health score 1
4.11.1 Minor Depression & Dysthymia, 18- 1 
59 year-old
4 .12 All depression scales, changes 3
4.12.1 Major depression 2
4.12.2 Minor Depression & Dysthymia, 18- 1 
59 year-old
4.12.3 Dysthymia, 60-year and older 1
4.12.4 Minor Depression, 60-year and older 1
68
329
124
111
94
124
124
461
131
123
109
98
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl)
2 .30 [-3.01, 7.61] 
-2 .70 [-5.20,-0.19] 
-3 .90 [-8.18, 0.38] 
-3 .40 [-7.49, 0.69] 
-0 .30 [-5.02, 4.42] 
-2 .80 [-5.64, 0.04] 
-2 .80 [-5.64, 0.04] 
0.21 [-0.02, 0.44] 
0.06 [-0.39, 0.51] 
0.44 [0.08, 0.80] 
0.39 [0.01, 0.77] 
-0 .02 [-0.41, 0.38]
5 PST versus Medication at 6-month follow-up
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate
5.1 Recovered cases (HDRS<7) at 6 month 1 286 Risk Ratio (M-H, 0.90 [0.65,1 .26]
follow-up [Oxman: Treatment completers only] Random, 95%  Cl)
5.1.1 Minor depression, 18 years and older 1 132 Risk Ratio (M-H, 0.77 [0.57,1 .02]
Random, 95%  Cl)
5.1.2 Dysthymia, 18 years and older 1 154 Risk Ratio (M-H, 1.07 [0.80,1 .44]
Random, 95%  Cl)
5 1 0 6 - 1 0 7
6 PST versus Medication at 12-month follow-up
Outcome or Subgroup Studies Participants S tatistical Method Effect Estimate
6.1 Change in BDI score 1 55 Mean Difference (IV, -0 .80 [-8.06, 6.46]
6.2 Change in HDRS score 1 55
Random, 95%  Cl) 
Mean Difference (IV, -1 .70 [-5.66, 2.26]
6.3 Recovered cases (HDRS<8) 1 75
Random, 95%  Cl) 
Risk Ratio (M-H, 1.11 [0.76,1 .63]
6.4 Change in CIS score 1 55
Random, 95%  Cl) 
Mean Difference (IV, -3 .60 [-9.92, 2.72]
6.5 Change in SAS score 1 55
Random, 95%  Cl) 
Mean Difference (IV, -0 .20 [-0.54, 0.14]
7 PST versus Placebo at 3-month follow-
Outcome or Subgroup Studies
up
Participants
Random, 95%  Cl) 
Statistical Method Effect Estimate
7.1 Change in HDRS score 2 418 Mean Difference (IV, -1 .89 [-4.16, 0.38]
7.1.1 Minor Depression & Dysthymia, 18-59 1 133
Random, 95%  Cl) 
Mean Difference (IV, -1 .30 [-3.02, 0.42]
year-old
7.1.2 Minor Depression & Dysthymia, 60- 1 230
Random, 95%  Cl) 
Mean Difference (IV, -0 .35 [-1.70,1.00]
years and older 
7.1.3 Major Depression 1 55
Random, 95%  Cl) 
Mean Difference (IV, -5 .70 [-9.21,-2.19]
7.2 Recovered cases (HDRS<8) 2 505
Random, 95%  Cl) 
Risk Ratio (M-H, 1.06 [0.77,1 .46]
7.2.1 Major depression 1 60
Random, 95%  Cl) 
Risk Ratio (M-H, 2.25 [1.16,4 .36]
7.2.2 Dysthymia, 1 8 -5 9 year-old 1 85
Random, 95%  Cl) 
Risk Ratio (M-H, 0.87 [0.52,1 .46]
7.2.3 Minor Depression, 18-59 year-old 1 76
Random, 95%  Cl) 
Risk Ratio (M-H, 0.90 [0.56,1 .43]
7.2.4 Dysthymia, 60-year and older 1 142
Random, 95%  Cl) 
Risk Ratio (M-H, 1.23 [0.83,1 .83]
7.2.5 Minor Depression, 60-year and older 1 142
Random, 95%  Cl) 
Risk Ratio (M-H, 0.77 [0.50,1 .19]
7.3 Change in BDI score 1 55
Random, 95%  Cl) 
Mean Difference (IV, -8 .40 [-14.44,-2.36]
7.4 Change in HSCL-D score 1 351
Random, 95%  Cl) 
Mean Difference (IV, 0.00 [-0.12, 0.13]
Random, 95%  Cl)
year-old
7.4.2 Minor depression, 60-years and olds
7.4.3 Dysthymia, 60-years and older
7.5 Change in HSCL-D score
7.5.1 Minor depression [Frank]
7.6 HSCL-D symptom resolution, 18-59 
year-old
7.6.1 week 0-2
7.6.2 week 2-11
7.7 Change in PSE score
7.8 Change in SAS score
7.9 Change in SF-36 Mental Health score
year-old
7.9.2 Dysthymia, 60 years and older
59 year-old
7.11 All depression scales, changes
7.11.1 Major Depression
59 year-old
7.11.3 Minor depression, 60-years and 
older
7.11.4 Dysthymia, 60-years and older
1 131 Mean Difference (IV, 
Random, 95%  Cl)
0.11 -0.11, 0.33]
1 103 Mean Difference (IV, 
Random, 95%  Cl)
-0.10 [-0.31, 0.11]
1 117 Mean Difference (IV, 
Random, 95%  Cl)
0.00 -0.22, 0.22]
1 168 Mean Difference (IV, 
Random, 95%  Cl)
-0.10 [-0.32, 0.12]
1 168 Mean Difference (IV, 
Random, 95%  Cl)
-0.10 [-0.32, 0.12]
1 322 Mean Difference (IV, 
Random, 95%  Cl)
0.03 -0.30, 0.37]
1 161 Mean Difference (IV, 
Random, 95%  Cl)
0.20 [0.03, 0.37]
1 161 Mean Difference (IV, 
Random, 95%  Cl)
-0.14 [-0.33, 0.05]
1 55 Mean Difference (IV, 
Random, 95%  Cl)
-6.10 [-10.47,-1.73]
1 55 Mean Difference (IV, 
Random, 95%  Cl)
-0.52 [-0.87,-0.17]
1 350 Mean Difference (IV, 
Random, 95%  Cl)
1.80 -2.08, 5.68]
1 131 Mean Difference (IV, 
Random, 95%  Cl)
-1.60 [-5.48, 2.28]
1 118 Mean Difference (IV, 
Random, 95%  Cl)
4.88 [1.91, 7.85]
1 101 Mean Difference (IV, 
Random, 95%  Cl)
1.63 -2.45, 5.71]
1 131 Mean Difference (IV, 
Random, 95%  Cl)
-2.00 [-4.64, 0.64]
1 131 Mean Difference (IV, 
Random, 95%  Cl)
-2.00 [-4.64, 0.64]
2 406 Std. Mean Difference 
(IV, Random, 95%  Cl)
-0.17 [-0.53, 0.20]
1 55 Std. Mean Difference 
(IV, Random, 95%  Cl)
-0.85 [-1.40,-0.29]
1 131 Std. Mean Difference 
(IV, Random, 95%  Cl)
0.17 -0.17, 0.51]
1 103 Std. Mean Difference 
(IV, Random, 95%  Cl)
-0.18 [-0.57, 0.21]
1 117 Std. Mean Difference 
(IV, Random, 95%  Cl)
0.00 -0.36, 0.36]
8 PST versus Placebo at 6-month follow-up
Outcome or Subgroup Studies Participants
8.1 Recovered cases (HDRS<7) at 6 months 1 290 
[Oxman: Treatment completers only]
8.1.1 Minor Depression 1 136
8.1.2 Dysthymia 154
Statistical Method
Risk Ratio (M-H, 
Random, 95%  Cl) 
Risk Ratio (M-H, 
Random, 95%  Cl) 
Risk Ratio (M-H, 
Random, 95%  Cl)
Effect Estimate
1.02 [0.75,1 .39]
0 .88 [0.65,1 .19] 
1.20 [0.87,1 .64]
9 PST versus Other Psychological Treatment at 3-month follow-up
Outcome or Subgroup
9.1 Change in HDRS score
9.2 Change in HADS depression score
9.3 Change in HADS anxiety score
9.4 Change in BDI score
9.5 Recovered cases on BDI
9.6 Change in SAS score
9.7 Change in CIS score
9.8 Change in GHQ-12 score
9.9 Change in SF-36 Mental Health score
9.10 Change in SF-36 Physical Health score
9.11 Change in Euroqol-5D score
Studies Participants Statistical Method
140
133
133
62
62
133
273
133
140
140
133
Mean Difference (IV, 
Random, 95%  C[ 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Risk Ratio (M-H 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl 
Mean Difference 
Random, 95%  Cl)
IV,
IV,
IV,
IV,
IV,
Effect Estimate
-0.30 [-2.16,1.56]
-0.01 [-1.54,1.52] 
-0.31 [-1.74,1.12]
6.30 [2.84, 9.76] 
0.49 [0.31, 0.76] 
0.00 [-0.14, 0.14] 
-0.83 [-3.22,1.57] 
-0.48 [-1.83, 0.87] 
1.40 [-5.87, 8.67]
3 .30 [-4.12,10.72] 
0.05 [-0.04, 0.14]
9.12 All depression scales, changes 3 335
9.12.1 Emotional symptoms 2 273
9.12.2 Minor Depression 1 62
9.13 All quality of life scales, changes 2 273
9.13.1 Emotional symptoms 2 273
Std. Mean Difference 0.22 [-0.31, 0.74] 
(IV, Random, 95%  Cl)
Std. Mean Difference -0 .06 [-0.30, 0.17] 
(IV, Random, 95%  Cl)
Std. Mean Difference 0.89 [0.37,1 .42] 
(IV, Random, 95%  Cl)
Std. Mean Difference 0.12 [-0.11, 0.36] 
(IV, Random, 95%  Cl)
Std. Mean Difference 0.12 [-0.11, 0.36] 
(IV, Random, 95%  Cl)
10 PST versus Other Psychological Treatment at 6-month follow-up
Outcome or Subgroup
10.1 Change in HADS depression score
10.2 Change in HADS anxiety score
10.3 Change in BDI score
10.4 Recoveries at BDI
10.5 Change in SAS score
10.6 Change in CIS score
10.7 Change in GHQ-12 score
10.8 Change in SF-36 Mental Health score
10.9 Change in SF-36 Mental Role score
10.10 Change in SF-36 Social Function 
score
10.11 Change in Euroqol-5D score
10.12 All depression scales, changes
10.12.1 Emotional symptoms
10.12.2 Depressive disorders
10.13 All quality of life scales, changes
10.13.1 Emotional symptoms
10.13.2 Depressive disorders
Studies Participants
1 133
133
172
178
133
133
133
172
172
172
133
305
133
172
305
133
172
Statistical Method
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference ( 
Random, 95%  Cl) 
Mean Difference ( 
Random, 95%  Cl) 
Risk Ratio (M-H, 
Random, 95%  Cl) 
Mean Difference ( 
Random, 95%  Cl) 
Mean Difference ( 
Random, 95%  Cl) 
Mean Difference ( 
Random, 95%  Cl) 
Mean Difference ( 
Random, 95%  Cl) 
Mean Difference ( 
Random, 95%  Cl) 
Mean Difference ( 
Random, 95%  Cl) 
Mean Difference ( 
Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl) 
Std. Mean Difference 
(IV, Random, 95%  Cl)
Effect Estimate
0.31 [-1.15,1.77]
0 .38 [-1.10,1.86] 
-2 .48 [-5.50, 0.54]
1.08 [0.83,1 .39] 
0 .11 [-0.04, 0.26]
4 .00 [0.12,7 .88] 
0.45 [-0.62,1.52]
2.55 [-3.92, 9.02]
3 .52 [-9.53,16.57] 
3 .22 [-6.03,12.47] 
0.03 [-0.06, 0.12] 
0.04 [-0.53, 0.62] 
0.35 [0.00, 0.69] 
-0 .25 [-0.55, 0.05] 
0.11 [-0.11, 0.34] 
0.11 [-0.23, 0.45] 
0.12 [-0.18, 0.42]
11 PST versus Other Psychological Treatment at 12-month follow-up
Outcome or Subgroup
11.1 Change in BDI score 1
11.2 Recoveries at BDI 1
11.3 Change in SF-36 Mental Health score 1
11.4 Change in SF-36 Mental Role score 1
11.5 Change in SF-36 Social Function score 1
Studies Participants Statistical Method
Mean Difference (IV, 
Random, 95%  Cl)
172
172
172
172
172
Risk Ratio (M-H, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl) 
Mean Difference (IV, 
Random, 95%  Cl)
Effect Estimate
-4.15 [-7.01,-1.29]
1.17 [0.90,1 .51] 
7 .69 [1.25,14.13]
13.61 [0.97, 26.25] 
6 .67 [-2.48,15.82]
12 Patient Satisfaction at 6-month follow-up
Outcome or Subgroup
12.1 PST versus Usual Care
12.2 PST versus Nurse Care
Studies Participants Statistical Method Effect Estimate
1 114 Mean Difference (IV, 6.00 [3.43, 8.57]
Random, 95%  Cl)
1 2 5 Mean Difference (IV, 0.40 [-1.66, 2.46] 
Random, 95%  Cl)
5 1 0 8 - 1 0 9
13 Days o ff work & Costs, PST versus Usual Care
Outcome or Subgroup
13.1 Total number of days o ff work, 6-month 
follow-up (Emotional symptoms)
13.2 Total number of days o ff work, 9-month 
follow-up (Emotional symptoms)
13.3 Total costs of days o ff work, 6 -mo nth 
follow-up (Emotional symptoms)
13.4 Total costs of days o ff work, 9 -mo nth 
follow-up (Emotional symptoms)
Studies Participants Statistical Method E ffect Estimate
2 192 Mean Difference (IV, -4.32 [-19.00, 10.36]
Random, 95%  Cl)
1 121 Mean Difference (IV, -9.50 [-30.38, 11.38]
Random, 95%  Cl)
1 122 Mean Difference (IV, 2093.00 [■ 1815.51,
Random, 95%  Cl) 6001.51]
1 121 Mean Difference (IV, -1683.00 [-4021.08,
Random, 95%  Cl) 655.08]
14 Days o ff work & Costs, PST versus Other Psychological Treatment, at 
6-month follow-up
Outcome or Subgroup
14 .1 Total number of days o ff work past 6 
months (Emotional symptoms)
14.2 Total costs of days o ff work past 6 
months (Emotional symptoms)
Studies Participants Statistical Method
1 113 Mean Difference (IV,
Random, 95%  Cl)
1 113 Mean Difference (IV,
Random, 95%  Cl)
Effect Estimate
3.60 [-5.85,13.05]
2186.00  [-1893.12, 
6265.12]
15 Health care use & Costs, PST versus Usual Care
Outcome or Subgroup
15.1 Total number of GP consultations, 
3-month follow-up (Emotional symptoms)
15.2 Total number of GP consultations, 
6-month follow-up (Emotional symptoms)
15.3 Total number of GP consultations, 
9-month follow-up (Emotional symptoms)
15.4 Total costs of GP consultations,
6-month follow-up (Emotional symptoms)
15.5 Total costs of GP consultations,
9-month follow-up (Emotional symptoms)
15.6 Total Medications costs, 6-month 
follow-up (Emotional symptoms)
15.7 Total Medications costs, 9-month 
follow-up (Emotional symptoms)
15.8 Total costs, 6-month follow-up 
(Emotional symptoms)
15.9 Total costs, 9-month follow-up 
(Emotional symptoms)
15.10 Costs o f hospital admissions, 6-month 
follow-up (Emotional symptoms)
15.11 Costs o f hospital admissions, 9-month 
follow-up (Emotional symptoms)
Studies Participants Statistical Method
1 129 Mean Difference (IV,
Random, 95%  Cl)
2 192 Mean Difference (IV,
Random, 95%  Cl)
1 121 Mean Difference (IV,
Random, 95%  Cl)
2 192 Mean Difference (IV,
Random, 95%  Cl)
1 121 Mean Difference (IV,
Random, 95%  Cl)
2 192 Std. Mean Difference
(IV, Random, 95%  Cl)
1 121 Std. Mean Difference
(IV, Random, 95%  Cl)
2 192 Mean Difference (IV,
Random, 95%  Cl)
1 121 Mean Difference (IV,
Random, 95%  Cl) 
122 Mean Difference (IV,
Random, 95%  Cl) 
121 Mean Difference (IV,
Random, 95%  Cl)
E ffect Estimate
-0.57 [-1.14,0.00]
-1.08 [-2.57, 0.42]
-0.70 [-2.09, 0.69]
-18.47 [-51.49, 
14.55]
-14.00 [-42.40, 
14.40]
-0.30 [-0.82, 0.21]
0 .06 [-0.29, 0.42]
168.61 [-94.62, 
431.83]
-2905.00  [-5940.71, 
130.71]
0.00 [-60.27, 60.27]
-450.00 [-1130.46, 
230.46]
16 Health care use & Costs, PST versus Other Psychological Treatment
Outcome or Subgroup
16.1 Total number of GP consultations,
3-month follow-up (Emotional symptoms)
16.2 Total number of GP consultations,
6-month follow-up (Emotional symptoms)
16.3 Total costs of GP consultations,
6-month follow-up (Emotional symptoms)
16.4 Total medications costs, 6-month 
follow-up (Emotional symptoms)
16.5 Total costs, 6-month follow-up 
(Emotional symptoms)
16.6 Costs o f hospital admissions, 6-month 
follow-up (Emotional symptoms)
Studies Participants S tatistical Method E ffect Estimate
1 140 Mean Difference (IV, -0.70 [-1.25,-0.15]
Random, 95%  Cl)
1 113 Mean Difference (IV, -1.22 [-2.21,-0.23]
Random, 95%  Cl)
1 113 Mean Difference (IV, -25.00 [-45.59,
Random, 95%  Cl) -4.41]
1 113 Mean Difference (IV, 4 .00 [-20.22, 28.22]
Random, 95%  Cl)
1 113 Mean Difference (IV, 32 .00 [-132.94,
Random, 95%  Cl) 196.94]
1 113 Mean Difference (IV, 13.00 [-35.09,
Random, 95%  Cl) 61.09]
1. PST versus Usual Care at 3-month follow-up
Analysis 1.1. Comparison 1 P ST  versus Usual Care at 3-month follow-up,
Outcome 1 Change in GHQ-28 score
Study or Subgroup
PST Usual Care Mean Difference
Mean SD Total Mean SD Total W eight IV, Random, 95% Cl
Mean Difference
IV, Random, 95% Cl
Catalan 1991 
Mynors-Wallis 1997
-12.8 7.22 
-4.4 7.89
21
34
■10.2 7.2 
-4.8 9.76
26
29
53.3%
46.7%
Total (95% Cl) 55 55 100.0%
Heterogeneity: Tau2 = 0.00; Chi2 = 0.94, df = 1 (P = 0.33); I2 = 0%
Test for overall effect: Z = 0.78 (P = 0.44)
-2.60 [-6.75, 1.55] 
0.40 [-4.03, 4.83]
-1.20 [-4.23, 1.83]
-10 -5 5 10
Favours PST Favours Usual Cs
Analysis 1.2. Comparison 1 PST versus Usual Care at 3-month follow-up, 
Outcome 2 Change in HADS depression score
PST Usual Care Mean Difference Mean Difference 
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl________IV, Random, 95% Cl
Kendrick 2005 
Schreuders 2007
-3.98 4.79 71 
-1.92 4.16 61
-3.62
-1.26
4.86
4.38
51
69
41.7%
58.3%
-0.36 [-2.10,1.38] 
-0.66 [-2.13,0.81] ------■ -
Total (95% Cl) 132
= 0.00: Chi2 =0.07. df = 1 IP  =
oOOÓ
120
= 0%
100.0% -0.53 [-1.66, 0.59]
— --------- 1--------- --------- 1— -----1—î i c i c i  u y c i  i c u y .  i a u  - u . w , -  u . u  i  , u i  -  i yr -  u . u u ) ,  i -  w o  4 2 0 2 4
Test for overall effect: Z = 0.93 (P = 0.35) '  Favoufs psT Favours Usua| c .
Analysis 1.3. Comparison 1 PST versus Usual Care at 3-month follow-up, 
Outcome 3 Change in HADS anxiety score
PST Usual Care Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference 
IV, Random, 95% Cl
Kendrick 2005 
Schreuders 2007
-3.96 4.35 
-1.45 4.17
-4.78 4.05 
-1.43 4.49
51
69
49.5%
50.5%
0.82 [-0.68, 2.32] 
-0.02 [-1.51,1.47]
Total (95% Cl) 132 120 100.0%
Heterogeneity: Tau2 = 0.00; Chi2 = 0.61, df = 1 (P = 0.44); I2 = 0%
Test for overall effect: Z = 0.73 (P = 0.46)
0.40 [-0.66,1.45]
-4 -2 0 2 4 
Favours PST Favours Usual Cc
Analysis 1.5. Comparison 1 PST versus Usual Care at 3-month follow-up, 
Outcome 5 Change in CIS score
Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight
Kendrick 2005 -10.4 11.92 71 -10.9 13.43 51 26.9%
Liu 2007 -9.7 9.17 63 -9.8 9.39 66 55.9%
Mynors-Wallis 1997 -7.4 11.56 34 -7.1 11.73 29 17.2%
Total (95% Cl) 168 146 100.0%
Heterogeneity: Tau2 = 0.00; Chi2 = 0.05, df = 2 (P = 0.98); l2 =:0%
Test for overall effect: Z = 0.11 (P = 0.91)
Mean Difference 
IV, Random, 95% Cl
0.50 [-4.11, 5.11] 
0.10 [-3.10, 3.30] 
-0.30 [-6.07, 5.47]
0.14 [-2.25, 2.53]
-4 -2 0 2 4
Favours PST Favours Usual Ce
5 1 1 0 - 1 1 1
Analysis 1.6. Comparison 1 PST  versus Usual Care at 3-month follow-up,
Outcome 6 Change in S A S  score
PST Usual Care Mean Difference
Study o r Subgroup Mean SD Total Mean SD Total W eight IV, Random, 95% Cl
Mean Difference
IV, Random, 95% Cl
Kendrick 2005  
Mynors-Wallis 1997
-0.34 0.43 
-0 .3  0.54
71 -0.34 0.48  
34 -0.1 0.72
51
29
74.2%
25.8%
Total (95% C l) 105
Heterogeneity: Tau2 = 0.00; Chi2 = 1.19, df = 1 (P =  0.28); I2 
Test for overall effect: Z  =  0.59 (P = 0.56)
80 100.0%
= 16%
0.00 [-0.17, 0.17] 
-0 .20  [-0.52, 0.12]
-0.05 [-0.22, 0.12]
-0.5 0 0.5 1 
Favours PST Favours Usual Ca
Analysis 1.11. Comparison 1 PST versus Usual Care at 3-month follow-up, 
Outcome 11 Change in SF-36 Mental Health score
PST Usual Care Mean Difference
Study or Subgroup M ean SD Total Mean SD Total W eight IV, Random, 95% Cl
Mean Difference 
IV, Random, 95% Cl
Liu 2007
Schreuders 2007
19.2 21.81 
3.67 11.62
63
61
21.2 23.51 
2.45 12.92
66
69
22.5%
77.5%
-2.00 [-9.82, 5.82] 
1.22 [-3.00, 5.44]
Total (95% Cl) 124 135 100.0%
Heterogeneity: Tau2 = 0.00; Chi2 =  0.50, df = 1 (P  = 0.48); I2 = 0%
Test for overall effect: Z  =  0.26 (P = 0.79)
0.49 [-3.22, 4.21]
-10 -5 0 5 10 
Favours Usual Care Favours PST
Analysis 1.12. Comparison 1 PST versus Usual Care at 3-month follow-up, 
Outcome 12 Change in SF-36 Physical Health score
PST Usual Care Mean Difference
Study or Subgroup M ean SD Total Mean SD Total W eight IV, Random, 95% Cl
Mean Difference 
IV, Random, 95% Cl
Liu 2007
Schreuders 2007
Total (95% Cl)
13.8 22.51 
2.84 12.06
63
61
14.4 22.34  
2.26 12.83
66
69
Heterogeneity: Tau2 = 0.00; Chi2 =  0.07, df = 1 (P  = 0.79); I2 = 0%  
Test for overall effect: Z  =  0.16 (P = 0.87)
23.4%
76.6%
-0.60 [-8.34, 7.14] 
0.58 [-3.70, 4.86]
0.30 [-3.44, 4.05]
-10 -5 5 10
Favours Usual Care Favours PST
Analysis 1.13. Comparison 1 PST versus Usual Care at 3-month follow-up, 
Outcome 13 Change in Euroqol-5D score
PST Usual Care Mean Difference M ean D ifference
Study or Subgroup M ean SD Total M ean SD Total W eight IV, Random , 95% Cl__________ IV, Random , 95% Cl
Kendrick 2005 0.17 0.28 71 0.13 0.23 51 64.0%  0.04 [-0 .05 ,0 .13 ] —  -  -------
Mynors-Wallis 1997 0.26 0.22 34 0.14 0.27 29 36.0%  0.12 [-0 .00 ,0 .24] -------------------
Total (95% Cl) 105 80 100.0%
Heterogeneity: Tau2 = 0.00; Chi2 = 1.05, df = 1 (P = 0.30); I2 = 5%
Test for overall effect: Z  = 1.79 (P = 0.07)
0.07 [-0.01, 0.14]
- 0.2 -0.1 0 0.1 0.2
Favours Usual Care Favours PST
Analysis 1.14. Comparison 1 P ST  versus Usual Care at 3-month follow-up,
Outcome 14 All depression scales, changes
PST Usual Care Std. Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Catalan 1991 -11.2 4.18 21 -8.2 5.05 26 9.5% -0.63 [-1.22, -0.04]
Kendrick 2005 -10.4 11.92 71 -10.9 13.43 51 24.4% 0.04 [-0.32, 0.40]
Liu 2007 -9.7 9.17 63 -9.8 9.39 66 26.4% 0.01 [-0.33, 0.36]
Mynors-Wallis 1997 -7.4 11.56 34 -7.1 11.73 29 13.3% -0.03 [-0.52, 0.47]
Schreuders 2007 -1.92 4.16 61 -1.26 4.38 69 26.4% -0.15 [-0.50, 0.19]
Total (95% Cl) 250 241 100.0% -0.09 [-0.28, 0.09]
Heterogeneity: Tau2 = 0.00; Chi2 = 4.23, df = 4 (P = 0 .38); I2 = 6%
Test for overall effect:
CT)
ÖIIN ÖnCL 33)
Std. Mean Difference 
IV, Random, 95% Cl
-1 -0.5 0 0.5 1 
Favours PST Favours Usual Ca
Analysis 1 .15. Comparison 1 PST versus Usual Care at 3-month follow-up, 
Outcome 15 All quality of life scales, changes
PST Usual Care Std. Mean Difference Std. Mean Difference  
Study or Subgroup Mean SD Total Mean SD Total W eight IV, Random, 95% Cl_________ IV, Random, 95% Cl
Kendrick 2005 0.17 0.28 71 0.13 0.23 51 27.0% 0.15 [-0.21, 0.51]
Liu 2007 19.2 21.81 63 21.2 23.51 66 29.0% -0.09 [-0.43, 0.26]
Mynors-Wallis 1997 0.26 0.22 34 0.14 0.27 29 14.9% 0.49 [-0.02, 0.99]
Schreuders 2007 3.67 11.62 61 2.45 12.92 69 29.1% 0.10 [-0.25, 0.44]
Total (95% Cl) 229 215 100.0% 0.12 [-0.09, 0.32]
Heterogeneity: Tau2 = 0.01; Chi2 = 3.45, d f=  3 (P = 0.33); I2 = 13% — tj----------+ : -------- -----------+ --------- f
Test for overall effect: Z = 1.13 (P = 0.26) Favours Usua| Cafe Favours psT
2 PST versus Usual Care at 6-month follow-up
Analysis 2.1. Comparison 2 PST versus Usual Care at 6-month follow-up, 
Outcome 1 Change in GHQ-28 score
PST Usual Care Mean D ifference Mean D ifference
Study o r Subgroup M ean SD Total M ean SD Total W eight IV, Random , 95% Cl IV, Random , 95% Cl_________
Catalan 1991 -13.1 7.53 21 -9 .9 8.28 26 48.5%  -3.20 [-7.73, 1 . 3 3 ]  
Mynors-Wallis 1997 -6.1 7.14 32 -8.2 8.71 26 51.5%  2.10 [-2 .06 ,6 .26] ---------
Total (95% Cl) 53 52 100.0% -0.47 [-5.66, 4.72]
Heterogeneity: Tau2 = 9 .12; Chi2 = 2.85, d f = 1 (P = 0.09): I2 = 65% ^ ----------J:----------- ^ ------------- +---------- —
Test for overall effect: Z = 0.18 (P = 0.86) '  Favours PST Favours Usual Ca
Analysis 2.2. Comparison 2 PST versus Usual Care at 6-month follow-up, 
Outcome 2 Change in SAS score
PST Usual Care Mean D ifference
Study o r Subgroup M ean SD Total M ean SD Total W eight IV, Random , 95% Cl
Mean Difference 
IV, Random, 95% Cl
Kendrick 2005  
Mynors-Wallis 1997
-0.4 0.44  
-0 .4  0.49
103
-0.46 0.43  
-0 .4  0.57
51
26
75.9%
24.1%
Total (95% Cl)
Heterogeneity: Tau2 = 0.00; Chi2 = 0.14, df = 1 (P  = 0.71); I2 = 0%  
Test for overall effect: Z  = 0.66 (P  =  0.51)
0.06 [-0.10, 0.22] 
0.00 [-0.28, 0.28]
77 100.0% 0.05 [-0.09, 0.18]
- 0.2 -0.1 0 0.1 0.2
Favours PST Favours Usual Ca
5 1 1 2 - 1 1 3
Analysis 2.3. Comparison 2 P ST  versus Usual Care at 6-month follow-up,
Outcome 3 Change in C IS  score
PST Usual Care Mean Difference
Study o r Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference
IV, Random, 95% Cl
Kendrick 2005 
Mynors-Wallis 1997
-12.6 12.3 
-10.5 10.53
-14.6 11.38 
-9.8 10.39
51
26
62.0%
38.0%
Total (95% Cl) 103
Heterogeneity: Tau2 = 0.00; Chi2 = 0.59, df = 1 (P =  0.44); I2 = 
Test for overall effect: Z  = 0.57 (P  =  0.57)
2.00 [-2.24, 6.24] 
-0 .70 [-6.11, 4.71]
77 100.0%
0%
0.97 [-2.36, 4.31]
-10 -5 0 5 10 
Favours PST Favours Usual Ce
Analysis 2 .13. Comparison 2 PST versus Usual Care at 6-month follow-up, 
Outcome 13 Change in Euroqol-5D score
PST Usual Care Mean Difference M ean D ifference
Study or Subgroup M ean SD Total M ean SD Total W eight IV, Random , 95% Cl__________ IV, Random , 95% Cl
Kendrick 2005 0.18 0.29 71 0.13 0.23 51 64.9%  0.05 [-0 .04 ,0 .14] ----------- -------------
Mynors-Wallis 1997 0.27 0.22 32 0.2 0.26 26 35.1%  0.07 [-0 .06 ,0 .20] --------------------------
Total (95% Cl) 103 77 100.0%
Heterogeneity: Tau2 = 0.00; Chi2 = 0.06, df = 1 (P  =  0.80); I2 = 0%
Test for overall effect: Z  = 1.50 (P =  0.13)
0.06 [-0.02, 0.13]
-0.2 - 0.1 0 0.1 0.2 
Favours Usual Care Favours PST
Analysis 2 .14. Comparison 2 PST versus Usual Care at 6-month follow-up, 
Outcome 14 All depression scales, changes
PST Usual Care Std. Mean Difference
Study or Subgroup Mean SD Total Mean SD Total W eight IV, Random, 95% Cl
Std. Mean Difference 
IV, Random, 95% Cl
2.14.1 Emotional symptoms
Catalan 1991 -12.3 4.69 21 -7.6 7.94 26 17.7% -0.69 [-1.28,-0.10]
Kendrick 2005 -12.6
Mynors-Wallis 1997 -10.5 
Subtotal (95% Cl) 
Heterogeneity: Tau2 = 0.12; Chi2
12.3
10.53
-14.6
-9.8
11.38
10.39
71 
32 
124
5.86, df = 2 (P =  0.05); i:
51
26
103
66%
89 -7.54 10.16
Test for overall effect: Z  = 0.62 (P  = 0.53)
2.14.2 Depressive disorders
Dowrick 2000 -10.63
Subtotal (95% Cl)
Heterogeneity: Not applicable
Test for overall effect: Z  = 2.22 (P  = 0.03)
Total (95% Cl) 213
Heterogeneity: Tau2 = 0.06; Chi2 = 7.42, df = 3 (P = 0.06); I2 : 
Test for overall effect: Z  = 1.16 (P  = 0.25)
129
129
28.3%
20 .6%
66.7%
33.3%
33.3%
232 100.0%
60%
0.17 [-0.19, 0.53] 
-0.07 [-0.58, 0.45] 
-0.15 [-0.63, 0.33]
-0.31 [-0.58, -0.04] 
-0.31 [-0.58, -0.04]
-0.19 [-0.52, 0.13]
-1 -0.5 0 0.5 1 
Favours PST Favours Usual Ca
Analysis 2 .15. Comparison 2 PST versus Usual Care at 6-month follow-up, 
Outcome 15 All quality of life scales, changes
PST Usual Care Std. Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Std. Mean Difference 
IV, Random, 95% Cl
2.15.1 Emotional symptoms
Kendrick 2005 0.18 0.29 71 0.13 0.23
Mynors-Wallis 1997 0.27 0.22 32 0.2 0.26 
Subtotal (95% Cl) 103
Heterogeneity: Tau2 = 0.00; Chi2 = 0.10, df = 1 (P = 0.75); I2 = 0 
Test for overall effect: Z = 1.45 (P = 0.15)
2.15.2 Depressive disorders
Dowrick 2000 19.11 22.15 128
Subtotal (95% Cl) 128
Heterogeneity: Not applicable
Test for overall effect: Z = 3.38 (P = 0.0007)
51 24.9 
26 12.0
189
189
63.1%
63.1%
Total (95% Cl) 231 266
Heterogeneity: Tau2 = 0.00; Chi2 = 0.91, df = 2 (P = 0.63); I2 = 0% 
Test for overall effect: Z = 3.57 (P = 0.0004)
0.19 [-0.17, 0.55] 
0.29 [-0.23, 0.81] 
0.22 [-0.08, 0.52]
0.39 [0.16, 0.62] 
0.39 [0.16, 0.62]
0.33 [0.15, 0.51]
-1 -0.5 0 0.5
Favours Usual Care Favours PST
3  PST versus Usual Care at 12-month follow-up
Analysis 3.5. Comparison 3 P ST  versus Usual Care at 12-month follow-up,
Outcome 5 Change in SF -3 6  Mental Health score
PST Usual Care Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference
IV, Random, 95% Cl
Dowrick 2000 21.82 22.72 89 17 22.32 129 35.6%
Schreuders 2007 5.94 11.79 59 5.38 11.84 68 64.4%
Total (95% Cl) 148 197 100.0%
Heterogeneity: Tau2 = 2.03; Chi2 = 1.29, df = 1 (P = 0.26); I2 = 22%
Test for overall effect: Z = 1.02 (P = 0.31)
4.82 [-1.27, 10.91] 
0.56 [-3.56, 4.
2.07 [-1.92, 6.07]
-10 -5 0 5 10 
Favours Usual Care Favours PST
Analysis 3.9. Comparison 3 PST versus Usual Care at 12-month follow-up, 
Outcome 9 All depression scales, changes
PST Usual Care Std. Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Std. Mean Difference 
IV, Random, 95% Cl
3.9.1 Emotional symptoms
Schreuders 2007 -2.98 8.45 59 -3.36 7.72 
Subtotal (95% Cl) 59
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.26 (P = 0.79)
3.9.2 Depressive disorders
Dowrick 2000 -11.96 9.32 89 -9.91 9.67
Subtotal (95% Cl) 8'
Heterogeneity: Not applicable 
Test for overall effect: Z = 1.55 (P = 0.12)
Total (95% Cl) 148 1«
Heterogeneity: Tau2 = 0.01 ; Chi2 = 1.34, df = 1 (P = 0.25); I2 = 2 
Test for overall effect: Z = 0.84 (P = 0.40)
40.8%
40.8%
129 59.2% 
129 59.2%
0.05 [-0.30, 0.40] 
0.05 [-0.30, 0.40]
-0.21 [-0.49, 0.06] 
-0.21 [-0.49, 0.06]
-0.11 [-0.36, 0.14]
-0.5 -0.25 0 0.25 0.5 
Favours PST Favours Usual Ca
Analysis 3 .10 . Comparison 3 PST versus Usual Care at 12-month follow-up, 
Outcome 10 All quality of life scales, changes
PST Usual Care Std. Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Std. Mean Difference 
IV, Random, 95% Cl
3.10.1 Emotional symptoms
Schreuders2007 5.94 11.79 59 5.38 
Subtotal (95% Cl) 59
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.26 (P = 0.79)
17 22.32 129 
129
3.10.2 Depressive disorders
Dowrick 2000 21.82 22.72 8
Subtotal (95% Cl) 8
Heterogeneity: Not applicable 
Test for overall effect: Z = 1.55 (P = 0.12)
Total (95% Cl) 148
Heterogeneity: Tau2 = 0.00; Chi2 = 0.55, df = 1 (P = 0.46); I2 = 0 
Test for overall effect: Z = 1.38 (P = 0.17)
37.6%
37.6%
62.4%
62.4%
0.05 [-0.30, 0.40] 
0.05 [-0.30, 0.40]
0.21 [-0.06, 0.48] 
0.21 [-0.06, 0.48]
0.15 [-0.06, 0.36]
-0.5 -0.25 0 0.25 0.5
Favours Usual Care Favours PST
5 114 115
4  PST versus Medication at 3-month follow-up
Analysis 4.1. Comparison 4 P ST  versus Medication at 3-month follow-up,
Outcome 1 Change in HDRS score
Study or Subgroup
PST Medication
Mean SD Total Mean SD Total Weight
Mean Difference
IV, Random, 95% Cl
Mean Difference 
IV, Random, 95% Cl
4.1.1 Minor Depression & Dysthymia, 18-59 year-old
Barrett 2000 -8.5 4.56 64 -8.8 4.51
Subtotal (95% Cl) 64
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.37 (P = 0.71 )
4.1.2 Minor depression & Dysthymia, 60-years and older 
Barrett 2000 -5.8 5.19 112 -7.S 
Subtotal (95% Cl) 112 
Heterogeneity: Not applicable 
Test for overall effect: Z = 2.41 (P = 0.02)
4.1.3 Major depression
103
103
36.4%
36.4%
43.7%
43.7%
0.30 [-1.28, 1.8 
0.30 [-1.28, 1.81
1.70 [0.32, 3.08]
1.70 [0.32, 3.08]
Mynors-Wallis 1995 -12.3 6.53 29 -11 6.8 27 9.8% -1.30 [-4.80, 2.20]
Mynors-Wallis 2000 -12 7.8 34 -14 6.66 34 10.0% NJ o o 4^ UI 5.45]
Subtotal (95% Cl) 63 61 19.8% 0.36 [-2.87, 3.60]
Heterogeneity: Tau2 = 2.31; Chi2 = 1.73, df = 1(P = 0.19); I2 = 42%
Test for overall effect: Z = 0.22 (P = 0.83)
Total (95% Cl) 239 226 100.0% 0.93 [-0.21, 2.07]
Heterogeneity: Tau2 = 0.28; Chi2 = 3.72, df = 3 (P = 0.29); I2 = 19%
Test for overall effect: Z =  1.59 (P = 0.11)
-4 -2 0 2 4 
Favours PST Favours Medicatk
Analysis 4.2. Comparison 4 PST versus Medication at 3-month follow-up, 
Outcome 2 Recovered cases (HDRS<8)
Study or Subgroup
PST
Events Total
Medication
Events Total Weight
Risk Ratio 
M-H, Random, 95% Ci
Risk Ratio 
M-H, Random, 95% Ci
4.2.1 Major depression
Mynors-Wallis 1995 18 30 16 31 15.3% 1.16 [0.74, 1.82]
Mynors-Wallis 2000 20 34 24 34 24.5% 0.83 [0.58, 1.19]
Subtotal (95% Cl) 64 65 39.9% 0.96 [0.69, '1.32]
Total events 38 40
Heterogeneity: Tau2 == 0.01; Chi2 = 1.31, df = 1 (P  = 0.25); I2 = 24%
Test for overall effect:: Z  = 0.27 (P;= 0.78)
4.2.2 Dysthymia, 18-59 year-old
Barrett 2000 16 43 17 42 10.8% 0.92 [0.54, 1.57]
Subtotal (95% Cl) 43 42 10.8% 0.92 [0.54, '1.57]
Total events 16 17
Heterogeneity: Not applicable
Test for overall effect: Z  = 0.31 (P  = 0.76)
4.2.3 Minor Depression, 18-59 year-old
Barrett 2000 17 37
Subtotal (95% Cl) 37
Total events 17
Heterogeneity: Not applicable 
Test for overall effect: Z  = 0.12 (P  = 0.90)
4.2.4 Dysthymia, 60-year and older
Barrett 2000 33 72
Subtotal (95% Cl) 72
Total events 33
Heterogeneity: Not applicable 
Test for overall effect: Z  = 0.80 (P  = 0.42)
38
38
-year and older
23 66 26
13.2%
13.2%
20.7%
20.7%
15.5%
15.5%
4.2.5 Minor Depression,
Barrett 2000 
Subtotal (95% Cl) 6(
Total events 23
Heterogeneity: Not applicable 
Test for overall effect: Z  = 0.41 (P  = 0.
Total (95% Cl) 282 282 100.0%
Total events 127 128
Heterogeneity: Tau2 = 0.00; Chi2 = 2.34, df = 5 (P  = 0.80); I2 = 0%  
Test for overall effect: Z  = 0.18 (P  = 0.86)
0.97 [0.60,1.57] 
0.97 [0.60,1.57]
1.17 [0.80,1.72]
1.17 [0.80,1.72]
0.91 [0.58,1.43] 
0.91 [0.58,1.43]
0.98 [0.83,1.17]
0.5 0.7 1 1.5 2
Favours Medication Favours PST
Analysis 4.3. Comparison 4 P ST  versus Medication at 3-month follow-up,
Outcome 3 Change in BDI score
PST Medication Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference
IV, Random, 95% Cl
Mynors-Wallis 1995 -17.5 10.84 29 -14.4 10.5 27 48.9% -3.10 [-8.69, 2.49]
Mynors-Wallis 2000 -16.9 11.69 34 -18.4 11.16 34 51.1% 1.50 [-3.93, 6.93]
Total (95% Cl) 63 61 100.0% -0.75 [-5.26, 3.76]
Heterogeneity: Tau2= 2.67; Chi2 = 1.34, df = 1 (P = 0.25); I2 =; 25%
Test for overall effect: Z = 0.33 (P = 0.74)
-10 -5 0 5 10 
Favours PST Favours Medicatii
Analysis 4.4. Comparison 4 PST versus Medication at 3-month follow-up, 
Outcome 4 HSCL-D symptom resolution, 18 -59  year-old
PST Medication Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference 
IV, Random, 95% Cl
80 -0.6 0.54
4.4.1 week 0-2
Barrett 2000 -0.36 0.54
Subtotal (95% Cl) 80
Heterogeneity: Not applicable 
Test for overall effect: Z = 2.81 (P = 0.005)
4.4.2 week 2-11
Barrett 2000 -0.43 0.63 80 -0.28 0.54
Subtotal (95% Cl) 80
Heterogeneity: Not applicable 
Test for overall effect: Z = 1.62 (P = 0.11)
Total (95% Cl) 160 160 100.0%
Heterogeneity: Tau2 = 0.07; Chi2 = 9.57, df = 1 (P = 0.002); I2 = 90%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Chi2 = 9.57, df = 1 (P = 0.002), I2 = 89.5%
50.4%
50.4%
80 49.6% 
80 49.6%
0.24 [0.07, 0.41] 
0.24 [0.07, 0.41]
-0.15 [-0.33, 0.03] 
-0.15 [-0.33, 0.03]
0.05 [-0.34, 0.43]
-0.5 -0.25 0 0.25 0.5 
Favours PST Favours Medicath
Analysis 4.5. Comparison 4 PST versus Medication at 3-month follow-up, 
Outcome 5 Change in HSCL-D score
PST Medication Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference
IV, Random, 95% Cl
----------------1-----1— --1-----1-------
4.5.1 Minor Depression & Dysthymia, 18-59 year-old
Barrett 2000 -0.7 0.5 62 -0.95 0.63
Subtotal (95% Cl) 62
Heterogeneity: Not applicable 
Test for overall effect: Z = 2.44 (P = 0.01)
59 -0.7 0.7
4.5.2 Dysthymia, 60-year and older 
Barrett 2000 -0.45 0.58
Subtotal (95% Cl) 5
Heterogeneity: Not applicable 
Test for overall effect: Z = 2.01 (P = 0.04)
4.5.3 Minor Depression, 60-year and older
Barrett 2000 -0.52 0.57 49 -0.51 0.53
Subtotal (95% Cl) 49
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.09 (P = 0.93)
Total (95% Cl) 170 160 100.0%
Heterogeneity: Tau2 = 0.01; Chi2 = 3.63, df = 2 (P = 0.16); I2 = 45%
Test for overall effect: Z = 1.86 (P = 0.06)
36.7%
36.7%
50 29.6% 
50 29.6%
49 33.7% 
49 33.7%
0.25 [0.05, 0.45] 
0.25 [0.05, 0.45]
0.25 [0.01, 0.49] 
0.25 [0.01, 0.49]
-0.01 [-0.23, 0.21] 
-0.01 [-0.23, 0.21]
0.16 [-0.01, 0.33]
-0.2 0 0.1 0.2 
Favours PST Favours Medicath
Analysis 4.8. Comparison 4 PST versus Medication at 3-month follow-up, 
Outcome 8 Change in SAS score
5 11 6- 11 7
PST Medication Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference 
IV, Random, 95% Cl
Mynors-Wallis 1995 -0.83 0.64 29 -0.59 0.53 27 51.2% -0.24 [-0.55, 0.07] -------- ■ -----
Mynors-Wallis 2000 -0.7 0.72 34 -0.9 0.69 34 48.8% 0.20 [-0.14, 0.54]
Total (95% Cl)
0.07: Chi2 = 3.60
63 
df = 1 (P =
'£Cd
61 100.0%
= 72%
-0.03 [-0.46, 0.41]
-------1------- 1------- -------1------- 1-----------
Test for overall effect: Z = 0.12 (P = 0.91)
-0.5 -0.25 0 0.25 0.5
Favours PST Favours Medicatk
Analysis 4.10. Comparison 4 PST versus Medication at 3-month follow-up,
Outcome 10 Change in S F -3 6  Mental Health score
PST Medication Mean Difference Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl_______ IV, Random, 95% Cl
4.10.1 Minor Depression & Dysthymia, 18-59 year-old
Barrett 2000 9.7 10.88
Subtotal (95% Cl)
Heterogeneity: Not applicable
Test for overall effect: Z = 1.79 (P = 0.07)
62
62
34.3%
34.3%
-3.90 [-8.18, 0.38] 
-3.90 [-8.18, 0.38]
4.10.2 Dysthymia, 60 years and older 
Barrett 2000 5.5 9.75 6
Subtotal (95% Cl) 6
Heterogeneity: Not applicable 
Test for overall effect: Z = 1.63 (P = 0.10)
37.5%
37.5%
-3.40 [-7.49, 0.69] 
-3.40 [-7.49, 0.69]
4.10.3 Minor Depression, 60 years and older 
Barrett 2000 6.96 12.33 48 7.26
Subtotal (95% Cl) 48
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.12 (P = 0.90)
28.2%
28.2%
-0.30 [-5.02, 4.42] 
-0.30 [-5.02, 4.42]
Total (95% Cl) 171 158 100.0% -2.70 [-5.20,-0.19]
Heterogeneity: Tau2 = 0.00; Chi2 = 1.41, df = 2 (P = 0.49); I2 = 0% 
Test for overall effect: Z = 2.11 (P = 0.03)
Test for subgroup differences: Chi2 = 1.41, df = 2 (P = 0.49), I2 = 0
Favours PST Favours Medicati
Analysis 4 .12. Comparison 4 PST versus Medication at 3-month follow-up, 
Outcome 12 All depression scales, changes
PST Medication Std. Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Std. Mean Difference 
IV, Random, 95% Cl
4.12.1 Major depression
Mynors-Wallis 1995 -12.3 6.53 29 -11 6.8 27 14.3% -0.19 [-0.72,0.33]
Mynors-Wallis 2000 -12 7.8 39 -14 6.66 36 17.7% 
Subtotal (95% Cl) 68 63 32.0%
Heterogeneity: Tau2 = 0.04; Chi2 = 1.71, df = 1 (P = 0.19); I2 = 42%
Test for overall effect: Z = 0.26 (P = 0.80)
4.12.2 Minor Depression & Dysthymia, 18-59 year-old
Barrett 2000 -0.7 0.5 62 -0.95 0.63
Subtotal (95% Cl) 62
Heterogeneity: Not applicable 
Test for overall effect: Z = 2.40 (P = 0.02)
4.12.3 Dysthymia, 60-year and older
Barrett 2000 -0.45 0.58 59 -0.7 0.7
Subtotal (95% Cl) 59
Heterogeneity: Not applicable 
Test for overall effect: Z = 2.01 (P = 0.04)
4.12.4 Minor Depression, 60-year and older
Barrett 2000 -0.52 0.57 49 -0.51 0.53
Subtotal (95% Cl) 49
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.09 (P = 0.93)
24.2%
24.2%
50
50
22.5%
22.5%
21.3% 
21.3%
Total (95% Cl) 238 223 100.0%
Heterogeneity: Tau2 = 0.02; Chi2 = 5.98, df = 4 (P = 0.20); I2 = 33%
Test for overall effect: Z = 1.81 (P = 0.07)
0.27 [-0.18, 0.73] 
0.06 [-0.39, 0.51]
0.44 [0.08, 0.80] 
0.44 [0.08, 0.80]
0.39 [0.01, 0.77] 
0.39 [0.01, 0.77]
-0.02 [-0.41, 0.38] 
-0.02 [-0.41, 0.38]
0.21 [-0.02, 0.44]
-0.5 -0.25 0 0.25 0.5
Favours PST Favours Medicatic
7 PST versus Placebo at 3-month follow-up
Analysis 7.1. Comparison 7 P ST  versus Placebo at 3-month follow-up, Outcome 1
Change in H D RS score
Study or Subgroup
PST Placebo Mean Difference
Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference
IV, Random, 95% Cl
7.1.1 M inor Depression & Dysthymia, 18-59 year-old
Barrett 2000 -8.5 4.56 64 -7.2 5.52 69 37.3%
Subtotal (95% Cl) 64 69 37.3%
Heterogeneity: Not applicable 
Test for overall effect: Z = 1.48 (P = 0.14)
7.1.2 Minor Depression & Dysthymia, 60-years and older
Barrett 2000 -5.8 5.19 112 -5.45 5.25 118 40.5%
Subtotal (95% Cl) 112 118 40.5%
Heterogeneity: Not applicable
Test for overall effect: Z = 0.51 (P = 0.61)
7.1.3 Major Depression
Mynors-Wallis 1995 -12.3 6.53 29 -6.6 6.73 26 22.2% 
Subtotal (95% Cl) 29 26 22.2%
Heterogeneity: Not applicable 
Test for overall effect: Z = 3.18 (P = 0.001)
Total (95% Cl) 205 213 100.0%
Heterogeneity: Tau2 = 2.84; Chi2 = 7.82, df = 2 (P = 0.02); I2 = 74%
Test for overall effect: Z = 1.63 (P = 0.10)
-1.30 [-3.02, 0.42] 
-1.30 [-3.02, 0.42]
-0.35 [-1.70, 1.00] 
-0.35 [-1.70, 1.00]
-5.70 [-9.21,-2.19] 
-5.70 [-9.21, -2.19]
-1.89 [-4.16, 0.38]
Favours PST Favours Placebo
Analysis 7.2. Comparison 7 PST versus Placebo at 3-month follow-up, Outcome 2 
Recovered cases (HDRS<8)
Study or Subgroup
PST 
Events Total
Placebo 
Events Total
7.2.1 Major depression 
Mynors-Wallis 1995 18 
Subtotal (95% Cl)
Total events 18
Heterogeneity: Not applicable 
Test for overall effect: Z  =  2.40 (P  =
7.2.2 Dysthymia, 18-59 year-old
Barrett 2000 16
Subtotal (95% Cl)
Total events 16
Heterogeneity: Not applicable 
Test for overall effect: Z  =  0.53 (P  =
Weight
Risk Ratio
M-H, Random, 95% Cl
Risk Ratio
M-H, Random, 95% Cl
0.02)
0.60)
7.2.3 Minor Depression, 18-59 year-old
Barrett 2000 17 37
Subtotal (95% Cl) 37
Total events 17
Heterogeneity: Not applicable 
Test for overall effect: Z  =  0.46 (P  =  0.64)
7.2.4 Dysthymia, 60-year and older
Barrett 2000 33 72
Subtotal (95% Cl) 72
Total events 33
Heterogeneity: Not applicable
Test for overall effect: Z  =  1.04 (P  =  0.30)
7.2.5 Minor Depression, 60-year and older
Barrett 2000 23
Subtotal (95% Cl)
Total events 23
Heterogeneity: Not applicable 
Test for overall effect: Z  =  1.17 (P  =
72
72
= 0.24)
30
30
42
42
39
39
70
70
70
70
14.3%
14.3%
18.7%
18.7%
20.9%
20.9%
23.9%
23.9%
22.1%
22 .1%
254 251 100.0%
101
5 1 1 8 - 1 1 9
Total (95% Cl)
Total events 107
Heterogeneity: Tau2 = 0.07; Chi2 = 8.61, df =  4 (P  = 0.07); I2 = 54%  
Test for overall effect: Z  =  0.37 (P  =  0.71)
2.25 [1.16, 4.36]
2.25 [1.16, 4.36]
0.87 [0.52,1.46] 
0.87 [0.52,1.46]
0.90 [0.56,1.43] 
0.90 [0.56, 1.43]
1.23 [0.83,1.83]
1.23 [0 .83 ,1 .83 ]
0.77 [0.50,1.19] 
0.77 [0 .50 ,1 .19 ]
1.06 [0.77,1.46]
0.2 0.5 1 2
Favours Placebo Favours PST
Analysis 7.4. Comparison 7 PST  versus Placebo at 3-month follow-up, Outcome 4
Change in H SCL-D  score
PST Placebo Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference
IV, Random, 95% Cl
7.4.1 Minor Depression & Dysthymia, 18-59 year-old
Barrett 2000 -0.7 0.5 62 -0.81 0.75
Subtotal (95% Cl) 62
Heterogeneity: Not applicable 
Test for overall effect: Z = 1.00 (P = 0.32)
33.5%
33.5%
0.11 [-0.11,0.33] 
0.11 [-0.11, 0.33]
7.4.2 Minor depression, 60-years and older 
Barrett 2000 -0.52 0.57 49 -0
Subtotal (95% Cl) 49
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.91 (P = 0.36)
33.9%
33.9%
-0.10 [-0.31, 0.11] 
-0.10 [-0.31, 0.11]
7.4.3 Dysthymia, 60-years and older 
Barrett 2000 -0.45 0.58 5S
Subtotal (95% Cl) 59
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.00 (P = 1.00)
32.5%
32.5%
0.00 [-0 .22 , 0 .22] 
0.00 [-0.22, 0.22]
Total (95% Cl) 170
Heterogeneity: Tau2 = 0.00; Chi2 = 1.82, df = 2 (P = 0.40); I2 = 
Test for overall effect: Z = 0.05 (P = 0.96)
181 100.0% 0.00 [-0.12, 0.13]
-0.5 -0.25 0 0.25 0.5 
Favours PST Favours Placebo
Analysis 7.6. Comparison 7 PST versus Placebo at 3-month follow-up, Outcome 6 
HSCL-D symptom resolution, 18 -59  year-old
PST Placebo Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference 
IV, Random, 95% Cl
7.6.1 week 0-2
Barrett 2000 -0.36 0.54 80 
Subtotal (95% Cl) 80
-0.56 0.54 81
81
51.1%
51.1%
0.20 [0.03, 0.37] 
0.20 [0.03, 0.37]
Heterogeneity: Not applicable
Test for overall effect: Z = 2.35 (P = 0.02)
7.6.2 week 2-11
Barrett 2000 -0.43 0.63 80 
Subtotal (95% Cl) 80
-0.29 0.63 81
81
48.9%
48.9%
-0.14 [-0.33, 0.05] 
-0.14 [-0.33, 0.05]
Heterogeneity: Not applicable
Test for overall effect: Z = 1.41 (P = 0.16)
Total (95% Cl) 160 
Heteroaeneitv: Tau2 = 0.05: Chi2 = 6.76. df = 1 (P = 0.009):
162
I2 = 8£
100.0%
%
0.03 [-0.30, 0.37]
— I-------- 1-------- ---- 1-------- 1-----
Test for overall effect: Z = 0.20 (P = 0.84)
Test for subgroup differences: Chi2 = 6.76, df = 1 (P = 0.0
-0.5 -0.25 0 0.25 0.5 
Favours PST Favours Placebo
Analysis 7.9. Comparison 7 PST versus Placebo at 3-month follow-up, Outcome 9 
Change in SF-36 Mental Health score
PST Placebo Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Mean Difference 
IV, Random, 95% Cl
7.9.1 Minor Depression & Dysthymia, 18-59 year-old
Barrett 2000 9.7 10.88 62 11.3 11.78 69 32.0%
Subtotal (95% Cl) 62 69 32.0%
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.81 (P = 0.42)
7.9.2 Dysthymia, 60 years and older
Barrett 2000 5.5 9.75 61 0.62 6.48 57 36.9%
Subtotal (95% Cl) 61 57 36.9%
Heterogeneity: Not applicable 
Test for overall effect: Z = 3.22 (P = 0.001)
7.9.3 Minor Depression, 60 years and older
Barrett 2000 6.96 12.33 48 5.33 7.83 53 31.0%
Subtotal (95% Cl) 48 53 31.0%
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.78 (P = 0.43)
Total (95% Cl) 171 179 100.0%
Heterogeneity: Tau2 = 8.31 ; Chi2 = 6.88, df = 2 (P = 0.03); I2 = 71 %
Test for overall effect: Z = 0.91 (P = 0.36)
Test for subgroup differences: Chi2 = 6.88, df = 2 (P = 0.03), I2 = 70.9%
-1.60 [-5.48, 2.28] 
-1.60 [-5.48, 2.28]
4.88 [1.91, 7.85]
4.88 [1.91, 7.85]
1.63 [-2.45, 5.71]
1.63 [-2.45, 5.71]
-10 -5 0 5 10
Favours PST Favours Placebo
Analysis 7.11. Comparison 7 P ST  versus Placebo at 3-month follow-up, Outcome
11 All depression scales, changes
PST Placebo Std. Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
7.11.1 Major Depression
Mynors-Wallis 1995 -12.3 6.53 29 -6.6 6.73 26 1«
Subtotal (95% Cl) 29 26 1!
Heterogeneity: Not applicable 
Test for overall effect: Z = 3.00 (P = 0.003)
-0.85 [-1.40, -0.29] 
-0.85 [-1.40, -0.29]
Std. Mean Difference 
IV, Random, 95% Cl
7.11.2 Minor Depression & Dysthymia, 18-59 year-old
Barrett 2000 -0.7 0.5 62 -0.81 0.75
Subtotal (95% Cl) 62
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.97 (P = 0.33)
27.6%
27.6%
0.17 [-0.17, 0.51] 
0.17 [-0.17, 0.51]
7.11.3 Minor depression, 60-years and older
Barrett 2000 -0.52 0.57 49 -0.42 0.54 54
Subtotal (95% Cl) 49 54
Heterogeneity: Not applicable
Test for overall effect: Z = 0.91 (P = 0.37)
25.8%
25.8%
-0.18 [-0.57, 0.21] 
-0.18 [-0.57, 0.21]
7.11.4 Dysthymia, 60-years and older
Barrett 2000 -0.45 0.58 59 -0.45 0.63
Subtotal (95% Cl) 59
Heterogeneity: Not applicable
Test for overall effect: Z = 0.00 (P = 1.00)
26.8%
26.8%
0.00 [-0.36, 0.36] 
0.00 [-0.36, 0.36]
Total (95% Cl) 207 100.0% -0.17 [-0.53, 0.20]
Heterogeneity: Tau2 = 0.09; Chi2 = 9.82, df = 3 (P = 0.02); I2 = 6 
Test for overall effect: Z = 0.90 (P = 0.37) -1 -0.5 0 0.5 1 Favours PST Favours Placebo
9 PST versus Other Psychological Treatment at 3-month follow-up
Analysis 9.7. Comparison 9 PST versus Other Psychological Treatment at 3-month 
follow-up, Outcome 7 Change in CIS score
PST Other psychol treatment Mean Différence Mean Difference
Study or Subgroup Mean SD Total Mean______ SD Total Weight IV, Random, 95% Cl___________IV, Random, 95% Cl
Kendrick 2005 -10.4 11.92 71 -10.1 12.15 62 34.1% -0.30 [-4.40,3.80]
Liu 2007 -9.7 9.17 63 -8.6 8.46 77 65.9% -1.10 [-4.05,1.85]
Total (95% CI) 134 139 100.0% -0.83 [-3.22,1.57]
Heterogeneity: Tau2 = 0.00; Chi2 = 0.10, df = 1 (P = 0.76); I2 = 0% ^ ------------£-------------- +---------------+------------ —
Test for overall effect: Z  = 0.68 <P = 0.50) '  favours P S T  Favours Other psychol
Analysis 9 .12. Comparison 9 PST versus Other Psychological Treatment at 
3-month follow-up, Outcome 12 All depression scales, changes
P S T  Other psychol treatment Std. Mean Difference
Study or Subgroup Mean SD  Total Mean______ SD Total Weight IV, Random, 95% Cl
Std. Mean Difference 
IV, Random, 95% Cl
9.12.1 Emotional symptoms 
Kendrick 2005 -3.98 4.79 71 -3.97 4.24 
Liu 2007 -9.7 9.17 63 -8.6 8.46 
Subtotal (95% Cl) 134
Heterogeneity:Tau2 = 0.00; Chi2 = 0.25, df= 1 (P = 0.61); l2 = 0% 
Test for overall effect: Z  = 0.53 (P = 0.59)
9.12.2 Minor Depression
Tezel 2006 -2.6 7.04 32 -8.9 6.86
Subtotal (95% Cl) 32
Heterogeneity: Not applicable
Test for overall effect: Z  = 3.35 (P = 0.0008)
Total (95% Cl) 166
Heterogeneity:Tau2 = 0.17; Chi2 = 10.92, df = 2 (P = 0.004); I2 = 82%
Test for overall effect: Z  = 0.81 (P = 0.42)
35.2%
35.5%
70.7%
29.3%
29.3%
-0.00 [-0.34,0.34] 
-0.12 [-0.46,0.21] 
-0.06 [-0.30,0.17]
0.89 [0.37,1.42] 
0.89 [0.37,1.42]
169 100.0% 0.22 [-0.31,0.74]
Favours P S T  Favours Other psychol I
5 120 121
Analysis 9.13. Comparison 9 PST versus Other Psychological Treatment at 
3-month follow-up, Outcome 13 All quality of life scales, changes
Other psychol treatment Std, Mean Difference
Study or Subgroup Mean SD  Total Mean SD Total Weight IV, Random, 95% Cl
Std, Mean Difference 
IV, Random, 95% Cl
9.13.1 Emotional symptoms 
Kendrick 2005 0.17 0.28 71 0.12 0.25
Liu 2007 19.2 21.81 63 17.8 21.86
Subtotal (95% Cl) 134
Heterogeneity:Tau2 = 0.00; Chi2 = 0.25, df = 1 (P = 0.61); I2 = 0% 
Test for overall effect: Z  = 1.02 (P = 0.31 )
Total (95% Cl) 134
Heterogeneity:Tau2 = 0.00; Chi2 = 0.25, df = 1 (P = 0.61); I2 = 0%
Test for overall effect: Z  = 1.02 (P = 0.31)
77 51.2% 
139 100.0%
0.19 [-0.15,0.53] 
0.06 [-0.27,0.40] 
0.12 [-0.11,0.36]
0.12 [-0.11,0.36]
Favours Other psychol treatment Favours P S T
10 PST versus Other Psychological Treatment at 6-month follow-up
Analysis 10 .12 . Comparison 10 PST versus Other Psychological Treatment at 
6-month follow-up, Outcome 12 All depression scales, changes
PST Other psychol treatment Std. Mean Difference
Study or Subgroup Mean SD Total Mean
10.12.1 Emotional symptoms
Kendrick 2005 -12.6 12.3 71 -16.6 10.£
Subtotal (95% Cl) 71
Heterogeneity: Not applicable 
Test for overall effect: Z  = 1.97 (P = 0.05)
10.12.2 Depressive disorders
Dowrick 2000 -10.63 9.83 89 -8.15 10.2
Subtotal (95% Cl) 89
Heterogeneity: Not applicable 
Test for overall effect: Z  = 1.60 (P = 0.11)
Total (95% Cl) 160
Heterogeneity:Tau2 = 0.15; Chi2 = 6.45, df= 1 (P = 0.01); I2 = 8- 
Test for overall effect: Z  = 0.15 (P = 0.88)
SD Total Weight IV, Random, 95% Cl
0.35 [0.00,0.69] 
0.35 [0.00, 0.69]
83 51.0% 
83 51.0%
-0.25 [-0.55,0.05] 
-0.25 [-0.55, 0.05]
0.04 [-0.53, 0.62]
Std. Mean Difference 
IV, Random, 95% Cl
0.5 -0.25 0 0.25 0.5 
Favours P S T  Favours Other psychol t
Analysis 10 .13. Comparison 10 PST versus Other Psychological Treatment at 
6-month follow-up, Outcome 13 All quality of life scales, changes
PST Other psychol treatment Std. Mean Difference
Study or Subgroup Mean SD  Total Mean SD Total Weight IV, Random, 95% Cl
Std, Mean Difference 
IV, Random, 95% Cl
10.13.1 Emotional symptoms 
Kendrick 2005 0.18 0.29 71 0.15 0.25 
Subtotal (95% Cl) 71 
Heterogeneity: Not applicable
Test for overall effect: Z  = 0.63 (P = 0.53)
10.13.2 Depressive disorders
Dow rick 2000 19.11 22.15 89 16.56 21.13
Subtotal (95% Cl) 89
Heterogeneity: Not applicable
Test for overall effect: Z  = 0.77 (P = 0.44)
Total (95% Cl) 160
Heterogeneity:Tau2 = 0.00; Chi2 = 0.00, df= 1 (P = 0.97); I2 = 0%
Test for overall effect: Z  = 0.99 (P = 0.32)
43.5%
43.5%
56.5%
56.5%
0.11 [-0.23,0.45] 
0.11 [-0.23,0.45]
0.12 [-0.18,0.42] 
0.12 [-0.18,0.42]
145 100.0% 0.11 [-0.11,0.34]
-0.5 -0.25 0 0.25
Favours Other psychol treatment Favours PST
13 Days o ff work & Costs, PST versus Usual Care
Analysis 13.1. Comparison 13 Days o ff work & Costs, PST versus Usual 
Care, Outcome 1 Total number of days o ff work, 6-month follow-up (Emotional 
symptoms)
PST Usual Care Mean Difference Mean Difference 
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl________IV, Random, 95% Cl______
Kendrick 2005 13.8 27.6 51 10.7 18.18 71 50.4% 3.10 [-5.58,11.78]
Mynors-Wallis 1997 4.35 10.35 40 16.23 23.82 30 49.6% -11.88 [-20.99,-2.77]
Total (95% Cl) 91 101 100.0% -4.32 [-19.00,10.36]
Heterogeneity: Tau2 = 91.61 ; Chi2 = 5.45, df = 1 (P = 0.02); I2 = 82%
Test for overall effect: Z = 0.58 (P = 0.56)
15 Health care use & Costs, PST versus Usual Care
Analysis 15.2. Comparison 15 Health care use & Costs, PST versus Usual Care, 
Outcome 2 Total number of GP consultations, 6-month follow-up (Emotional 
symptoms)
PST Usual Care Mean Difference Mean Difference 
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl_______ IV, Random, 95% Cl______
Kendrick 2005 2.72 2.14 51 4.39 3.67 71 62.1% -1.67 [-2.71,-0.63] ------  ------  |
Mynors-Wallis 1997 5 4.1 40 5.1 3.7 30 37.9% -0.10 [-1.94,1.74]
Total (95% Cl) 91 101 100.0% -1.08 [-2.57, 0.42]
Heterogeneity: Tau2 = 0.65; Chi2 = 2.13, df = 1 (P = 0.14); I2 = 53%
Test for overall effect: Z = 1.41 (P = 0.16) Favours PST Favours Usual Ce
-20 -10 0 10 20 
Favours PST Favours Usual Ca
Analysis 15.4. Comparison 15 Health care use & Costs, PST versus Usual 
Care, Outcome 4 Total costs of GP consultations, 6-month follow-up (Emotional 
symptoms)
PST Usual Care Mean Difference Mean Difference 
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl________IV, Random, 95% Cl______
Kendrick 2005 56 44 51 91 76 71 51.0% -35.00 [-56.41, - 1 3 .5 9 ] ----------------- |
Mynors-Wallis 1997 63.9 52 40 65.2 46.9 30 49.0% -1.30 [-24.57,21.97]
Total (95% Cl) 91 101 100.0% -18.47 [-51.49,14.55]
Heterogeneity: Tau2 = 437.73; Chi2 = 4.36, df = 1 (P = 0.04); I2 = 77%
Test for overall effect: Z = 1.10 (P = 0.27) -50 -25 0 25 50 Favours PST Favours Usual Cai
Analysis 15.6. Comparison 15 Health care use & Costs, PST versus Usual Care, 
Outcome 6 Total Medications costs, 6-month follow-up (Emotional symptoms)
PST Usual Care Std. Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl
Std. Mean Difference 
IV, Random, 95% Cl
Kendrick 2005 
Mynors-Wallis 1997 6.4 12.8 40 20.1 31.7 30
54.9%
45.1%
Total (95% Cl) 91 101 100.0%
Heterogeneity: Tau2 = 0.09; Chi2 = 2.95, df = 1 (P = 0.09); I2 = 66%
Test for overall effect: Z = 1.15 (P = 0.25)
-0.06 [-0.42, 0.30] 
-0.59 [-1.08, -0.11]
-0.30 [-0.82, 0.21]
-1 -0.5 0 0.5 1 
Favours PST Favours Usual Ca
5 1 2 2 - 1 2 3
Analysis 15.8. Comparison 15 Health care use & Costs, P ST  versus Usual Care,
Outcome 8 Total costs, 6-month follow-up (Emotional symptoms)
PST Usual Care Mean Difference Mean Difference
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl IV, Random, 95% Cl
Kendrick 2005 631 501 51 316 327 71 45.7% 315.00 [157.86,472.14] ----
Mynors-Wallis 1997 132 55.3 40 86.6 54.9 30 54.3% 45.40 [19.33,71.47]
Total (95% Cl) 91 101 100.0% 168.61 [-94.62, 431.83]
Heterogeneity: Tau2 = 33039.81 ; Chi2 = 11.01, df = 1 (P = 0.0009); I2 = 91%
Test for overall effect: Z = 1.26 (P = 0.21 ) -500 -250 0 250 500 Favours PST Favours Usual Cai
Appendices 
1 CCDAN-CTR search strategy
August 2009 :
l"C ochrane Depression, Anxiety and 
Neurosis Group"gc.
2. problem solving.mp. [mp=title, 
original title, abstract, mesh headings, 
heading words, keyword]
3. problem solving therapy.mp. 
[mp=title, original title, abstract, mesh 
headings, heading words, keyword]
4. problem solving treatment.mp. 
[mp=title, original title, abstract, mesh 
headings, heading words, keyword]
5. pstÿ.mp. [mp=title, original title, 
abstract, mesh headings, heading 
words, keyword]
6. 2 or 3 or 4 or 5
7. 1 and 6
2 MEDLINE search strategy
1950-August 2009 :
1. randomised controlled trial.pt.
2. controlled clinical trial.pt.
3. randomised controlled tria ls/
4. random allocation/
5. Double-Blind Method/
6. single blind method/
7. clinical trial.pt.
8. clinical tria ls/
9. (clinÿ adj25 trial$).ti,ab.
10. ((singlÿ or doublé or treble or tripl$) 
adj25 (blind# or mask$)).ti,ab.
11. placebos/
12. placebo$.ti.
13. placebo$.ab.
14. random$.ti.
15. random$.ab.
16. research design/
17. comparative study/
18. evaluation studies/
19. follow up studies/
20. prospective studies/
21. control#.ti.
22. control#.ab.
23. prospective.ti.
24. prospective.ab.
25. volunteer#.ti.
26. volunteer#.ab.
27. 1 or 2 or 3 or 4 or 5 or 5 or 7 or 8 
or 9 or 10 or 11 or 12  or 13 or 14 or 
15 or 16 or 17 or 18 or 19 or 20 or 21 
or 22  or 23  or 24 or 25  or 26
28. (animals not human).sh.
29. 27  not 28
30. problem solving.mp. and treatment 
outcome/
31. problem solving therapy.mp. 
[mp=title, original title, abstract, name 
of substance, mesh subject heading]
32. problem solving treatment.mp. 
[mp=title, original title, abstract, name 
of substance, mesh subject heading]
33. pst#.mp. [mp=title, original title, 
abstract, name of substance, mesh 
subject heading] 
3 4 .3 0 o r 3 1 o r 3 2 o r 3 3
35. exp "behaviour and behaviour 
mechanisms”/ or exp "psychological 
phenomena and processes”/ or exp 
mental disorders/ or exp "behavioural 
disciplines and activ ities”/
36. 35  and 34  and 29
3  EMBASE search strategy
1980-August 2009 :
1 .Randomised Controlled Trial/
2. Clinical Trial/
3. Randomization/
4. Double Blind Procedure/
5. Single Blind Procedure/
6. Major Clinical Study/
5 1 2 4 - 1 2 5  7. Controlled Study/
8. Multicenter Study/
9. Placebo/
10. placebo#.ti.
11. placebo#.ab.
12. random#.ti.
13. random#.ab.
14. Methodology/
15. Evidence Based Medicine/
16. Comparative Study/
17. exp "evaluation and follow up”/
18. Follow Up/
19. Prospective Study/
20. controlÿ.ti.
21. control#.ab.
22. prospective.ti.
23. prospective.ab.
24. volunteer#.ti.
25. volunteer#.ab.
26. ((singl# or doubl# or trebl# or tripl#) 
adj (blind# or mask# or dummy)).ti,ab.
27. (clinic# adj (trial# or study or 
studies#)).ti,ab.
28. 1 or 2 or 3 or 4 or 5 or 5 or 7 or 8 
or 9 or 10 or 11 or 12  or 13 or 14 or 
15 or 16 or 17 or 18 or 19 or 20  or 21 
or 22  or 23 or 24  or 25 or 26  or 27
29. human.de.
30. nonhuman.de.
31. 29  and 30
32. 30  not 31
33. 28  not 32
34. (problem solving.mp.) and 
(treatment outcome/)
35. problem solving therapy.mp. 
[mp=title, abstract, subject headings, 
drug trade name, original title, device 
manufacturer, drug manufacturer name]
36. problem solving treatment.mp. 
[mp=title, abstract, subject headings, 
drug trade name, original title, device 
manufacturer, drug manufacturer name]
37. pst#.mp. [mp=title, abstract, 
subject headings, drug trade name, 
original title, device manufacturer, drug 
manufacturer name]
38. 34  or 35  or 36  or 37
39. (exp mental function/) or (exp 
"psychological and psychosocial 
phenomena”/) or (exp mental disease/) 
or (exp "psychological and psychiatric 
procedures, techniques and concepts”/)
40. 39  and 38  and 33
4  CINAHL search strategy
1982-August 2009 :
1. (MH "Random Assignment'!
2. (MH "Double-Blind Studies")
3. (MH “Single-Blind Studies")
4. PT clinical trial
5. (MH "Clinical Trials+'l
6. Tl clin* W 25 trial*
7. AB clin* W 25 trial*
8. (singl* or doubl* or tripl* or trebl*) 
AND (blind* or mask* or dummy*)
9. (MH "Placebos")
10. Tl placebo*
11. AB placebo*
12. Tl random*
13. AB random*
14. (MH "Comparative Studies")
15. (MH "Evaluation Research+'T
16. (MH "Prospective Studies+'l
17. Tl control*
18. AB control*
19. Tl prospectiv*
20. AB prospectiv*
21. Tl volunteer*
22. AB volunteer*
23. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
or 9 or 10 or 11 or 12  or 13 or 14 or
15 or 16 or 17 or 18 or 19 or 20 or 21 
or 22
24. pst*
25. (MH "Problem Solving+'l
26. problem solving therapy
27. problem solving treatment
28. 24  or 25  or 26  or 27
29. (MH "Mental Disorders+'l
30. (MH "Behavior and Behavior 
Mechanisms+'l
31. (MH "Psychological Processes and
Principles+")
32. 29  or 30  or 31
33. 3 2  and 28 and 23
5 PsyclNFO search strategy
1806-August 2009 :
problem AND solving (Limiters: 
Population Group: Human; 
Methodology: Treatment Outcome/ 
Randomised Clinical Trial)
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A bstract
Introduction
In general practice many patients 
present with emotional symptoms. Both 
patients and physicians desire effective 
non-pharmacological treatments.
To study the effectiveness of problem­
solving treatm ent (PST) delivered by 
trained general practice (GP) registrars 
fo r patients w ith emotional symptoms.
Methods
In a controlled clinical trial we 
compared the effectiveness of PST 
versus usual care fo r patients w ith 
emotional symptoms. Dutch GP 
registrars provided PST or usual care, 
according to their own preference. 
Patients were included if they (a) 
had presented fo r three or more 
consultations w ith emotional symptoms 
in the past 6 months; and (b) scored 
four or more on the 12-item  General 
Health Questionnaire. Outcomes at 3 
and 9 month follow-up were standard 
measures of depression, anxiety and 
quality of life.
Results
Thirty-eight GP registrars provided PST 
and included 98 patients; 43  provided 
usual care and included 104  patients. 
PST patients improved significantly 
more than usual care patients: at 
9-month follow-up recovery rates 
for somatoform disorder and anxiety 
were higher in the PST group (OR 
6.50, p=0 .01  respectively OR 11.25, 
p=0.03). PST patients had improved 
significantly more on the domains 
social functioning, role lim itation due to 
emotional problems and general health 
perception.
Discussion
Patients w ith emotional symptoms 
improved significantly more after PST 
delivered by motivated GP registrars 
than after usual care by GP registrars. 
Further research, w ith randomization of 
interested registrars or interested GPs, 
is needed.
Introduction
In general practice many patients 
have emotional symptoms and/or 
psychosocial problems.1-2 Most patients 
are treated adequately, but in a 
minority of cases a pattern of recurrent 
or chronic symptoms develops w ith a 
negative impact on quality of life3 and 
frequent consultations.4 This makes 
diagnosis and treatm ent of emotional 
symptoms an important task in general 
practice. General practicioners (GPs) 
often prescribe medication, usually 
benzodiazepines or antidepressants2 
but medication is not always 
appropriate. It has important side 
e ffects,5-6 patient adherence is low7 and 
the effectiveness of antidepressants 
is being disputed.8 Alternative 
approaches have to be considered. This 
looks attractive as most patients prefer 
non-pharmacological treatm ents.9 
Counseling is nearly always part of the 
treatm ent in general practice10 and has 
the potential to strengthen patients' 
self-management. However, its content 
often varies and evidence fo r its long­
term effectiveness is weak.11 
Problem-solving treatment (PST) might 
be an attractive option because of its
structured approach w ith a focus on 
patient-empowerment.12 PST is a brief 
psychological intervention suitable 
for primary care, focusing on how to 
deal w ith everyday problems. PST is 
effective in anxiety and depression, 
especially in major depression,1214and 
there are indications tha t it is effective 
for unexplained physical symptoms15 
and in palliative care.16 A recent 
Cochrane review recommended further 
research on the effectiveness of PST 
in patients w ith emotional symptoms, 
irrespective of whether these fulfil the 
criteria fo r DSM-IV disorders.17 
Concurrently, GPs and GP registrars 
have expressed the need fo r an 
effective psychological treatm ent they 
can deliver themselves to manage 
patients w ith emotional symptoms.18“
20 Training GP registrars in PST could 
meet GPs' need in an early career stage. 
A pilot study w ith 11 GP registrars 
showed tha t registrars can be trained 
successfully in PST but the authors 
recommended further investigation 
w ith a larger sample of registrars and 
evaluation of patient outcomes.21 
We aimed to study the effectiveness of 
PST delivered by trained GP registrars
Figure 1 Problem-solving treatm ent (PST)
A brief psychological treatm ent w ith 7 stages:
1. Explanation and rationale
2. C larification and definition of the problems
3. Establishing achievable goals
4. Generating solutions
5. Selecting preferred solution
6. Implementing solution
6  1 3 0 - 1 3 1  7. Evaluation of progress
fo r patients w ith recurrent or chronic 
emotional symptoms.
Methods
Design
We compared, in a pragmatic controlled 
clinical trial, the effectiveness of PST 
versus usual care fo r patients w ith 
emotional symptoms. PST and usual 
care were applied by GP registrars.
This design promotes external 
validity, which means that it increases 
the applicability of a trial's results 
to situations other than the trial 
s ituation.22
Setting
The study took place in a Dutch 
three-year GP residency programme. 
From 2 0 0 3  to 2 0 0 5  the residency 
programme scheduled the participation 
of all third-year registrars (81) in this 
study as part of the core programme. 
Registrars participated in two groups, 
PST and 'usual care! Initially, we 
assigned registrars randomly to PST 
or usual care. We had to change this 
selection as registrars who were 
uncomfortable w ith PST did not include 
any patients. We allowed the next year 
group (2004-2005) to choose the 
strategy they were most comfortable 
with: PST (including training) or usual 
care. Ethical approval was obtained 
according to local protocols.
Recruitment and selection criteria  
We asked registrars to recruit adult 
patients who presented emotional 
symptoms, during their regular 
clinical work in their training practice 
(September 2 0 0 3  to April 2006). We 
asked each registrar to recruit 4-6  
patients because, from a logistical 
perspective, this was regarded as the
maximum feasible number w ithin one 
year of residency. We defined emotional 
symptoms as sub threshold as well as 
formal disorders of depressed mood, 
anxiety or stress, and psychosocial 
problems. Patients were included in 
the study, if they (a) had presented 
emotional symptoms during three 
or more consultations in the past 6 
months; and (b) had a score of four or 
more on the 12-item  General Health 
Questionnaire (GHQ-12).23 
Exclusion criteria were (a) severe 
physical disease; (b) severe mental 
morbidity (organic psychiatric disorder, 
substance misuse, active suicidal 
ideas); (c) current or recent (past year) 
psychiatric or psychological treatment 
or cognitive behavioural therapy; (d) 
insufficient mastery of Dutch language. 
Registrars received support of a 
research assistant in the selection 
of suitable patients. All participating 
patients signed informed consent.
Treatment and training 
PST is a brief psychological treatment, 
derived from cognitive behavioural 
therapy, teaching patients how to use 
their own skills to cope w ith everyday 
life problems in a systematic way. It 
is assumed tha t symptoms reduce if 
control over problems is (re)gained.12 
PST comprises seven stages (Figure 
1). The treatm ent consists of four 
to six consultations over a period of 
approximately 8 -12  weeks w ith a 
duration of no more than 30  minutes, 
except fo r the firs t session which may 
last 60  minutes.
The registrars were trained by 
experienced PST trainers in a two- 
day course, followed by supervised 
treatment and feedback meetings. 
Trainers assessed the quality of PST 
through registrars' PST work sheets.
Details about the feasibility of this 
training programme during residency 
were published before.24 
The exact nature of'usual care'was 
retrieved from patient records after 
the trial. Both treatm ent groups were 
allowed to prescribe medication.
Follow-up and outcomes  
Primary outcomes were the proportion 
of patients who remitted, the reduction 
of symptoms, and improvement of 
quality of life. We used the Primary 
Health Questionnaire (PHQ) assessing 
the presence of five DSM-IV 
disorders,25 the Hospital Anxiety
and Depression Scale (HADS)26, 
the 36-item  MOS short form (SF- 
36)27 and the 5-dimension Euroqol 
measuring quality of life (EQ-5D)28, 
and the social problem-solving (skills) 
inventory-revised measuring problem­
solving skills (SPSI-R)29. Secondary 
outcomes were: patient satisfaction 
(a self developed questionnaire based 
on the Consultation Satisfaction 
Questionnaire30 w ith 9 items measuring 
satisfaction w ith the doctor and 7 
items measuring satisfaction w ith the 
treatment); number of disability days 
(TiC-P)31; and health care utilization. 
Health care utilization data were
Figure2 Flow chartPST-tria l
2 0 2  patients met 
entry criteria
104  patients assigned 
to receive usual care
I
98 patients assigned 
to receive PST
i
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92  responders 86 responders
at baseline at baseline
i 4,
63 responders at 65  responders at
10-week follow-up (64%) 10-week follow-up (63%)
60 responders at 63  responders at
36-w eek follow-up (61%) 36-w eek follow-up (61%)
collected from the patients' records: 
data on referrals and medication, and 
numbers of contacts w ith the GP.
Higher scale scores indicated better 
patient outcome, except fo r the PHQ 
and HADS w ith lower scores indicating 
better scores.
Participants received self-completing 
questionnaires at baseline (TO), after 
treatm ent (at 3 months, T1) and at 9- 
month follow-up (T2). Record data of 
the six-month period before treatment 
were compared to data of the six-month 
period after treatment.
Sample size
We aimed to detect a clinically 
relevant difference of 30%  between 
interventions w ith the primary outcome 
measure PHQ. To provide a power 
of 80%  at a two-sided 5%  level of 
significance, we needed 4 2  patients 
w ith full data in each group.
Analysis o f  effectiveness  
We conducted statistical analyses 
using SPSS 16.0, according to 
the intention-to-treat principle.
We analysed all cases w ith data at 
baseline and data a t T l  and/orT2. 
Subsequently, we repeated the analysis
Table 1 Baseline characteristics
Patient characteristics PST
(n=98)
Usual care
(n=104)
p-value
Mean age , years (SD) 40 .3  (13.3) 46 .0 (16 .3 ) 0.01
Female, No. (%) 7 9 /9 8  (81%) 63 /1 0 4 (6 1 % ) <0.001
Married or living w ith partner, No. (%) 6 2 /9 2  (67%) 5 1 /7 9  (65%) 0.98
Ethnicity, white, No. (%) 8 3 /91 (91% ) 9 5 /9 8  (97%) 0.09
Paid employment, No. (%) 6 1 /9 2  (66%) 5 1 /8 6  (59%) 0.33
Clinical characteristics (n=92) (n=86)
GHQ-12, mean (SD) 9 .30 (2 .37 ) 7 .58 (2 .56 ) <0.001
PHQ somatoform disorder, No. (%) 37 (40%) 31 (36%) 0.57
PHQ major depressive syndrome, No. (%) 37 (40%) 25 (29%) 0 .12
PHQ other anxiety syndrome, No. (%) 3 2 (35% ) 18 (21%) 0.04
HADS depression score, mean (SD) 9 .26 (4.25) 8 .09 (4 .60 ) 0.05
HADS anxiety score, mean (SD) 10.41 (3.28) 9.14 (4.81) 0 .08
SF-36 social functioning, mean (SD) 47 .64 (19 .20 ) 5 1 .4 9 (2 3 .8 5 ) 0 .29
SF-36 mental health, mean (SD) 43 .51  (13.56) 4 9 .1 8 (2 0 .2 8 ) 0 .05
SF-36 role lim itation due to 24 .20  (30.05) 4 6 .4 8 (4 1 .5 9 ) <0.001
emotional problems, mean (SD)
SF-36 general health perception, mean (SD) 5 5 .12 (19 .45 ) 55 .68  (19.94) 0 .87
EQ-5D score, mean (SD) 0 .69(0 .16) 0.71 (0.19) 0 .60
SPSI-R total score, mean (SD) 9 .07 (2 .64 ) 9 .91 (2 .72 ) 0.04
with missing data being imputed by 
the last observations carried forward 
(LOCF) principle.
We compared differences w ithin the 
treatm ent groups w ith McNemar tests 
and paired t-tests to assess changes 
over time. In order to investigate the 
e ffect of the intervention, we used 
univariate general linear models 
and binary logistic regression using 
gender, age and baseline values as 
covariates to correct for baseline 
differences between treatment groups. 
We separately analysed the e ffect of 
treatm ent at T l  and T2. The e ffect of 
the intervention was the difference
in outcome between the PST group 
and the usual care group (level of 
significance p<0.05).
Results
Recruitment  & fo llow-up  
Thirty-eight registrars (28 women) 
provided PST and 43  (29 women) 
provided usual care. They included 
2 0 2  patients: 98 in the PST group and 
104  in the usual care group (Figure 
2). Patients in the PST group were 
significantly younger and more often 
female, had at baseline significantly 
higher symptom severity and
Table 2 Numbers of cases at Patient Health Questionnaire (PHQ) at 3-m onth follow-up (T l) and 
9-m onth follow-up (T2) and binary logistic regression fo r differences in e ffec ts  between PST and 
Usual care a t T l  and T2 compared to baseline (with gender, age and baseline values as covariates).
No of Cases (%) Odds Ratio (95%  Cl) for
Outcome PST Usual Care achievement of remission
PHQ somatoform disorder
TO 3 7 /9 2 (4 0 .2 % ) 3 1 /8 6  (36.0%) ref
T l 6 /63  (9.5%) 2 0 /6 5 (3 0 .8 % ) 6 .52 (1 .94  to 21.91)*
T2 4 /6 0  (6.7%) 16 /63 (25 .4% ) 6.50  (1.74 to 24.31)*
PHQ major depressive syndrome
TO 3 7 /9 2 (4 0 .2 % ) 25 /86 (29 .1% ) ref
T l 8 /6 3  (12.7%) 1 1 /6 5  (16.9%) 1 .90 (0.61 to 5.92)*
T2 5 /60 (8 .3% ) 4 /6 3  (6.3%) 0 .6 2 (0 .1 4  to 2.76)*
PHQ other anxiety syndrome
TO 3 2 /9 2 (3 4 .8 % ) 1 8 /8 6 (2 0 .9 % ) ref
T l 6 /63  (9.5%) 8 /65  (12.3%) 2 .02  (0.56 to 7.31)*
T2 1 /60(1 .7% ) 7 /63  (11.1%) 11.25 (1.21 to 104.26)*
PST = problem-solving treatment; Cl = confidence interval; re f = reference group; * adjusted for gender, age and baseline values
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significantly worse SPSI-scores than 
patients in the control group (Table 
1). Overall, 128  (63%) participants 
returned follow-up questionnaires at 
T l  and 123  (61%) a tT2 . Patients lost 
to follow-up did not d iffer significantly 
from those who completed the study 
w ith regard to age, gender, PST or usual 
care, or baseline values. Recorded 
reasons fo r loss to follow-up were: no 
more interest/time (n=7), psychosocial 
problems (n=6), aggravation of 
psychological symptoms (n=5), physical 
complaints (n=4), being moved (n=2), 
language (n= l). Medical records were 
retrieved fo r 96  PST patients and 99 
control group patients (1 patient died 
and 6 patients moved).
Clinical outcome and qual ity  o f  life 
Both treatm ent groups improved 
significantly over time. Tables 2 and
3 show the results at T l  and T2 
compared to TO. From the PHQ we 
analysed the three most prevalent 
disorders: major depression (n=62), 
somatoform disorder (n=68), and other 
anxiety syndrome (n=50) (Table 1). The 
PST group showed significantly better 
recovery rates fo r somatoform disorder 
at T l  and T2 and fo r anxiety at T2, 
but not fo r major depression (Table 2). 
The HADS depression score improved 
significantly more in the PST group 
than in the usual care group a tT l ;  the 
HADS anxiety score did so at T l  and 
T2. In the PST group general health 
perception improved significantly more 
at T l  and T2. In table 3 we present the 
three SF-36 domains most relevant to 
a mental health oriented intervention: 
social function and mental role 
lim itation improved significantly more 
in the PST group a tT2 ; mental health 
improved in both groups but did not 
d iffer significantly between groups at
T l  norT2. The EQ-5D scale improved 
more in the PST group a tT l .  Regarding 
problem-solving skills, the SPSI-R 
total scores did not show significant 
differences in change between groups. 
When analyzing only those PST 
patients who attended 4 or more 
sessions -  the number recommended 
for effectiveness -  the differences 
were more pronounced and the HADS 
depression score differed significantly 
in favour of PST at T2 too (p=0.020). 
There were no significant differences 
between patients recruited during the 
firs t year and the second year when the 
randomization was released.
A fter imputing missing data by LOCF 
both quality of life and psychological 
symptom scores differed significantly 
in favour of PST.
Health care util ization  & disabil i ty  days 
The numbers of patients being 
referred or using psychotropic 
medication during treatment did not 
d iffer significantly between groups.
The changes in consultation rate and 
numbers of patients being referred or 
using psychotropic medication in the six 
months before versus the six months 
after treatm ent were not significantly 
different from usual care but all in 
favour of PST.
Absence of work did not d iffer 
significantly (TiC-P). PST patients 
experienced significantly less 
difficulties during unpaid activities than 
usual care patients (T1 B-coefficient 
-0 .90, p<0.001; T2 B-coefficient 
-0 .46, p=0.04).
Patient sat is fac tion  
No significant differences in patient 
satisfaction were found. A t T1, PST 
patients scored 25.7  (SD 5.0) and 
usual care patients 24 .8  (SD 5.8)
on the 45-po in t'satisfaction with 
physician'scale and 20 .5  (SD 4.3) and 
19.4  (SD 4.6) respectively on the 35- 
point 'satisfaction w ith treatment' scale.
Treatment received  
Patients in the intervention group 
received on average 4 .3  PST sessions 
(range 1-7), including the consultation 
of study inclusion accompanied by 
the intake of PST. F ifty-three patients 
completed treatment (» 4 sessions) 
w ith on average 5.3 sessions (range
4-7). The mean number of consultations 
in addition to PST sessions during the 
3-month treatm ent period was 0.7 
(range 0-5). Based on work sheets 
of PST sessions the PST supervisor 
reported good quality performance of 
PST.
In the usual care group, the average 
number of consultations -  fo r any 
reason -  during the 3-month treatment 
period was 3 .3  (range 1-12). Most 
registrars used counseling in most 
consultations, but content and duration 
were not described in the records.
Discussion
Both PST and usual care patients 
w ith chronic or recurrent emotional 
symptoms improved significantly over 
time. However, patients who were 
treated by GP registrars providing 
PST, had significant better outcomes 
than patients who were treated by 
registrars providing usual care. PST 
patients reported significantly fewer 
symptoms of depression and anxiety, 
and a significantly higher general health 
perception than usual care patients did, 
both short- and long-term. PST patients 
had a significantly higher chance of 
recovery from somatoform disorder 
short-term. Long-term this was also
6  136-137  the case fo r anxiety. Long-term they
reported significantly better scores of 
social function and role lim itation due 
to emotional problems, corresponding 
w ith a relevantly better subjective 
function in daily life. This fits  in with 
earlier research tha t found significantly 
better improvements of quality of life 
after PST than after usual care.14 
The PHQ did not show significant 
differences in recoveries of major 
depressive disorder but significant 
differences in favour of PST were 
found on the HADS concerning the 
severity of anxiety and depressive 
symptoms. Thus, PST did not diminish 
the number of cases  of depression but 
reduced symptom severity. Strikingly, 
SPSI scores did not d iffer significantly 
between groups. This could be due to 
the fac t tha t actual problem-solving 
performance is not necessarily a 
function of cognitive- behavioural skills 
in generating solutions.32
Strengths and lim itat ions o f  the s tudy  
Notwithstanding these positive 
findings, this study has limitations. 
Firstly, the lack of randomization of 
registrars providing PST. The registrars 
who were initially randomised to PST 
and were uncomfortable w ith it, did 
not recruit patients not allowing any 
comparison. We realize that changing 
the selection of registrars by offering 
the choice between PST and usual 
care may have resulted in potentially 
overestimating the impact of PST, 
because PST registrars were probably 
more motivated to deliver mental health 
care than their usual care colleagues. 
However, there were no differences in 
outcome between patients of registrars 
randomly allocated to PST and patients 
of registrars who made a choice fo r it. 
Also, registrars in the usual care group 
were not necessarily unmotivated for
Table 3. Mean scores on main outcome scales at 3-month follow-up (T l) and 9-month follow-up 
(T2) and ANCOVA for differences in effects over time between PST and Usual care (with gender, 
age and baseline values as covariates).
Mean difference (95%  
Cl) between PST and 
Mean score (SD) Usual care
Outcome# PST* Usual care* B -coeffic ient
Hospital Anxiety and Depression Scale
Depression score
TO 9.26 (4 .25 ) 8 .09 (4 .60 ) ref
T l 4 .97  (4.12) 6 .73(4 .40) -1.88 (-3.11 to -0 .6 4 )'
T2 4 .55  (4.45) 5.47 (3.65) -1 .23  (-2.49 to 0 .021-
Anxiety score
TO 10.41 (3 .28 ) 9.14 (4.81) ref
T l 6 .98 (3 .94 ) 8 .33 (4 .80 ) -2.17 (-3.44 to -0 .9 0 )'
T2 6 .65 (3 .25 ) 7 .05(4 .93) -1.33 (-2.50 to -0 .15 )'
3F-36
Social functioning
TO 47.64 (19 .20 ) 51 .49  (23.85) ref
T l 6 5 .97  (23.42) 57 .33(25 .73) 5 .81  (-3.73 to 15 .36 )-
T2 7 3 .2 3  (18.30) 6 2 .8 0 (2 3 .4 5 ) 9.83 (1.27 to 18 .3 9 )'
Mental health
TO 4 3 .5 1 (1 3 .5 6 ) 4 9 .1 8 (2 0 .2 8 ) ref
T l 64 .2 5 (1 8 .1 6 ) 61 .36  (21.37) 3 .69  (-3.13 to 10 .51)-
T2 6 8 .0 0  (17.06) 6 6 .2 6 (1 8 .6 4 ) 4 .49  (-2.13 to 1 1 .121-
Role lim itation due to emotional problems
TO 24 .2 0 (3 0 .0 5 ) 4 6 .4 8  (41.59) ref
T l 6 3 .8 9  (42.85) 5 6 .6 7 (4 4 .8 0 ) 9 .58  (-8.44 to 27.60)-
T2 80 .3 0 (3 6 .1 7 ) 7 0 .2 9 (4 2 .3 0 ) 17.18 (0.69 to 3 3 .6 7 )'
General health perception
TO 55 .1 2 (1 9 .4 5 ) 55 .6 8 (1 9 .9 4 ) ref
T l 6 4 .6 9 (2 2 .9 9 ) 57 .94 (19 .98 ) 8.00 (1.81 to 14 .2 0 )'
T2 7 0 .3 9 (1 9 .4 8 ) 6 1 .4 8 (2 0 .2 7 ) 10.48 (3.66 to 17.30)'
=uroQol-5D
TO 0.69(0 .16) 0 .71(0 .19) ref
T l 0 .81(0 .17) 0 .71(0.16) 0.09 (0.03 to 0 .14 )'
T2 0 .82 (0 .18 ) 0.79 (0.14) 0 .02  (-0.03 to 0 .071-
Social Problem Solving Inventory - revised
TO 9.07 (2.64) 9.91 (2.72) ref
T l 9 .98  (2.68) 10 .57 (2 .49 ) -0 .49  (-1.20 to 0 .21 )-
T2 10.13 (2.58) 1 0 .86 (2 .52 ) -0 .13  (-0.87 to 0 .60)-
PST = problem-solving treatment; SD = standard deviation; Cl = confidence interval; #HADS=21-point scales; SF-36=100-point
scales; EQ -5D=l-point scale; SPSI-R=20-point scale; *PST group: atTO n=92; a tT l  n=63 ; a tT 2  n=60. Usual care group: atTO 
n=86; a tT l  n=65; a tT 2  n=63.; -Adjusted for gender, age and baseline values
mental health care: they mentioned 
'time investment' most often as a 
reason fo r not participating in PST 
training (78%  of registrars). They 
received in their programme training of 
the prevailing Dutch College guidelines 
of depression and anxiety.33-34 
Furthermore, patient satisfaction 
w ith their GP registrar treatm ent was 
not significantly different between 
treatm ent groups.
The second lim itation was the selection 
of patients, w ith registrars in the 
intervention group selecting patients 
mainly themselves. Registrars in the 
usual care group partly did so, but to 
reach the numbers planned in advance, 
had to be assisted by a research 
assistant. PST registrars enrolled 
patients they thought would benefit 
from PST. Although this reflected daily 
practice in the sense that GPs offer 
only treatments to patients when 
they expect a positive e ffect on their 
health status, it resulted in a biased 
selection of patients: all patients met 
the eligibility criteria of 'emotional 
symptoms', a consultation rate of three 
or more, and a GHQ-12 score of four or 
more but PST patients were more often 
female, younger and had more severe 
psychological symptoms. Patients in 
the PST group might have been more 
suitable, and more motivated for 
treatm ent whereas patients selected 
fo r the usual care group were not 
specifically motivated. This limitation 
also might have overestimated 
treatm ent effects of PST. Although we 
corrected fo r the baseline differences 
in our analyses and still found 
significant advantages of PST above
UC, this lim itation -  together w ith the 
lack of randomization of registrars - 
compromises the internal validity. It 
therefore remains unclear whether 
the effects were the results of a. 
specific PST techniques, b. motivated 
registrars, c. more open attitudes of 
PST patients towards treatment, or d. 
a treatm ent like PST as a vehicle for 
registrars to incorporate non-specific 
skills -  such as empathy, warmth and 
the doctor-patient relationship -  better 
into their consultations w ith patients 
w ith emotional problems. The last 
option might be realistic, because 
a recent focus group study showed 
that registrars expressed tha t they 
implemented many new skills during 
PST.35 For instance, they mentioned 
to appreciate the patient-centered 
and patient-empowering character, 
including the activation of patients 
to implement their own solutions in 
daily life. Patient-empowering skills 
are increasingly valued as important 
w ithin primary care, especially in 
mental health care.36 Therefore, we 
think that a treatm ent like PST might 
be a practical vehicle fo r registrars to 
incorporate non-specific treatment 
skills more manifestly in their patient 
contacts.
A strength of our study is that, to our 
knowledge, this was the firs t study 
w ith PST being provided by physicians 
of the patients' own general practice. 
All other PST studies involved PST 
therapists who were unknown to 
the patient whereas usual care was 
delivered by the patient's own GP. This 
probably overestimated usual care 
effects in earlier studies because the
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doctor-patient relationship influences 
patient outcome importantly.37 Another 
strength is that this study was one of 
the very few studies w ith GP registrars  
providing a specific psychological 
treatm ent fo r emotional symptoms, 
including measurement of patient 
outcomes. An earlier American pilot 
study only measured feasibility and 
recommended measurement of patient 
outcomes.21 Recent Chinese research 
w ith registrars providing PST voluntarily 
did not show significant benefit of PST 
over placebo group intervention. These 
registrars, however, only provided 3 
sessions of PST.38 Unfortunately, the 
d ifficu lties we encountered in this 
study suggest that involving registrars 
in a randomised  trial was not optimal, 
because their motivation was essential 
in providing a psychological treatment.
Recommendations for fu r the r  research  
We recommend a trial with 
randomization of registrars who are 
interested to provide PST. In this trial, 
measurement of motivation must be 
part of the design. Furthermore, we 
suggest investigating the effectiveness 
of PST when provided by the patient's 
own GP, because effects build upon 
the more longstanding relation w ith the 
patient.
Conclusion
Patients w ith emotional symptoms 
improved significantly more after PST 
delivered by motivated GP registrars 
than after usual care by GP registrars. 
Further research, w ith randomization of 
interested registrars or interested GPs, 
is needed.
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7 General discussion
The aim of this thesis was to 
investigate the feasib ility  of Problem­
solving treatm ent (PST) during general 
practice (GP) residency and the 
effectiveness of PST, when provided 
by GP registrars, fo r patients w ith 
emotional symptoms in prim ary care.
In this final chapter, the results of the 
foregoing chapters will be discussed 
in relation to each other and the 
literature. Also, some methodological 
issues will be considered. And finally, 
suggestions fo r fu rthe r research 
and fo r general practice will be 
made, followed by a main conclusion. 
Throughout th is thesis we referred to 
the same category of patients w ith the 
terms em otional symptoms, emotional  
problems  and menta l health problems.
Regarding the feasib ility  of PST 
during residency, we found that PST 
training is feasible. Our observational 
and questionnaire study showed 
tha t training in PST during residency 
is feasible because GP registrars 
participated in the two-day training 
programme and subsequent 
supervision, and their evaluation of the 
training was positive. Furthermore, 
they provided PST as taught in the 
protocol and patients were willing 
to receive PST of the registrars 
(Chapter 2). Besides being feasible, 
PST training was also helpful during 
residency, as was shown in the focus 
group study (Chapter 3). Registrars 
thought that PST training provided 
them w ith a practical tool in the 
management of emotional problems.
In daily practice, however, they would 
prefer implementing elements rather 
than the entire treatm ent, because 
they thought the entire treatm ent 
costs too much time and is not 
7 144-145 their task. An im portant barrier in
the experiences of the registrars 
was their obligatory participation 
in this study. This prompted our 
interest in the views of registrars 
about participation in research in 
general. A questionnaire survey on 
this topic showed that registrars are 
interested in partic ipating in research, 
especially when they can learn a new 
skill, but participation should not be 
compulsory, and registrars prefer to 
choose their own research subjects 
(Chapter 4).
Regarding the effectiveness of PST 
fo r patients w ith emotional problems 
in primary care, the Cochrane review 
indicated tha t PST was more effective 
than control treatm ents fo r major 
depression in prim ary care (Chapter 5). 
In major depression, PST patients had 
a sta tis tica lly  significant and clinically 
im portant better SF-36 social function 
score and a higher recovery rate at 
the BDI (2.54, 95%  Cl 1 .85  to 3.50) 
than usual care patients at 6-month 
follow-up. Also, PST patients had 
sta tis tica lly  significant and clinically 
im portant higher recovery rates at the 
HDRS than patients in the placebo 
medication group at 3-m onth follow- 
up (RR 2.25, 95%  Cl 1.16 to 4.36).
For emotional problems other than 
major depression, however, there 
was insu ffic ient evidence to show 
sta tis tica lly  significant differences 
between PST and usual care, (placebo) 
medication, or other psychological 
treatm ents. Further research of PST 
fo r these problems was recommended. 
The controlled clinical trial described 
in this thesis provided indications tha t 
PST by motivated registrars might 
be more favourable fo r patients w ith 
emotional symptoms than usual care 
by registrars (Chapter 6). A t 9-month
follow-up PHQ recovery rates fo r 
somatoform disorder and anxiety 
were higher in the PST group (OR
6.50, p=0 .01  respectively OR 11.25, 
p=0.03). Depressive symptoms did 
not improve significant d iffe ren tly  
between treatm ent groups. PST 
patients had improved significantly 
more on the 100 -po in t SF-36 domains 
social functioning, role lim itation due to 
emotional problems and general health 
perception (B -coeffic ient of the mean 
difference respectively 9 .83 , p=0.03; 
17.18, p=0.04; 10 .48 , pcO.OOl). 
However, due to a considerably 
compromised valid ity of the trial, it 
remains unclear whether the e ffec t 
in this trial can be attribu ted  to the 
intervention. This will be described and 
discussed below.
In the performance of the studies 
described in this thesis we faced 
several themes and problems. We 
categorised these into four main 
themes: A. S trengths and weaknesses;
B. Specific and non-specific effects;
C. General considerations of research 
of psychological interventions; D. 
Realization of training during GP 
residency.
A. Strengths and weaknesses
There were a number of strengths in 
the studies described in this thesis.
-  Overall, it is an im portant strength 
tha t we used mixed methods by 
perform ing both quantitative 
and qualitative studies. Using a 
mixed methods design gives the 
broadest view possible,1 in this 
case on the feasib ility  of PST 
training during GP residency and 
the use of PST in daily practice.
On the one side we quantita tive ly 
analysed data on participation in
the training, recruited patients 
and time investment. And on the 
other side we qualitatively analysed 
reg istrars 'v iew s on PST during 
residency. In this way we came 
to both objective and subjective 
findings which informed us about 
the facts, barriers and enablers of 
PST during residency and PST in 
everyday practice. For instance, we 
found tha t registrars appreciated 
specific elements of PST but that 
they thought the entire treatm ent 
cost too much time. Furthermore, 
qualitative research has the 
advantage of generating unexpected 
insights. We, fo r instance, got to 
know registrars 'v iew s on their role in 
mental health care management.
-  The performance of a systematic 
review and meta-analysis by means 
of a Cochrane review is also a 
strong point in this thesis. Cochrane 
reviews are generally regarded as 
the strongest level of evidence. 
A lthough more reviews on PST have 
been perform ed,2 4 these did not 
specifically focus on PST in primary 
care. In our review, we included all 
kinds of emotional problems rather 
than only depression and we focused 
on primary care studies.
-  Also, perform ing a controlled trial 
w ith a large number of registrars 
(n=81) who provided either PST or 
usual care is a strength. A trial w ith 
this number of registrars had not 
been done before in PST research 
nor in studies of other psychological 
treatments.
-  Furthermore, the trial described in 
this thesis was unique because it 
was the firs t w ith physicians of the 
patients 'own practice providing PST. 
Therapists in all other PST studies so 
fa r were unfam iliar to the patient, in
the sense that PST was headed over 
to a provider outside of the practice.
-  Another strength of the trial was 
the highly pragmatic character 
which reflected daily practice. For 
instance, we included the broad 
range and/or m ixture of emotional 
symptoms which characterises 
general practice as GPs often 
see mixed symptoms rather 
than specific, full blown DSM-IV 
disorders.5 Most mental health 
research, however, is undertaken 
on people experiencing a 'pure' 
form  of a psychiatric disorder, fo r 
instance major depression. Varieties 
or co-morbid symptoms are often 
deliberately excluded from studies, 
diminishing the external validity, 
especially in general practice.6
This, however, also brings us to some
methodological lim itations of the trial.
- The firs t lim itation was the release 
of randomisation of registrars. We 
started  our effectiveness study as 
a randomised controlled trial w ith 
the registrars being randomised in 
groups. However, as described in 
Chapter 6, registrars who did not 
feel com fortable w ith or motivated 
fo r PST, did not recru it patients. We 
therefore had to change the design 
in order to allow any comparison 
between PST and usual care.
This led to selection of registrars 
partic ipating in the PST group. 
Probably, these registrars are more 
motivated to deliver mental health 
care than their non-PST colleagues 
who provided care as usual. This 
higher motivation intensifies non­
specific elements of the treatment. 
Therefore, this might have caused 
an overestimation of the e ffects 
7 146-147 of PST and an underestimation of
the e ffec ts  of usual care. The use 
of a formal instrum ent to measure 
the level of motivation of registrars 
towards mental health care or their 
a ttitudes towards psychosocial 
issues would have helped us to 
reveal the significance of this 
difference. Unfortunately, however, 
we did not measure motivation.
A second methodological lim itation 
in the trial was the selection of 
patients. The registrars selected 
patients who all met the inclusion 
criteria of: 1. being diagnosed w ith 
emotional symptoms; 2. a score of
4 or more at the 12-item  General 
Health Questionnaire; 3. having 
had 3 or more consultations in 
the past half year. Next to that, 
registrars considered patients 
to be appropriate fo r the type of 
treatm ent they offered, which 
reflects daily practice: doctors 
o ffe r treatm ents w ith the highest 
chance of success fo r the individual 
patient. This is im portant as patient 
and physician choice determine 
outcome importantly.7 From 
this pragmatic perspective, the 
external va lid ity of the trial was 
therefore high. However, there 
were differences in the selection 
of patients between intervention 
and control group. Registrars in 
the intervention group selected 
patients themselves; registrars in 
the usual care group partly did so, 
but to reach the numbers planned 
in advance, had to be assisted by 
a research assistant. This has 
resulted in a biased selection of 
patients w ith the supposed result 
tha t patients who were selected in 
the intervention group were more 
suitable and motivated fo r the 
treatm ent whereas patients selected
fo r the usual care group were not 
specifically motivated. This lim itation 
also results in more influence of non­
specific elements in the treatm ent 
and, in this study, favours the 
intervention group.
We conclude tha t the selection 
bias of both registrars and patients 
compromised the valid ity of the trial 
considerably enhancing the non­
specific elements of the treatm ent, 
thus causing an overestimation of 
the intervention as compared w ith 
usual care. Therefore, we cannot 
be sure whether the positive trial 
findings were the result of a. specific 
PST techniques, b. non-specific 
e ffects  because PST registrars were 
probably more motivated, c. more open 
a ttitudes of PST patients towards 
active treatm ent, or d. a treatm ent 
like PST as a valuable vehicle for 
registrars to incorporate non-specific 
skills better into their consultations 
w ith patients w ith emotional problems. 
The last option might be realistic, 
because the focus group study 
showed tha t registrars thought tha t 
they implemented many new skills 
during PST. Registrars mentioned 
to appreciate the concretising and 
structuring character, the patient- 
centered and patient empowering 
character, including the activation of 
patients to th ink of and implement 
their own solutions in daily life, w ith 
patients being responsible fo r their 
own solutions. Patient empowering 
skills are increasingly valued as 
im portant w ithin prim ary care, 
especially in mental health care.8 
Therefore, we th ink tha t a treatm ent 
like PST might be a practical vehicle for 
registrars to incorporate non-specific 
treatm ent skills more manifestly in
their patient contacts.
B. Specific and non-specific 
effects
There are several factors influencing 
patient outcome in psychological 
treatm ents. Lambert and Barely gave 
a clear overview of these factors: 
extratherapeutic factors such as 
spontaneous remission and social 
support; expectancy effec ts  such as 
the placebo effect; specific therapy 
techniques; and non-specific factors 
such as empathy, warmth, and the 
therapeutic alliance.9 They state, 
based on data from a large number 
of studies, tha t the specific therapy 
techniques account fo r only 15%  
to treatm ent outcome, whereas the 
non-specific factors w ithin the doctor- 
patient relationship account fo r 30% , 
the expectancy e ffec ts  fo r 15%  and 
the extratherapeutic change fo r 40% . 
With regard to the positive findings in 
our review tha t PST is more effective 
than control treatm ents in patients 
w ith major depression, it is not clear 
whether these favourable e ffects are 
based on specific PST ingredients and/ 
or on non-specific ingredients -  w ith 
PST as the vehicle -  because these 
non-specific ingredients have not been 
described or studied in detail in any 
trial included in the review.
The fa c t tha t the review did not show 
effectiveness of PST fo r emotional 
problems might have been related 
to an overestimation of the control 
treatm ents in the review, mostly usual 
care. Usual care was always provided 
by patients' own GPs, whereas PST 
was provided by therapists unfamiliar 
to patients. So, usual care patients 
had the advantage of longer-standing 
relationships w ith their GPs, which 
usually is related to be tte r patient
outcome. In this light, it is conceivable 
tha t GPs applying PST to their own 
patients would have better results. 
Furthermore, it was not described 
whether GPs who delivered usual care 
might have applied some psychological 
skills too. It has been shown that 
therapists in general tend to use 
several skills interchangeably.10 
To rule out differences in relationships
-  and other non-specific ingredients
-  between treatm ent groups, we 
need fu rthe r research w ith equally 
optim ised conditions: a trial comparing 
the effectiveness of PST to the 
effectiveness of control treatm ents, 
w ith all treatm ents being provided by 
the patient's own GP.
C. General considerations of 
research of psychological interven­
tions
RCTs in psychotherapy research 
have been critiqued already fo r a long 
time, since RCTs in this field have 
some im portant lim itations.7-11 These 
lim itations concern aspects of internal 
and external validity. Concerning 
internal validity, RCTs assessing the 
value of psychotherapy are inherently 
less valid than RCTs assessing the 
value of medication, because of the 
im possibility to adequately blind RCTs 
in psychotherapy.
Concerning external validity, there 
are even more lim itations. Firstly, in 
general an RCT assesses e fficacy
-  whether the treatm ent works 
in a controlled environment -  not 
whether it works in the real world 
(effectiveness). For instance, RCTs use 
randomization of patients rather than a 
naturalistic treatm ent selection. RCTs 
use homogeneous patient populations
-  due to s tr ic t diagnostic inclusion 
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adherence, rather than 'real' patients 
who do not adhere always optimally. 
Also, proper comparison groups are 
sometimes lacking as waiting list 
controls might be disappointed and 
therefore do worse than intervention 
subjects.
Secondly, RCTs are mostly based on 
the biomedical model rather than on 
the contextual model. The biomedica l  
m odel in terprets the treatm ent as a 
mixture of specific ingredients tha t are 
critical to the outcome of therapy. It is 
more im portant whether the ingredient 
is received by the patient than who 
delivers the ingredient. Therefore, in 
RCTs treatm ents are manualised and 
controlled highly, which is at the cost 
of deviating from usual practice.11 
This has been critiqued widely,12 since 
many opponents comment the specific 
treatm ent e ffec ts  and rather believe 
in generic e ffects  such as hope and 
com fort provided by psychotherapy. 
The con tex tua l model considers non­
specific factors essential in treatm ent 
outcome. This model regards the 
person of the therapist as critical 
because the model recognises that 
there will be variability  in the manner 
in which treatm ents are delivered, 
meaning tha t the skills of therapists 
and their belief in treatm ent will 
vary.13 The therapist's motivation, 
a ttitude and belief are related to 
the therapist's communication14 
and to patient outcome: the greater 
the therapist's belief in treatm ent's 
efficacy, the be tter the outcom e.15 
Furthermore, non-specific factors 
such as the doctor's empathy, warmth 
and the doctor-patient relationship, 
including the therapeutic alliance 
(i.e. the collaborative and affective 
bond between the patient and the 
therapist and their ab ility  to agree
on treatm ent goals and tasks) 
are im portantly related to patient 
outcome.9-16 Kaptchuk et al. for 
instance showed tha t non-specific 
e ffec ts  of placebo acupuncture in 
irritable bowel syndrome produced 
significant outcomes, w ith the doctor- 
patient relationship as the strongest 
component.17 This highlights the 
importance of the development and 
maintenance of the therapeutic 
relationship as this is a primary 
curative component of treatm ent and 
provides the context in which specific 
techniques exert their influence.9 
And also, it stresses the importance 
of measuring this im portant fac to r in 
outcomes research.
We would therefore advocate to 
measure some of these im portant non­
specific treatm ent factors in RCTs, 
because these are usually not tested 
in traditional RCTs of psychological 
treatments.
D. Realization of training 
during GP residency
We performed the studies presented 
in this thesis w ithin a local residency 
programme fo r two main reasons. 
Firstly, we intended to provide 
young doctors w ith a tool fo r the 
management of emotional problems 
already in an early stage of their 
career. Secondly, we expected GP 
registrars to be an appropriate group 
of doctors fo r the study, because we 
could insert the training and study 
in the existing training situation. The 
registrars, however, were not as 
accessible as we had expected them to 
be. Instead, we met a lot of resistance 
in the course of our research. We 
took the opportun ity  to learn from 
this situation and adjusted the design 
of the trial in order to complete it.
This also gave us the opportun ity  to 
learn more about the exact residency 
training situation and the combination 
of this w ith implementation of research 
and PST training. We identified three 
main themes w ithin the setting of our 
research project: 1. Research during 
residency; 2. R eg istrars 'a ttitude 
towards PST training; 3. Registrars' 
perspective on mental health 
management.
1. R esearch  during residency  
We performed this study in the 
registrars' th ird -  and last -  year of 
residency. This usually is a very busy 
year w ith many topics and intensive 
tasks to be finished by the registrars. 
Because participation in the study 
was obligatory and perceived as 
'extra' ballast, many registrars 
had d ifficu lty  to find a positive 
motivation in an already full year to 
participate. The resistance towards 
participation they showed instead, 
did not only count fo r the PST group 
but also fo r many of the registrars 
in the usual care group. When we 
adjusted the design of the study and 
registrars received the choice of 
delivering either PST or usual care, 
the m ajority was neutral or positive 
about participation. Especially those 
registrars who chose fo r providing 
PST were satisfied, because they were 
trained and supervised in a treatm ent 
they fe lt a need or interest for. This 
was underpinned by the results 
of the questionnaire study about 
participation in research in general: 
registrars mentioned to be interested 
in research participation but they 
emphasised that they like to choose 
the research topic themselves. This 
suggests tha t a residency research 
programme tha t offers several
options would be attractive. We 
think tha t researchers and residency 
programmes should cooperate in such 
a way tha t they can o ffe r a research 
programme tha t will be a ttractive 
fo r registrars. But this study may 
illustrate tha t th is cooperation is 
not easily realised, even in a setting 
where the residency programme 
is an integral part o f a university 
departm ent w ith an established 
research programme. To bridge the 
worlds of education and research, 
it is im portant tha t the teachers are 
involved in research as well as the 
researchers to be involved in training. 
Enthusiastic facu lty  are necessary to 
serve as a role model and to integrate 
research into residency training. 18 20 
This might create helpful conditions 
fo r registrars to participate w ithout 
reservations in research during their 
residency.21 A more positive a ttitude 
towards research would f i t  in w ith the 
enthusiasm tha t most registrars show 
towards the evidence-based guidelines 
of the Dutch College of General 
P ractitioners.22 Finally, registrars 
m ight be motivated by colleague 
peers who are actively involved in 
research. From this perspective it is 
highly encouraging tha t the group 
of registrars in the Netherlands who 
combine their residency training w ith 
research training is grow ing.23
2 . R eg istra rs'attitud e towards
P S T  training
We thought tha t the registrars would 
be open fo r PST training. The training, 
however, did not only teach new knowl­
edge but also requested a change of 
behaviour of professionals as they 
had to implement new communication 
skills. It can be discussed how change- 
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professionals still is, especially since 
young Dutch doctors have been receiv­
ing intense communication skills tra in ­
ing at medical school fo r some time 
now.24 New skills training should con­
nect to these higher levels of communi­
cations skills at the s ta rt and it should 
meet registrars' needs. But when do 
registrars or GPs perceive the need 
to learn a psychological treatm ent like 
PST? This might be a fte r their resi­
dency, when they have been practising 
fo r some time and are getting to know 
both their patients and the workload 
of mental health problems better.25 
On the other side, in the focus group 
study w ith registrars who obligatorily 
participated, we saw a difference be­
tween indiv idual  registrars: some had 
a particu lar need or interest to learn 
a treatm ent like PST, others hadn't.
We therefore recommended to imple­
ment generic problem solving skills 
in an early stage of the GP residency 
programme, and to o ffe r more specific 
skills in a later stage to those who opt 
fo r this.
Another interesting focus group fin d ­
ing w ith regard to using practical skills 
was tha t many registrars implemented 
PST in a way they fe lt a t ease with. 
From an educational perspective this is 
encouraging: we offered all registrars 
the same training, but each individual 
registrar fam iliarises him /herself in 
another -  his /her own -  way w ith it. 
From a research perspective, however, 
this loss of un iform ity might be disap­
pointing because, as outlined before, 
psychotherapy research generally 
aims to provide treatm ents in a proto- 
colised way.10
3. Registrars' perspective  on mental 
health care  
From the focus group study it 
appeared tha t registrars thought it is 
their task to diagnose mental health 
problems adequately, to o ffe r patients 
a listening ear and to o ffe r the patient 
some treatm ent. O ffering a specific 
full psychological treatm ent, however, 
was not regarded by them as their 
task, not even when it concerned a 
brief treatm ent such as PST, which 
in our study took on average 1.7 
consultations per patient more than 
usual care did. In the light of the 
desire of patients to receive non- 
pharmacological treatm ent from  their 
own GP it is an im portant question 
what makes registrars somewhat 
defensive against this. Could this be 
related to their level of experience: 
are they still mainly biomedically 
oriented? Does it request more life and 
practice experience to discover the 
workload of mental health in primary 
care and the accompanying challenge 
of managing this adequately? In 
contrast, a Canadian study showed 
tha t most GPs are very interested in 
the detection and treatm ent of mental 
health problems.26 The a ttitude of the 
registrars could also be in line w ith 
Hall's question whether a m ajority of 
GP registrars ta ilor their practice to a 
narrower spectrum of care rather than 
the wide spectrum of total, personal, 
context-bound and continuous health 
care.27 Hall calls fo r discussion 
whether or not GP registrars hold firm  
to the definition of a GP as described in 
many national guidelines.
Recommendations for clinical 
practice
As described above, we found 
tha t PST was favourable fo r major
depressed patients, and tha t there 
is no evidence tha t PST is better 
as compared w ith usual care fo r 
emotional problems. However, thus 
far, no studies have focussed on 
PST w ith in the context of the GP- 
patient relation. This is an im portant 
deficiency of the evidence base, as 
this would in all probability strengthen 
the 'a-specific ' treatm ent effects.
PST might be a vehicle to incorporate 
these non-specific factors more 
prom inently into patient contacts. 
Possibly PST training provides doctors 
w ith a s tructure and optimism for 
treatm ent of mental health problems. 
We encourage the registrars who 
participated in the PST training, and 
meanwhile graduated as a GP, to 
continue using their skills -  whether 
specific or not -  fo r their patients w ith 
emotional problems.
Based on our findings w ith motivated 
registrars and despite currently 
lacking evidence of effectiveness, 
we invite interested GPs to take 
part in a PST training. It can meet 
their need fo r a practical tool in the 
non-pharmacological treatm ent of 
emotional problems and we expect 
it to have positive e ffects fo r their 
patients, especially since they already 
have longer lasting relationships w ith 
their patients. In the Netherlands, a 
two-day PST training fo r GPs has been 
organized since 2 0 0 7  by the Dutch 
College of General Practitioners.
An im portant logistical reason fo r 
registrars' lim ited motivation to 
perform a psychological treatm ent 
could be the current lack of financial 
reimbursements fo r providing 
psychological treatm ents combined 
w ith its time investment. In order to 
facilita te  the graduated registrars and 
other GPs to provide a treatm ent like
PST, there should be a compensation 
fo r their time investment. The Health 
Care Insurance Board has given a 
positive advice to health insurances to 
o ffe r a financial remuneration fo r GPs 
to provide PST, but unfortunate ly this 
advice has not been followed up yet. 
Another way of coping w ith the 
time investment of treatm ents like 
PST is to schedule the consulting 
hours differently, fo r instance by 
arranging dedicated sessions or by 
creating a brief session of 5-m inute 
consultations fo r simple somatic 
reasons to compensate fo r the longer 
psychological treatm ent sessions. 
Some GPs might, like the registrars, 
implement only elements of PST 
rather than the entire treatm ent, 
so tha t sessions have a maximum 
of 20 minutes each, which does 
f i t  into normal consulting hours. 
A lthough this sounds a ttractive  and 
an official protocol fo r Brief Problem 
Solving (BPS) exists,28 evidence fo r 
effectiveness of BPS is currently 
lacking.
The use of mental health nurses 
working in the practice could be 
helpful. Dutch research of PST 
provided by nurses did not show 
additional e ffec ts  above usual GP 
care fo r patients w ith emotional 
symptoms,29 whereas British 
research suggests tha t fo r major 
depressed patients the effectiveness 
of PST by nurses is as good as the 
effectiveness of PST by research 
GPs.30 Combining this knowledge w ith 
the findings of our review, we could 
advocate it when GPs ask mental 
health nurses to provide PST fo r 
patients w ith major depression. Other 
studies investigated PST as part of a 
stepped-care programme and showed 
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review we did not conclude anything 
about these programmes, as these 
studies were not included. Stepped- 
care programmes take d iffe ren t 
patient needs into account, depending 
on the characteristics of their mental 
health problems and their personal and 
social circumstance. An advantage 
of these programmes is their self- 
correcting character, meaning that 
another technique is tried if one 
technique is not working (sufficiently). 
This follows daily practice in a realistic 
way. However, most stepped-care 
programmes are protocolised whereas 
doctors in some cases would prefer 
to s ta rt w ith another option than the 
programme protocol prescribes.
Further research for patients with 
emotional symptoms
Both patients and GPs desire effective 
psychological treatm ents by the GPs 
themselves. We, therefore, need 
evidence on the effectiveness of 
PST by the patient's own GP. PST 
has not yet been investigated when 
provided by the patient's own GP.
Also, as outlined above, the review 
did not provide us w ith definitive 
answers about the exact mechanism 
of effectiveness of PST as we do 
not know the non-specific factors 
in detail. Furthermore, there was an 
inter treatm ent group imbalance in 
the doctor-patient relationships w ith 
usual care being delivered by patients' 
own GPs. To rule out differences in 
relationships -  and other non-specific 
ingredients -  between treatm ent 
groups, we need an RCT in which all 
treatm ent groups have the advantage 
of their own GP delivering the 
treatm ent. We therefore recommend 
a trial w ith PST by the patient's own 
GP compared to a control group w ith
time and attention, and a control 
group delivering usual care both also 
by the patient's own GP. We suggest 
to recru it GPs who are interested to 
provide PST and then randomise them 
into one of the three groups, w ith 
the non-PST GPs being offered PST 
training a fte r the trial.
Inclusion rather than exclusion of 
non-specific treatm ent factors is 
essential in order to know more about 
specific versus non-specific factors. 
We therefore recommend baseline 
measurement of a. the GP-patient 
relationship, including the GP-patient 
alliance; b. the GP's general beliefs 
in psychosocial aspects of patient 
care; c. the GP's allegiance (i.e. the 
GP's belief in the treatm ent's efficacy) 
in PST or control treatm ent; and 
d. personality characteristics and 
personal and social circumstances 
of patients recruited by the doctors. 
Many instrum ents exist fo r measuring 
the doctor-patient relationship and the 
doctor-patient alliance.16 The Physician 
Belief Scale can measure GPs' beliefs 
in psychosocial aspects33 as could the 
Depression A ttitude  Questionnaire 
in depression research.34 Allegiance 
can easily be rated fo r instance on a
5-po in t scale.15 By measuring these 
non-specific factors, we might also 
be able to reveal some components 
tha t produce the power of usual 
care. Quality of life, including daily 
functioning of patients, should be 
one of the main treatm ent outcomes, 
rather than focusing only on specific 
symptom reduction. Also, it can be 
useful to evaluate the symptoms tha t 
patients themselves regard as most 
hindering. Follow-up should be at least 
one year in order to know more about 
the long-term effects. The need for 
more research is underpinned by the
latest NICE-guideline on depression 
not recommending PST because of 
its lim ited evidence,35 and a Dutch 
mental health summary describing it 
as 'promising'.36 
The review concluded tha t PST 
was not more effective than control 
treatm ents fo r emotional problems.
In order to know whether PST is 
as e f fec t ive  as control treatm ents, 
equivalence tria ls are needed.37 If 
PST turns out to be as effective, it 
could be an a ttractive  alternative fo r 
patients and doctors when fo r instance 
medication is not an option.
A recent trial in Hong Kong used an 
adapted, 3-session form of PST but 
did not show favourable e ffec ts  of 
PST above placebo treatm ent for 
depressed patients of 60  years and 
older. However, th is was not Brief 
Problem Solving (BPS) which fits  into 
normal consultations rather than 
being applied in d istinct sessions. The 
developers of BPS have described it 
as a promising tool in the treatm ent 
of depression and anxiety.23 However, 
we do not yet know exactly whether it 
works through its specific treatm ent 
techniques or -  as a vehicle -  through 
optim isation of non-specific elements 
w ithin consultations, and if so, 
which non-specific elements these 
specifically are. If these questions are 
being answered and it turns out to be 
effective, BPS might su it GPs better 
than PST in their tim e-constricted 
schedules.
Recommendations for residency 
programmes
We recommend residency programmes 
to provide their registrars w ith 
psychological skills training, fo r 
instance PST training, because it 
fu lfils  their need fo r a practical tool
in the management of patients w ith 
emotional problems. As outlined in 
Chapter 3 we recommend to teach 
the general skills in the beginning of 
the residency programme, whereas 
the more specific problem solving 
skills can be taught in a later stage 
when registrars perceive a greater 
need fo r these skills. Since 2 0 0 8  
we have been training our registrars 
in this way. Evaluations have been 
positive. Emphasizing the importance 
and helpfulness of many generic skills 
taught in the training -  rather than 
training them a specific psychological 
treatm ent -  might have reduced their 
resistance against the training.
It is im portant to motivate registrars 
positively to use their problem solving 
skills, because when delivered in 
a motivated way these skills have 
positive e ffec ts  on patient outcome. 
Registrars could possibly become 
more motivated through discussions 
w ith their role models -  facu lty  and 
teaching GPs -  about mental health 
care and providing psychological 
interventions. Residency programmes 
should facilita te  reflective thinking and 
debate on mental health management 
in general as it concerns so many 
patients w ithin prim ary care. As Gask 
set out, we need to challenge the 
potentially negative a ttitudes tha t 
doctors develop towards treating 
mental health problems, perhaps as a 
result of exposure to 'medical' models 
of mental illness in early training that 
do not f i t  w ith their later experiences.38 
Furthermore, residency programmes 
should emphasise the importance of 
relationship and other common factors 
much more as these enhance patient 
outcome fa r more than the focus 
on specific techniques.9 In fact, this 
7 154-155  should yet happen in medical school,
as fo r many GPs their practice is 
considerably influenced by the training 
they received as medical students.38 In 
the current teaching, there is attention 
fo r thoughts and feelings of patients 
and how these should be addressed in 
the consultation. But there is scarce 
attention fo r non-specific factors that 
relate to the doctor. Students and 
registrars should be stimulated to be 
aware of and to experiment more w ith 
non-specific factors such as warmth, 
empathy, com fort, hope, relationship, 
alliance, et cetera rather than focus on 
collecting all biomedical information 
of the patient. Registrars could fo r 
instance watch consultation videos 
of each other or of their teaching GP 
and label the non-specific aspects 
that might contribute to the quality of 
the doctor-patient relationship and to 
treatm ent outcome.
We also recommend residency 
programmes to o ffe r registrars 
a ttractive  research programmes as 
some registrars are very resistant 
to the idea of research,39 and many 
registrars fe lt frus tra ted  and resentful 
at being forced to participate in 
research.40 This was underpinned by 
the results from the focus group study 
in this thesis. Registrars thought that 
participation in research is interesting, 
but they should be offered choice, 
time and resources. An American 
residency programme recently 
introduced a new system requiring tha t 
each registrar accumulates 'scholarly 
activ ity  points'. This point system 
allowed registrars to pursue their own 
interests rather than being told what 
type of scholarly ac tiv ity  to participate 
in. It has transform ed the atmosphere 
w ithin the residency into a 'culture 
of inquiry'.40 Research networks,
research departm ents and residency 
training programmes must collaborate 
to realise to most optimal programme. 
Next to tha t it is im portant to have 
energetic and motivated facu lty  
involved in research to act as role 
models, to discuss research in fron t of, 
and w ith, registrars regularly, and to 
generate an atmosphere conducive to 
research.39-41 The goal is to increase 
registrars' interest in and likelihood 
of conducting or participating in 
research. This is im portant because 
research in prim ary care is essential 
since evidence to underpin this care 
cannot be based on hospital-based 
research alone.42
Further research in residency
We recommend to study whether 
the current, adapted PST training 
programme during residency meets 
the needs of registrars adequately, 
which specific and non-specific skills 
they actually pick up, and how they 
keep using these skills in daily practice. 
Regarding the needs of registrars a 
questionnaire survey or another focus 
group study could be performed. Video 
recordings could reveal registrars' 
use of specific and non-specific 
treatm ent skills in everyday practice. 
This is essential as the development 
and maintenance of the GP-patient 
relationship provides the context in 
which specific techniques exert their 
influence.
We recommend residency programmes 
to o ffe r an a ttractive  research 
programme in order to increase 
research appreciation and interest.
It needs fu rthe r research whether 
offering such an a ttractive  research 
programme leads to more actively 
involved GPs in research a fte r their 
residency training.
Prospective studies w ith educational 
outcomes will need to be done to 
conclude the best methods of teaching 
GP registrar research knowledge, 
attitudes, and skills.
Conclusion
Training in problem-solving treatm ent 
(PST) during GP residency was 
feasible. Registrars thought that PST 
training was interesting and helpful, 
but they thought that implementing a 
full psychological treatm ent is not their 
task and costs too much time in daily 
practice. They especially appreciated 
specific elements of the treatm ent. All 
said they would use these elements in 
daily practice.
In a Cochrane review we found that 
PST was more favourable than control 
treatm ents fo r patients w ith a major 
depression but not fo r patients w ith 
emotional problems other than major 
depression. In a pragmatic controlled 
trial we found indications tha t PST 
by motivated registrars might have 
positive e ffec ts  on prim ary care 
patients w ith emotional problems. 
However, due to limited internal 
validity, we are not sure whether 
these positive e ffects  are the result 
of specific or non-specific treatm ent 
factors. We assume tha t non-specific 
factors probably are most promising in 
the treatm ent of emotional problems. 
PST could be a vehicle to incorporate 
these non-specific factors more 
prom inently into patient contacts. We 
encourage the -  meanwhile graduated
-  registrars who participated in the 
PST training to continue using their 
skills fo r their patients w ith emotional 
problems. We recommend residency 
programmes to teach the non-specific 
factors more explicitly, fo r instance 
through PST training. We furtherm ore
suggest residency programmes to 
o ffe r registrars a ttractive  research 
programmes, in order to increase 
registrars' interest in research
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Summary
This thesis focused on problem-solving 
treatm ent (PST), a brief psychological 
treatm ent fo r patients w ith mental 
health problems in prim ary care. The 
general objectives were to investigate 
1. the feasib ility  of PST training during 
general practice (GP) residency, and 2. 
the effectiveness of PST fo r patients 
w ith emotional symptoms in primary 
care.
Chapter 1. General introduction
In this chapter the rationale, aims and 
outline of this thesis are explained. 
Mental health problems are common, 
w ith one in four adults suffering from 
symptoms of depression, anxiety, 
sleeping problems, irritability, stress, 
or psychosocial problems. Quality 
of life is influenced negatively and 
many patients v is it the ir general 
practitioner (GP) frequently. Therefore, 
mental health problems account fo r 
a substantial proportion of the GP's 
workload.
Both patients and physicians desire 
e ffective non-pharmacological 
treatm ents, especially because 
medication is not always the best 
option in the treatm ent of mental 
health problems. GP registrars often 
express the need fo r more expertise 
of psychological treatm ent skills fo r 
patients w ith mental health problems. 
Problem-solving treatm ent (PST) could 
be an a ttractive  option. PST is a brief 
psychological treatm ent teaching 
patients how to use their own skills 
to cope w ith problems. PST has been 
158-159  shown to be e ffective fo r patients w ith
depression, but the effectiveness fo r 
the broader range of mental health 
problems -  typical fo r prim ary care
-  had not been investigated before. 
Training in PST was introduced in a 
Dutch GP residency programme to 
meet the registrars' need. We aimed 
to assess 1. the feasib ility  of PST 
training during GP residency, and 2. 
the effectiveness of PST fo r patients 
w ith emotional symptoms in primary 
care. In this thesis we referred to the 
same category of patients w ith the 
terms em otional symptoms, emotional  
problems  and m enta l health  problems.
Part I. Feasibility o f problem-solving 
treatm ent during general practice  
residency 
Chapter 2. Feasibility of training 
in problem-solving treatment for 
geeral practice registrars
In this chapter the feasib ility  of PST 
training during residency is described. 
For this purpose we used data from 
an observational study of 20  GP 
registrars who received a two-day PST 
training and subsequent supervision 
in the treatm ent of patients w ith 
mental health problems. The registrars 
evaluated the training positively. All 
registrars subsequently used PST, 
treated 52  patients, and received 
supervision. Registrars appreciated 
PST fo r its s tructure and the active 
role of patients during treatment.
The conclusion was tha t training GP 
registrars in PST is feasible.
Chapter 3. Problem-solving 
treatment in general practice 
residency: a focus group study of 
registrars'views
In this chapter the results of a 
qualitative focus group study are 
presented. We aimed to explore GP 
registrars 'v iew s on PST training during 
residency and on the actual use of PST 
in general practice. We interviewed 
18 Dutch registrars -  divided over 4 
groups -  who had been trained in PST 
during residency. Registrars expressed 
tha t PST training during residency was 
feasible, interesting and helpful, but 
theyfound tha t it took too  much time in 
everyday practice and tha t it was not a 
GP's task. All registrars, however, said 
they would use specific elements in a 
varie ty of consultations, fo r instance 
concretising problems, brainstorming 
about practical solutions, and 
activating patients. We recommended 
residency programmes to o ffe r training 
in PST or another psychological 
treatm ent w ith comparable elements.
Chapter 4. General practice 
registrars and research - Attitudes 
toward participation
Primary care research is im portant 
and early exposure of GPs to research 
is recommended to increase fam ily 
medicine research capacity. The 
participation of GP registrars in 
the study described in this thesis 
enabled us to determine their actual 
participation and to explore their views 
on participation in research in general. 
This chapter presents the results of an 
observational study of 67  registrars'
participation, and a questionnaire 
survey of their opinions of research 
and participation in research in daily 
practice. The registrars recruited 
2 0 8  patients. They were interested in 
participating in research, especially 
when they can learn a new skill. 
Obligatory participation, lack of 
time and d ifficu lties w ith patient 
recruitm ent were im portant barriers 
to participation. Registrars reported 
tha t participation should not be 
compulsory, and they preferred to 
choose their own research subjects. 
Assuming a desire fo r research to be 
part of the culture of fam ily medicine, 
we suggested tha t researchers and 
residency programmes o ffe r research 
in such a way tha t registrars will find it 
a ttractive  to partic ipate in it.
Part II. Effectiveness o f problem­
solving treatm ent for patients with 
emotional symptoms in prim ary care
Chapter 5. Problem-solving 
treatment for emotional problems in 
primary care -  a Cochrane review
Many patients w ith emotional problems 
prefer psychological treatm ents 
delivered w ithin the prim ary care 
setting. Evidence fo r psychological 
treatm ents, however, comes largely 
from studies in secondary care 
settings where patients are referred 
to a specialist. PST has been shown 
to be effective in patients w ith 
depression but its effectiveness 
has not been proven fo r the broader 
range of emotional problems seen
in prim ary care. Chapter 5 contains 
the results of a system atic review 
according to the principles of the 
Cochrane Collaboration. This review 
aimed to assess the effectiveness of 
PST versus usual care, medication or 
other psychological treatm ents in adult 
patients w ith emotional problems in 
prim ary care. We included 12  studies 
w ith 2 2 6 1  participants. Four studies 
were of good quality, five studies of 
moderate quality and three studies 
of low quality. Three studies were in 
favour of PST, three were in favour of 
control treatm ent and six did not show 
significant differences between PST 
and control treatments.
Overall, PST was not d iffe ren t from 
usual care, antidepressants, placebo 
medication or other psychological 
treatm ents. For patients w ith 
major depression, however, two 
good quality studies showed that 
PST was more effective than usual 
care, placebo medication and group 
psychoeducation: PST patients had 
a significantly im portant be tter SF- 
36  social function score and a higher 
recovery rate at the BDI (2.54, 95%
Cl 1 .85  to 3.50) than usual care 
patients at 6-m onth follow-up. Also, 
PST patients had significantly higher 
recovery rates at the HDRS than 
patients in the placebo medication 
group at 3-m onth follow-up (RR 
2 .25 , 95%  Cl 1.16 to 4.36). For 
emotional problems other than 
major depression, however, there 
1 6 0 - 1 6 1  was insuffic ient evidence to show
significant differences between PST 
and usual care, (placebo) medication, 
or other psychological treatm ents.
We therefore recommended fu rthe r 
research of PST fo r these problems. 
Costs and health care use did not 
show major differences between 
PST and control treatm ents. Patients 
were more satisfied a fte r PST or 
generic care from a mental health 
nurse than a fte r usual GP care or a fte r 
antidepressant medication.
Chapter 6. Effectiveness of 
problem-solving treatment by 
general practice registrars for 
patients with emotional symptoms
This chapter describes the results 
of a pragmatic controlled trial. We 
aimed to study the effectiveness 
of PST delivered by trained GP 
registrars fo r patients w ith mental 
health problems. We compared the 
effectiveness of PST versus usual 
care fo r patients w ith mental health 
problems. GP registrars provided PST 
or usual care, according to their own 
preference. Patients were included 
if they (a) had presented fo r three or 
more visits w ith emotional symptoms 
in the past 6 months; and (b) scored 
four or more on the 12-item  General 
Health Questionnaire. Outcomes at 3 
and 9 month follow-up were standard 
measures of depression, anxiety 
and quality of life. Th irty-e ight GP 
registrars provided PST and included 
98 patients; 4 3  provided usual care 
and included 104  patients. PST
patients improved significantly more 
than usual care patients: at 9-m onth 
follow-up PHQ recovery rates fo r 
somatoform disorder and anxiety 
were higher in the PST group (OR
6.50, p=0 .01  respectively OR 11.25, 
p=0.03). Depressive symptoms did 
not improve significantly d iffe ren t 
between treatm ent groups. PST 
patients had improved significantly 
more on the 100 -po in t SF-36 domains 
social functioning, role lim itation due 
to emotional problems and general 
health perception (B-coefficient of 
the mean difference respectively 
9 .83, p=0.03; 17.18, p=0.04; 10.48, 
p<0.001). A lthough these results 
provided indications tha t PST by 
motivated registrars might be more 
favourable fo r patients w ith mental 
health problems than usual care by 
registrars, it remained -  due to a 
compromised va lid ity of the trial -  
unclear whether the e ffec t in this trial 
could be a ttribu ted  to the intervention.
Chapter 7. General discussion
The final chapter considers the results 
described in this thesis together w ith 
some methodological issues, and ends 
w ith suggestions fo r fu rthe r research 
and general practice.
Due to lim ited internal va lid ity of the 
trial described in this thesis, it was 
not sure whether the positive trial 
e ffec ts  were the result of specific or 
non-specific treatm ent factors w ithin 
the doctor-patient relationship. Non­
specific factors account fo r a greater
part to psychological treatm ent 
outcome than specific factors, but 
are scarcely studied in trials. We 
assumed tha t non-specific factors 
probably were most promising in the 
treatm ent of emotional problems.
PST could be a vehicle to incorporate 
these non-specific factors more 
prom inently into patient contacts. We 
therefore encourage the registrars 
who participated in the PST training, 
and meanwhile graduated as a GP, to 
continue using their skills -  whether 
specific or not.
The most im portant recommendations 
fo r fu rthe r research were: a. An RCT 
w ith equally optim ised doctor-patient 
relationships -  and other non-specific 
factors -  in all treatm ent groups, 
comparing the effectiveness of 
PST to the effectiveness of control 
treatm ents, w ith all treatm ents 
being delivered by the patient's 
own GP; b. Measurement of non­
specific treatm ent factors in tria ls of 
psychological treatm ents.
The most im portant recommendations 
fo r residency programmes were: a.
An a ttractive  research programme in 
order to increase registrars' interest in 
research; b. Implementation of training 
in PST or a psychological treatm ent 
w ith comparable elements; c. More 
explicit teaching of non-specific 
treatm ent factors.
Samenvatting
Dit p roe fschrift beschrijft een onder­
zoek naar problem-solving treatm ent 
(PST). PST is een korte psychologi­
sche behandeling voor patiënten met 
psychische klachten in de huisartsen­
praktijk. Doel was om te onderzoeken 
of: 1. PST training haalbaar is tijdens 
de huisartsopleiding; 2. PST e ffec­
tie f is voor patiënten met psychische 
klachten in de huisartsenpraktijk. Deze 
Nederlandse samenvatting is bestemd 
voor lezers die niet over een medische 
achtergrond beschikken. Lezers die 
graag meer details lezen, verw ijs ik 
naar de voorgaande hoofdstukken.
Hoofdstuk 1. Algemene inleiding
In d it hoofdstuk worden de achter­
grond, doelen en opbouw van d it proef­
sch rift toegelicht. Psychische klachten 
komen veel voor. Ongeveer een op de 
vier volwassenen heeft last van symp­
tomen van depressie, angst, slaap­
problemen, stress, prikkelbaarheid, of 
psychosociale problemen. De kwalite it 
van leven w ord t hierdoor vaak negatief 
beïnvloed en veel patiënten met deze 
problematiek bezoeken hun huisarts 
frequent. Daarmee zorgen psychische 
klachten voor een substantieel deel 
van de w erklast van de huisarts.
Zowel patiënten als artsen wensen 
effectieve niet-medicamenteuze be­
handelingen, vooral omdat medicatie 
niet altijd de beste optie is in de be­
handeling van psychische klachten. 
A rtsen in opleiding to t huisarts geven 
vaak aan dat zij behoefte hebben aan 
meer deskundigheid op het gebied van 
psychologische behandel vaardigheden 
voor patiënten met psychische klach-
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zou hiervoor een aantrekkelijke optie 
kunnen zijn. PST is een korte psycholo­
gische behandeling die patiënten leert 
hoe ze hun eigen vaardigheden kunnen 
gebruiken om met problemen om te 
gaan. PST is e ffec tie f gebleken voor 
patiënten met een depressie, maar 
de e ffec tiv ite it voor de bredere range 
aan psychische klachten -  die ju is t zo 
typisch voor de huisartsenpraktijk is
-  was nog niet eerder onderzocht. Om 
tegemoet te komen aan de behoefte 
van artsen in opleiding to t huisarts 
introduceerden we, de onderzoekers 
van d it project, PST training in de Nij­
meegse huisartsopleiding. We wilden 
het volgende beoordelen: 1. De haal­
baarheid van PST training tijdens de 
huisartsopleiding; en 2. De e ffec tiv ite it 
van PST voor patiënten met psychi­
sche klachten in de huisartsenpraktijk.
Deel I. Haalbaarheid van problem­
solving treatm ent tijdens de huis­
artsopleiding 
Hoofdstuk 2. Haalbaarheid van PST 
training voor artsen in opleiding tot 
huisarts
Dit hoofdstuk beschrijft de haalbaar­
heid van PST training tijdens de huis­
artsopleiding. We observeerden 20 
artsen in opleiding to t huisarts die 
deelnamen aan een tweedaagse PST 
training en aansluitend supervisie kre­
gen op hun behandeling van patiënten 
met psychische klachten. De artsen 
beoordeelden de training positief. Alle 
artsen in opleiding to t huisarts pasten 
PST vervolgens toe, ze behandelden 
52 patiënten, en ontvingen hierop 
supervisie. Ze waardeerden PST van-
wege de structuur en de actieve rol 
van patiënten tijdens de behandeling. 
De conclusie was dat PST training in 
de huisartsopleiding haalbaar is.
Hoofdstuk 3. PST tijdens de huis­
artsopleiding: een focusgroepstudie 
van de opvattingen van artsen in 
opleiding tot huisarts
In d it hoofdstuk worden de resultaten 
van een focusgroepstudie gepresen­
teerd. Doel was om te onderzoeken 
w at de meningen van artsen in op­
leiding to t huisarts waren over PST 
training tijdens de huisartsopleiding en 
w at hun meningen waren over het ge­
bruik van PST in de huisartsenpraktijk. 
We interviewden 18 Nederlandse a rt­
sen in opleiding to t huisarts -  verdeeld 
over 4 groepen -  die getraind waren in 
PST tijdens hun huisartsopleiding.
De artsen in opleiding gaven aan dat 
PST training tijdens de huisartsoplei­
ding haalbaar, interessant en nuttig 
was, maar ze vonden dat het teveel tijd 
kostte in de dagelijkse praktijkvoering 
en dat het toepassen van een psycho­
logische behandeling niet de taak van 
een huisarts is. Ze zeiden echter allen 
dat ze specifieke elementen u it de 
behandeling zouden toepassen in een 
varië te it aan consulten. Ze noemden 
als waardevolle elementen met name 
het concretiseren van problemen, het 
brainstormen over praktische oplossin­
gen, en het activeren van patiënten.
We adviseerden huisartsopleidingen 
om training in PST, of een andere psy­
chologische behandeling met vergelijk­
bare elementen, aan te bieden aan hun 
artsen in opleiding.
Hoofdstuk 4. Artsen in opleiding tot 
huisarts en onderzoek -  Opvattingen 
over deelname aan onderzoek
Huisartsgeneeskundig wetenschap­
pelijk onderzoek is belangrijk en 
vroege blootstelling van huisartsen 
aan onderzoek is aanbevolen zodat de 
onderzoekscapaciteit toeneemt. De in 
d it p roe fschrift beschreven deelname 
van artsen in opleiding to t huisarts aan 
onderzoek gaf ons de mogelijkheid om 
hun daadwerkelijke onderzoeksdeel- 
name vast te stellen en om hun opvat­
tingen in kaart te brengen over deel­
name aan onderzoek in het algemeen. 
D it hoofdstuk beschrijft enerzijds de 
resultaten van een observationele 
studie van de deelname van 67 artsen 
in opleiding to t huisarts, en anderzijds 
de resultaten van een vragenlijststudie 
naar hun opvattingen over onderzoek 
en over deelname aan onderzoek in de 
dagelijkse praktijk. De 67 artsen in op­
leiding sloten in totaal 2 0 8  patiënten in 
het onderzoek in. Ze gaven aan geïnte­
resseerd te zijn in deelname aan onder­
zoek, vooral wanneer ze een nieuwe 
vaardigheid kunnen leren. Verplichte 
deelname, tijdgebreken moeilijkheden 
met patiëntenwerving waren volgens 
hen belangrijke barrières in deelname. 
Artsen in opleiding to t huisarts gaven 
aan dat onderzoeksdeelname niet 
verplicht zou moeten zijn, en ze gaven 
er de voorkeur aan om hun eigen on­
derzoeksonderwerp te kiezen. Ervan 
uitgaande dat onderzoek een wenselijk 
deel uitm aakt van de huisartsgenees­
kunde, suggereerden we dat onder­
zoekers en huisartsopleidingen onder­
zoek zodanig aanbieden dat artsen in 
opleiding to t huisarts het aantrekkelijk
vinden om eraan deel te nemen.
Deel II. E ffectiv ite it van problem­
solving treatm ent voor patiënten  
m et psychische klachten in de huis­
artsenpraktijk
Hoofdstuk 5. Problem-solving treat­
ment voor psychische klachten in de 
eerste lijn -  een Cochrane review
Veel patiënten met psychische 
klachten geven de voorkeur aan psy­
chologische behandeling binnen de 
huisartsenpraktijk. Onderzoek naar 
psychologische behandelingen vond 
to t op heden echter vooral plaats in 
de tweede lijn, zoals de psychiatrie, 
waar patiënten verwezen worden naar 
een specialist. In eerder onderzoek 
bleek PST e ffec tie f bij patiënten met 
depressie maar het is nog onduidelijk in 
hoeverre PST ook e ffec tie f is voor de 
bredere range aan psychische klach­
ten die ju is t zoveel gezien w ord t in de 
huisartsenpraktijk. Hoofdstuk 5 omvat 
de resultaten van een systematisch 
literatuuroverzicht volgens de princi­
pes van de Cochrane Collaboration, 
een internationaal netwerk dat helpt 
om op basis van gestructureerde lite ­
ratuuroverzichten besluiten te nemen 
om trent gezondheidsvraagstukken.
Dit literatuuroverzicht had als doel om 
de e ffec tiv ite it te beoordelen van PST 
ten opzichte van gebruikelijke zorg, 
medicatie of andere psychologische 
behandelingen bij volwassen patiënten 
met psychische klachten in de huisart­
senpraktijk. In ons overzicht namen we 
12 studies op met in totaal 2 2 6 1  deel­
nemende patiënten. Vier studies waren 
van goede kwalite it, v ijf studies van ge­
middelde kw alite it en drie studies van 
lage kwaliteit. De uitkomsten van drie 
studies waren ten gunste van PST, drie 
ten gunste van de controlebehandeling 
en zes studies lieten geen significante
verschillen zien tussen PST en andere 
behandelingen.
Overall waren de effecten van PST niet 
anders dan die van gebruikelijke zorg, 
antidepressiva, placebo medicatie, of 
andere psychologische behandelingen. 
Voor patiënten met een ernstige de­
pressie echter, toonden twee studies 
van goede kw alite it aan dat PST ef­
fectiever was dan gebruikelijke zorg, 
placebo medicatie of groepseducatie. 
Echter, voor andere psychische klach­
ten dan een ernstige depressie vonden 
we onvoldoende bewijs dat PST andere 
effecten heeft dan gebruikelijke zorg, 
(placebo) medicatie, of andere psycho­
logische behandelingen. Daarom advi­
seerden we verder onderzoek van PST 
voor deze klachten. We vonden geen 
noemenswaardige verschillen tussen 
PST en andere behandelingen voor wat 
be tre ft kosten en gezondheidszorg- 
consumptie. Wel was duidelijk dat pati­
ënten meer tevreden waren na PST of 
na zorg van een GGz-verpleegkundige 
dan na gebruikelijke zorg door de huis­
arts of na gebruik van antidepressiva.
Hoofdstuk 6. Effectiviteit van pro- 
blem-solving treatment door artsen 
in opleiding tot huisarts voor patiën­
ten met psychische klachten
Dit hoofdstuk beschrijft de resultaten 
van een patiëntenonderzoek. We be­
oogden de e ffec tiv ite it te bestuderen 
van PST, gegeven door getrainde 
artsen in opleiding to t huisarts, aan 
patiënten met psychische klachten.
We vergeleken de e ffec tiv ite it van PST 
met die van gebruikelijke zorg voor 
patiënten met psychische klachten in 
de huisartsenpraktijk. A rtsen in oplei­
ding to t huisarts leverden gedurende 
het gehele onderzoek ofwel PST ofwel 
gebruikelijke zorg, afhankelijk van hun 
eigen voorkeur. Patiënten werden in 
het onderzoek ingesloten als zij (a)
driemaal of vaker met psychische 
klachten bij de huisarts waren geweest 
in het afgelopen halfjaar; en (b) een 
score van vier of hoger hadden op de 
12-item  General Health Question­
naire (een zelfrapportagelijs t voor het 
meten van psychische klachten). Na 3 
en 9 maanden vulden de deelnemende 
patiënten vragenlijsten in met vragen 
over depressie, angst en kw alite it van 
leven. Achtendertig  artsen in opleiding 
to t huisarts leverden PST en sloten 98 
patiënten in het onderzoek in; 43  a rt­
sen in opleiding to t huisarts leverden 
gebruikelijke zorg en sloten 104  pati­
ënten in. PST-patiënten verbeterden 
significant meer dan controlepatiënten 
die gebruikelijke zorg ontvingen: PST- 
patiënten rapporteerden significant 
minder symptomen van depressie en 
angst en een betere kw alite it van leven 
dan controlepatiënten, zowel na 3 als 
na 9 maanden. Hoewel deze resultaten 
er op wijzen dat PST door artsen in 
opleiding to t huisarts waarschijnlijk 
beter is voor patiënten met psychische 
klachten dan gebruikelijke zorg door 
artsen in opleiding to t huisarts, b lijft 
het -  ten gevolge van een beperkte va­
lid ite it van het onderzoek- onduidelijk 
of het positieve e ffec t in d it onderzoek 
toegeschreven kan worden aan PST.
Hoofdstuk 7. Algemene discussie
Het laatste hoofdstuk p laatst de resul­
taten van d it p roe fschrift in een per­
spectief en bespreekt enkele methodo­
logische kwesties. Tenslotte geeft het 
suggesties voor verder onderzoek en 
voor de huisartsenpraktijk en hu isarts­
opleiding. Doordat de interne valid ite it 
van het patiëntenonderzoek beschre­
ven in d it p roe fschrift beperkt is, is het 
niet geheel duidelijk of de positieve ef­
fecten het resultaat zijn van specifieke 
of non-specifieke behandelfactoren 
binnen de arts-patiëntre latie . Non-
specifieke factoren (zoals empathie, 
warmte, hoop geven) dragen voor een 
groter deel bij aan het e ffec t van een 
psychologische behandeling dan de 
specifieke factoren. Maar deze non- 
specifieke factoren worden nauwelijks 
bestudeerd in wetenschappelijk on­
derzoek. Wij veronderstellen dat non- 
specifieke factoren waarschijnlijk het 
meest belovend waren in de behande­
ling van psychische klachten. PST zou 
een vehikel kunnen zijn om deze non- 
specifieke factoren meer prominent 
te incorporeren in patiëntcontacten. 
Daarom moedigden wij artsen in op­
leidingen to t huisarts, die deelnamen 
aan de PST training en inmiddels ge­
certificeerd huisarts zijn, aan om hun 
vaardigheden te blijven gebruiken -  al 
dan niet specifiek. De belangrijkste 
aanbevelingen voor verder onderzoek 
waren:
a. Een gerandomiseerd onderzoek 
waarbij de arts-patiëntre laties - 
en andere non-specifieke factoren
-  in alle behandelgroepen even 
optimaal zijn. D it onderzoek ver­
gelijkt dan de e ffec tiv ite it van PST 
met de e ffe c tiv ite it van andere 
behandelingen, waarbij alle behan­
delingen worden gegeven door de 
eigen huisarts van de patiënt;
b. Het meten van non-specifieke 
behandelfactoren in onderzoeken 
van psychologische behandelin­
gen.
De belangrijkste aanbevelingen voor 
huisartsopleidingen waren:
a. Een aantrekkelijk onderzoeks­
programma om de interesse voor 
onderzoek bij artsen in opleiding 
to t huisarts te vergroten;
b. Implementatie van training in PST 
of een psychologische behande­
ling met vergelijkbare elementen;
c. Explicieter onderwijs van non- 
specifieke behandelfactoren.
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focusgroepinterviews.
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op de goede afloop?
Leuke collega's zijn onmisbaar voor 
zowel het werkplezier als het opdoen 
van allerlei praktische tips en ideeën.
Ik bedank mijn (ex-)collega-AIOTHO's 
Erik Bischoff, W outer van Dijk, Rhona 
Eveleigh, Floris van de Laar, Els Licht, 
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niet deed. Lotte, bedankt voor al je 
praktische en zorgzame tips. Annema­
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onze Singaporese hotelkamer -  kamer­
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pseudo-AIOTHO Hiske van Raveste- 
ijn, geweldig om met jou te fantaseren 
over de ideale dokter, dikke buiken en 
kinderen.
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de gang, tijdens de lunch of op congres
(lange leve de fam ily rooms, Saskia!) 
als ook voor alle hulp bij print- of 
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Lieve Wendy en Niels, avondjes met 
jullie staan garant voor geanimeerde 
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al onze tochtjes door de Ooijpolder en
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ontmoetingen met jullie.
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apetrots opjullie! Ik waardeer jullie 
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betrokkenheid. Daarnaast heb ik het 
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geworden, bedankt! Gert, het is super 
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Lieve Madelien, met jou erbij is het 
alleen maar nog gezelliger! Bedankt 
voor je hulp bij de review en onze leuke 
gesprekken.
Lieve mama en papa, jullie hebben me 
altijd enorm gestimuleerd om me te 
ontwikkelen to t wie ik nu ben. Jullie 
optim istische levenskijk en 'niet zeu­
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waardevol. Jullie waren altijd intens 
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Jullie grote enthousiasme voor jullie 
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voor jullie onvoorwaardelijke steun en 
vertrouwen. Ik weet dat jullie er altijd 
voor me zijn.
Lieve Jaap en Huub, jullie zijn mijn 
grootste trots! Wat ontzettend gezellig 
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me, met een beetje mazzel verlies ook 
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